,date,title,stock,close,volume,1_past_close,2_past_close,3_past_close,4_past_close,5_past_close,next_close,next_volume
0,2009-10-21,AMGN Posts Better Than Expected,AMGN,0.021672084967528704,0.2289751478417863,-0.03486082175595495,-0.017612396994921564,-0.008248327293361335,0.02080228346232449,0.021933385378938297,-0.04292947691616267,0.5434942287513116
1,2009-10-30,NY AG Cuomo Accuses Amgen (AMGN) of Giving Kickbacks,AMGN,-0.012341692192354592,0.6969132930044981,0.010799384629207598,-0.012865414640051531,0.0014727739507429671,-0.032758126352747,-0.011961222787459591,-0.022193115868659463,-0.1052600963935516
2,2009-12-15,"NASDAQ's Most Advanced Today (LIMS, ARRY, SGEN, JASO, JAZZ)",AMGN,-0.019521891702870997,0.2749180367099815,0.009767485452797597,0.0019573390164706606,0.0021394894775859097,0.0026825686459908127,-0.009738448601819383,-0.012197415130739908,0.29154387611450017
3,2009-12-18,"Benzinga’s News Roundup (DEER, NPO, AMGN, ITT)",AMGN,0.022352358111794812,0.9479049436479587,-0.008897542942066905,-0.012197415130739908,-0.019521891702870997,0.009767485452797597,0.0019573390164706606,0.016666806206113494,-0.5244247580131962
4,2010-01-06,Celgene’s (CELG) 2010 Guidance To Set The Trend,AMGN,-0.007515012529506926,-0.23693357690160854,-0.008662305288025585,0.020328559219876752,-0.016857660853567324,0.00034772910403346735,-0.002428282073904109,-0.009156720391468753,0.7242606107961629
5,2010-01-07,"Experts To Re-Evaluate Use of Anaemia Drugs, (AMGN, JNJ)",AMGN,-0.009156720391468753,0.7242606107961629,-0.007515012529506926,-0.008662305288025585,0.020328559219876752,-0.016857660853567324,0.00034772910403346735,0.008885978271887307,-0.36596089320837677
6,2010-01-19,Success For Johnson & Johnson’s (JNJ) Stelara ,AMGN,0.0231110608123124,0.18371546961325969,0.0016024915864620848,-0.006545193722150122,0.008923578612402006,-0.01736217277953589,0.004403766130239184,-0.006081641453538622,-0.226881833350836
7,2010-01-21,"Bright 2010 Prospects For US Biotechnology (AMGN, BIIB, CELG, GENZ, GILD)",AMGN,-0.009965183338550898,-0.11953453974674377,-0.006081641453538622,0.0231110608123124,0.0016024915864620848,-0.006545193722150122,0.008923578612402006,-0.0005293378644195545,0.02295284296415656
8,2010-01-25,Amgen Lower Before Earnings (AMGN),AMGN,-0.015724554266728252,0.1259802935853609,-0.0005293378644195545,-0.009965183338550898,-0.006081641453538622,0.0231110608123124,0.0016024915864620848,0.0156170158376292,1.2145280828645415
9,2010-01-25,"Earnings Overview For Companies Reporting Today (ETN, HAL, DGX, ERIC, TXN, AMGN, AAPL)",AMGN,-0.015724554266728252,0.1259802935853609,-0.0005293378644195545,-0.009965183338550898,-0.006081641453538622,0.0231110608123124,0.0016024915864620848,0.0156170158376292,1.2145280828645415
10,2010-01-26,AMGN Reports Mixed 4Q Results,AMGN,0.0156170158376292,1.2145280828645415,-0.015724554266728252,-0.0005293378644195545,-0.009965183338550898,-0.006081641453538622,0.0231110608123124,0.02050135059971714,-0.34846743681242986
11,2010-02-03,California Losing Its Edge In Biopharma,AMGN,-0.002701519691502563,-0.0754872142959705,0.008685271705769715,0.004104250706932433,0.006886908430184802,0.0058885161664787855,0.02050135059971714,-0.026070824354717304,0.34618642871261973
12,2010-02-09,Amgen Sees Favorable Results In Bone Drug Study,AMGN,-0.004351151312850465,2.149433403947678,-0.0038141417406737377,0.0026077831032644827,-0.026070824354717304,-0.002701519691502563,0.008685271705769715,-0.006467487575984365,-0.6786762900246635
13,2010-03-09,"Five Biotech ETFs, Which One Is Worth A Look?",AMGN,0.002603984030513873,0.1556029301703219,0.00646328815019892,0.008279319065277013,-0.0022848668891803925,0.0005277357832935703,-0.0005274574251361575,0.0003462842702326441,-0.09316246025827213
14,2010-05-06,"Top 5 NASDAQ Stocks In The Healthcare Sector With The Highest Sales (AMGN, TEVA, GILD, MYL, BIIB)",AMGN,-0.03268567045774373,0.6273337563875623,-0.004047075071345496,-0.013196663148436039,0.004885687104616787,-0.021846487514089796,0.0070467854705218436,-0.005296980674131535,0.08577908217716113
15,2010-05-20,"Amgen Gets “Outperform” Rating (AMGN, JNJ)   ",AMGN,-0.0419833616176728,0.2543279066169266,0.010791921557962603,-0.002554266693167828,0.002194618823557093,-0.021295906519570584,-0.01272108657811033,-0.009444431837775102,0.4444718555980429
16,2010-05-28,"Afternoon Market Update (AAPL, AMGN, GSK)",AMGN,0.0068049348180259095,0.5247416629127593,0.021247260168329563,-0.041674535110518884,-0.00208882100551,0.0041949713014035606,-0.009444431837775102,-0.019698498361300665,-0.34917366470303857
17,2010-06-01,"Benzinga's After Hours Gainers (AMGN, THC, AGU) ",AMGN,-0.019698498361300665,-0.34917366470303857,0.0068049348180259095,0.021247260168329563,-0.041674535110518884,-0.00208882100551,0.0041949713014035606,0.10500398083696294,2.606622097501926
18,2010-06-02,"Benzinga’s Volume Movers (ISLE, AMGN, TSRA, LAYN)",AMGN,0.10500398083696294,2.606622097501926,-0.019698498361300665,0.0068049348180259095,0.021247260168329563,-0.041674535110518884,-0.00208882100551,-0.008022914296273997,-0.6119983065521937
19,2010-06-02,"Afternoon Market Update (T, VZ, AMGN, ALXN)",AMGN,0.10500398083696294,2.606622097501926,-0.019698498361300665,0.0068049348180259095,0.021247260168329563,-0.041674535110518884,-0.00208882100551,-0.008022914296273997,-0.6119983065521937
20,2010-06-02,Jefferies Reiterates Buy Rating On Amgen (AMGN),AMGN,0.10500398083696294,2.606622097501926,-0.019698498361300665,0.0068049348180259095,0.021247260168329563,-0.041674535110518884,-0.00208882100551,-0.008022914296273997,-0.6119983065521937
21,2010-06-02,"Benzinga’s Top Pre-Market Gainers (DIVX, HERO, AMGN, VVUS, JOYG)",AMGN,0.10500398083696294,2.606622097501926,-0.019698498361300665,0.0068049348180259095,0.021247260168329563,-0.041674535110518884,-0.00208882100551,-0.008022914296273997,-0.6119983065521937
22,2010-06-03,"Top 5 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margins (QLTI, PDLI, TECH, GILD, AMGN)",AMGN,-0.008022914296273997,-0.6119983065521937,0.10500398083696294,-0.019698498361300665,0.0068049348180259095,0.021247260168329563,-0.041674535110518884,-0.023364710185325155,0.018018460812551096
23,2010-06-21,News Summary ,AMGN,0.023913296408862195,-0.06356490568471884,-0.004328932572902566,0.003984059670620876,0.001813975659792133,0.019419276969329546,-0.0005545667489976758,-0.007077354319150797,-0.4273034116964013
24,2010-07-13,"Oppenheimer: Earnings Preview Of GILD, CELG, AMGN, GENZ",AMGN,0.006102239233584106,-0.08167054454863809,-0.002282871538270781,0.006318151186627707,0.016147973987293396,0.001949352072358801,-0.007736783528544455,-0.0026538047355132433,0.044940369555202864
25,2010-07-29,Amgen Beats EPS Estimates (AMGN),AMGN,-0.00725429668941846,0.1947264124236665,-0.013759415774612815,0.015651708778314344,0.01744059752065996,-0.010505026108723947,0.020287395849709178,0.021735111237658478,0.21951797440931564
26,2010-07-29,Amgen Beats On Top And Bottom Line (AMGN),AMGN,-0.00725429668941846,0.1947264124236665,-0.013759415774612815,0.015651708778314344,0.01744059752065996,-0.010505026108723947,0.020287395849709178,0.021735111237658478,0.21951797440931564
27,2010-07-29,Earnings Due On July 29,AMGN,-0.00725429668941846,0.1947264124236665,-0.013759415774612815,0.015651708778314344,0.01744059752065996,-0.010505026108723947,0.020287395849709178,0.021735111237658478,0.21951797440931564
28,2010-07-30,Oppenheimer Thinks Amgen Is Severely Undervalued (AMGN),AMGN,0.021735111237658478,0.21951797440931564,-0.00725429668941846,-0.013759415774612815,0.015651708778314344,0.01744059752065996,-0.010505026108723947,0.006235058318747599,-0.2329919227246232
29,2010-08-16,"Afternoon Market Update (LOW, HD, AMGN)",AMGN,-0.017084938275153005,0.023113626880023164,0.004931564960074297,0.019742989447788295,-0.03643226937645061,0.0010782322525184629,-0.005005432547618427,-0.0022187083286144826,-0.11352472824641358
30,2010-08-16,"Cautious Outlook On Biotech Stocks (GILD, DNDN, AMGN, CELG, BIIB, GENZ)",AMGN,-0.017084938275153005,0.023113626880023164,0.004931564960074297,0.019742989447788295,-0.03643226937645061,0.0010782322525184629,-0.005005432547618427,-0.0022187083286144826,-0.11352472824641358
31,2010-08-16,"Amgen Phase III Immunotherapy Trials Fail; CVM Last Player On Deck This Year (AMGN, TEVA, DNDN, CVM)",AMGN,-0.017084938275153005,0.023113626880023164,0.004931564960074297,0.019742989447788295,-0.03643226937645061,0.0010782322525184629,-0.005005432547618427,-0.0022187083286144826,-0.11352472824641358
32,2010-09-22,Savient Pharmaceuticals Rising On Takeover Rumor (SVNT),AMGN,0.009327353847145448,-0.01486158329286058,-0.0033966385658478204,0.013038816806887787,0.0021776355007880888,-0.0036165143137135702,0.01430672094031471,-0.009773973944402381,-0.09437980674423185
33,2010-10-06,"3 Companies Working Toward Cancer Treatment (DNDN, AMGN, GENZ)",AMGN,-0.005167488258390529,-0.1670147628483193,0.019436814429392157,-0.00828690218499617,0.007258431730852388,0.0030943111732910644,-0.01892877278707006,0.0023285656420015677,0.2657565951610483
34,2010-10-11,Eli Lilly Drug Fails Phase 3 Trial (LLY),AMGN,-0.005142564457765619,-0.030411209531671868,0.007683854822518876,0.0023285656420015677,-0.005167488258390529,0.019436814429392157,-0.00828690218499617,-0.0028521546684666665,0.4434140279823269
35,2010-10-25,Amgen's Third Quarter 2010 Revenue Unchanged; EPS $1.36 ,AMGN,0.006950600300607457,0.3893240343347639,-0.0012151176025885224,-0.0019054636749811227,0.006977091134883651,-0.010869338965304287,0.022041760400494326,-0.01190692710050234,0.36131598254624087
36,2010-10-25,US Stock Futures Up After G-20 Nations Meeting,AMGN,0.006950600300607457,0.3893240343347639,-0.0012151176025885224,-0.0019054636749811227,0.006977091134883651,-0.010869338965304287,0.022041760400494326,-0.01190692710050234,0.36131598254624087
37,2010-10-25,"Stocks To Watch For October 25 (RSH, CCE, AMGN, TXN, LO)",AMGN,0.006950600300607457,0.3893240343347639,-0.0012151176025885224,-0.0019054636749811227,0.006977091134883651,-0.010869338965304287,0.022041760400494326,-0.01190692710050234,0.36131598254624087
38,2010-10-25,"Earnings Scheduled For October 25 (LO, CR, TXN, NS, SNV, RSH, AMGN, IVZ, ROP, HRS, MAS, LUX, WRB, PCL)",AMGN,0.006950600300607457,0.3893240343347639,-0.0012151176025885224,-0.0019054636749811227,0.006977091134883651,-0.010869338965304287,0.022041760400494326,-0.01190692710050234,0.36131598254624087
39,2010-10-26,"US Stock Futures Down As Investors Await Earnings, Consumer Confidence Data",AMGN,-0.01190692710050234,0.36131598254624087,0.006950600300607457,-0.0012151176025885224,-0.0019054636749811227,0.006977091134883651,-0.010869338965304287,-0.004016773600416523,-0.19602030975208484
40,2010-10-26,"Stocks To Watch For October 26 (F, TXN, DD, AMGN, BMY)",AMGN,-0.01190692710050234,0.36131598254624087,0.006950600300607457,-0.0012151176025885224,-0.0019054636749811227,0.006977091134883651,-0.010869338965304287,-0.004016773600416523,-0.19602030975208484
41,2010-10-26,A Peek Into The Market Before The Trading Starts,AMGN,-0.01190692710050234,0.36131598254624087,0.006950600300607457,-0.0012151176025885224,-0.0019054636749811227,0.006977091134883651,-0.010869338965304287,-0.004016773600416523,-0.19602030975208484
42,2010-12-06,ETFs For Biotech M&A Mania,AMGN,-0.006141765582512226,-0.4277167654411145,-0.002043135942391361,0.005979487334932365,0.01575194038334815,-0.011815114145275474,-0.004481168472035724,-0.0050562394030766455,0.43244171779141105
43,2011-01-06,Amgen and Xencor Enter Option Deal (AMGN),AMGN,-0.0031726002018779287,-0.21761862917398944,-0.00035235676923495163,0.021602172860079927,0.011839589413774387,-0.011345352008505505,-0.006085697806129331,0.007603685966571128,0.31431459538383777
44,2011-01-24,Amgen Reports Q4 EPS $1.17 vs. $1.10,AMGN,0.005616837427656174,-0.06383331399492786,-0.005932696838367391,0.005791544057360376,-0.005410902203556778,0.013982265681129924,0.0031958780647636242,-0.002268865438240786,0.5836254824887568
45,2011-01-24,Amgen to Acquire BioVex for up to $1.0B,AMGN,0.005616837427656174,-0.06383331399492786,-0.005932696838367391,0.005791544057360376,-0.005410902203556778,0.013982265681129924,0.0031958780647636242,-0.002268865438240786,0.5836254824887568
46,2011-01-24,"US Stock Futures Mixed As Investors Await Earnings Reports, McDonald's In Focus",AMGN,0.005616837427656174,-0.06383331399492786,-0.005932696838367391,0.005791544057360376,-0.005410902203556778,0.013982265681129924,0.0031958780647636242,-0.002268865438240786,0.5836254824887568
47,2011-01-25,"CEL-SCI Corp. (CVM) moving due to (AMGN) buying private company BIOVEX  in 1 billion dollar deal, same space as CVM in head and neck phase 3  , $1 billion dollar deal would value cvm @ $4 plus a share",AMGN,-0.002268865438240786,0.5836254824887568,0.005616837427656174,-0.005932696838367391,0.005791544057360376,-0.005410902203556778,0.013982265681129924,-0.011896529936268219,-0.2359570661896243
48,2011-02-16,"Benzinga's Top Pre-Market NASDAQ Losers (WRES, LOGM, ARMH, AMGN)",AMGN,-0.016530454425396024,1.2285630954695703,-0.00037126335821291434,0.0022327448288486096,-0.00976608708805382,-0.0029391921494273943,-0.009282840075674814,-0.010198129717518545,-0.22186450290101645
49,2011-02-18,ETF Showdown: A Biotech Battle,AMGN,-0.003243682611230092,0.10756172493440674,-0.010198129717518545,-0.016530454425396024,-0.00037126335821291434,0.0022327448288486096,-0.00976608708805382,-0.0068916461675727625,-0.34460765952277306
50,2011-03-04,Amgen Files Mixed Security Shelf,AMGN,-0.0009546148195863635,-0.11211030256606669,0.019069873753281952,-0.010017531743710784,0.011299512441795612,-0.017795585599241326,0.025711540957335854,-0.011085800690495362,0.09291371188984932
51,2011-03-04,Amgen Completes Acquisition of BioVex ,AMGN,-0.0009546148195863635,-0.11211030256606669,0.019069873753281952,-0.010017531743710784,0.011299512441795612,-0.017795585599241326,0.025711540957335854,-0.011085800690495362,0.09291371188984932
52,2011-03-17,"Benzinga's Volume Movers (JOBS, GLNG, PANL, AMGN)",AMGN,0.016511539604145087,0.06336264109140632,-0.005848396754491891,-0.00971609137826146,-0.00018701584474956068,0.032600178891585285,-0.012195275845664821,-0.011575832688729859,0.20450492726419522
53,2011-03-23,Amgen Announces Prolia Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial,AMGN,-0.001704919882480338,-0.18567472306142996,-0.00583925300883259,0.002833397433398499,-0.011575832688729859,0.016511539604145087,-0.005848396754491891,0.011007758025751269,0.12483713534880647
54,2011-03-23,"Amgen Announces Treatment With Prolia Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate ",AMGN,-0.001704919882480338,-0.18567472306142996,-0.00583925300883259,0.002833397433398499,-0.011575832688729859,0.016511539604145087,-0.005848396754491891,0.011007758025751269,0.12483713534880647
55,2011-03-30,Amgen Announces Top-Line Results of Pivotal Phase 3 Motesanib Trial in Advanced Non-Squamous Non-Small Cell Lung Cancer Patients Did Not Meet Primary Objective ,AMGN,0.008796585752490538,0.2776968746499384,0.014814762087985045,-0.00940759651151224,-0.0022525407219521343,0.011007758025751269,-0.001704919882480338,-0.00834870226174933,-0.013435910924075034
56,2011-03-30,Amgen to Appeal CHMP Opinion on Vectibix Use With Chemotherapy in Metastatic Colorectal Cancer in Europe ,AMGN,0.008796585752490538,0.2776968746499384,0.014814762087985045,-0.00940759651151224,-0.0022525407219521343,0.011007758025751269,-0.001704919882480338,-0.00834870226174933,-0.013435910924075034
57,2011-04-08,Amgen Acquires Brazilian Pharmaceutical Company Bergamo for $215M,AMGN,-0.0012972960632610109,0.003289025994646755,-0.0011102855101327025,-0.0007398326185669157,0.0007403803761192318,0.01789719125401046,-0.006922065009090095,0.0076067266235051445,0.4304447107232483
58,2011-04-08,Amgen Establishes Commercial Operations in Brazil ,AMGN,-0.0012972960632610109,0.003289025994646755,-0.0011102855101327025,-0.0007398326185669157,0.0007403803761192318,0.01789719125401046,-0.006922065009090095,0.0076067266235051445,0.4304447107232483
59,2011-04-20,Amgen Reports EPS $1.34 vs. $1.29 Estimate; Revenues $3.71B vs. $3.68B Estimate (AMGN),AMGN,0.018122544675565733,0.2321428571428572,-0.0007241462855451797,-0.005224550420550811,0.012401694994444323,-0.002001668165823034,0.005858498968535741,-0.04432194425132452,1.3845010702550886
60,2011-04-20,"Earnings Preview: Amgen (AMGN, BIIB, DNDN)",AMGN,0.018122544675565733,0.2321428571428572,-0.0007241462855451797,-0.005224550420550811,0.012401694994444323,-0.002001668165823034,0.005858498968535741,-0.04432194425132452,1.3845010702550886
61,2011-04-20,Amgen Rising After Earnings (AMGN),AMGN,0.018122544675565733,0.2321428571428572,-0.0007241462855451797,-0.005224550420550811,0.012401694994444323,-0.002001668165823034,0.005858498968535741,-0.04432194425132452,1.3845010702550886
62,2011-04-21,Amgen Says Will Institute Dividend This Year (AMGN),AMGN,-0.04432194425132452,1.3845010702550886,0.018122544675565733,-0.0007241462855451797,-0.005224550420550811,0.012401694994444323,-0.002001668165823034,0.018625099109856658,-0.3910209495929009
63,2011-04-21,Amgen Guides FY2015 Revenues $16-$18B; Adj. EPS of $7.25-$8.60; Authorized to Repurchase $5B in Amgen Shares (AMGN),AMGN,-0.04432194425132452,1.3845010702550886,0.018122544675565733,-0.0007241462855451797,-0.005224550420550811,0.012401694994444323,-0.002001668165823034,0.018625099109856658,-0.3910209495929009
64,2011-04-21,UPDATE: Amgen CEO Says Will Institute Dividend of 20% of Net Income This Year (AMGN),AMGN,-0.04432194425132452,1.3845010702550886,0.018122544675565733,-0.0007241462855451797,-0.005224550420550811,0.012401694994444323,-0.002001668165823034,0.018625099109856658,-0.3910209495929009
65,2011-04-28,Five Cash-Generating Dividend Stocks to Consider,AMGN,0.005632209559830015,-0.2464962211805224,0.010671905321415043,0.027976297478380152,0.018625099109856658,-0.04432194425132452,0.018122544675565733,-0.0050753335143438605,2.1581787306978146
66,2011-05-10,Amgen CEO Guides 2015 EPS $7.25+/Share (AMGN),AMGN,0.010573592803927001,0.30130486358244357,0.0010414635400015637,0.0036571567537457828,-0.004507937621208491,0.003130202458270004,0.0020916436607933964,0.009605533892130591,0.5263615356893006
67,2011-05-17,Prostate Cancer Drug From Amgen Eases Pain While Slowing Spread -Bloomberg (AMGN),AMGN,0.017207063409777845,0.1740944170200931,-0.0100880017353292,0.013577011276256101,0.013591461909009617,0.009605533892130591,0.010573592803927001,0.004598604753201174,-0.5615562266832475
68,2011-05-17,UPDATE: Amgen Announces Phase 3 Data Demonstrate XGEVA is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men With Advanced Prostate Cancer,AMGN,0.017207063409777845,0.1740944170200931,-0.0100880017353292,0.013577011276256101,0.013591461909009617,0.009605533892130591,0.010573592803927001,0.004598604753201174,-0.5615562266832475
69,2011-05-20,EMA Adopts Positive Opinion For Xgeva -Bloomberg,AMGN,-0.0029488370340491343,0.5695121951219513,-0.0021253710419119054,0.004598604753201174,0.017207063409777845,-0.0100880017353292,0.013577011276256101,-0.006572408218133652,-0.20404798453578943
70,2011-05-20,Amgen Receives CHMP Positive Opinion for XGEVA in the European Union,AMGN,-0.0029488370340491343,0.5695121951219513,-0.0021253710419119054,0.004598604753201174,0.017207063409777845,-0.0100880017353292,0.013577011276256101,-0.006572408218133652,-0.20404798453578943
71,2011-05-20,Amgen Receives CHMP Positive Opinion for XGEVA,AMGN,-0.0029488370340491343,0.5695121951219513,-0.0021253710419119054,0.004598604753201174,0.017207063409777845,-0.0100880017353292,0.013577011276256101,-0.006572408218133652,-0.20404798453578943
72,2011-06-08,Health Canada Approves Amgen's Xgeva™ for Reducing Risk of Developing Skeletal-Related Events in Patients with Bone Metastases from Solid Tumours,AMGN,0.0020396539159426297,-0.02943557865594071,0.003925185288562449,-0.001533586569308576,-0.009451606332044227,-0.007537690386791862,-0.013874893267931787,-0.0011874415967715324,0.4430301399354144
73,2011-06-24,Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease,AMGN,-0.015363890311504202,1.5955754141238012,-0.0037832253876918243,-0.00034349051495774496,-0.004790572947851901,0.007585068067640366,-0.005656184152458943,0.014726714293750387,-0.5558382667842298
74,2011-06-24,Amgen Receives Positive CHMP Opinion for Vectibix in Combination With Chemotherapy ,AMGN,-0.015363890311504202,1.5955754141238012,-0.0037832253876918243,-0.00034349051495774496,-0.004790572947851901,0.007585068067640366,-0.005656184152458943,0.014726714293750387,-0.5558382667842298
75,2011-06-27,Amgen Submits Application to Expand Indication for XGEVA to Prevent or Delay Spread of Prostate Cancer to the Bone ,AMGN,0.014726714293750387,-0.5558382667842298,-0.015363890311504202,-0.0037832253876918243,-0.00034349051495774496,-0.004790572947851901,0.007585068067640366,0.013303148910685625,-0.22991700224982514
76,2011-06-29,Wednesday's S&P 500 Sector Recap 6/29/11,AMGN,-0.014833646133380896,0.8490376117057841,0.013303148910685625,0.014726714293750387,-0.015363890311504202,-0.0037832253876918243,-0.00034349051495774496,0.00986515226257878,-0.3268406028015668
77,2011-07-05,Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss,AMGN,-0.006177149339482657,-0.13409854423292278,-0.001199739780699982,0.00986515226257878,-0.014833646133380896,0.013303148910685625,0.014726714293750387,-0.003798249926121544,0.09988145274275251
78,2011-07-15,Amgen Announces XGEVA Granted Marketing Authorization in the European Union ,AMGN,-0.011314695808981923,0.2788246566592143,-0.016428233941272574,-0.005096740076722228,0.0,-0.012838121829269356,-0.0046626384496440965,-0.007084583216528384,-0.3222212570038657
79,2011-07-20,Five Health Care ETFs Your Broker Forget To Mention,AMGN,-0.005066294304299279,-0.16590315451074944,0.011160197290625673,-0.007084583216528384,-0.011314695808981923,-0.016428233941272574,-0.005096740076722228,0.009092628598134755,0.33442536073037354
80,2011-07-21,Biogen IDEC Earnings Preview: Analysts Expect Falling Revenue Over Last Quarter,AMGN,0.009092628598134755,0.33442536073037354,-0.005066294304299279,0.011160197290625673,-0.007084583216528384,-0.011314695808981923,-0.016428233941272574,-0.004865891464548744,-0.4406816376633692
81,2011-07-26,"Amgen Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",AMGN,-0.0036424902207198295,0.3951041240036546,-0.005794936721570609,-0.004865891464548744,0.009092628598134755,-0.005066294304299279,0.011160197290625673,-0.016453756985915557,0.4684973578429159
82,2011-07-27,Check Out The Chart: An Unhealthy Biotech ETF?,AMGN,-0.016453756985915557,0.4684973578429159,-0.0036424902207198295,-0.005794936721570609,-0.004865891464548744,0.009092628598134755,-0.005066294304299279,-0.006877414888984856,0.012809866519037927
83,2011-07-28,Pfizer Earnings Preview: Analysts Expect Falling EPS,AMGN,-0.006877414888984856,0.012809866519037927,-0.016453756985915557,-0.0036424902207198295,-0.005794936721570609,-0.004865891464548744,0.009092628598134755,0.02376990245542454,0.6155539697241159
84,2011-07-29,Stocks To Watch For July 29,AMGN,0.02376990245542454,0.6155539697241159,-0.006877414888984856,-0.016453756985915557,-0.0036424902207198295,-0.005794936721570609,-0.004865891464548744,-0.017002146725743517,-0.1658521456363602
85,2011-07-29,Amgen's Profit Falls in Second Quarter,AMGN,0.02376990245542454,0.6155539697241159,-0.006877414888984856,-0.016453756985915557,-0.0036424902207198295,-0.005794936721570609,-0.004865891464548744,-0.017002146725743517,-0.1658521456363602
86,2011-07-29,US Stock Futures Down On Debt Worries,AMGN,0.02376990245542454,0.6155539697241159,-0.006877414888984856,-0.016453756985915557,-0.0036424902207198295,-0.005794936721570609,-0.004865891464548744,-0.017002146725743517,-0.1658521456363602
87,2011-07-29,Earnings Scheduled For July 29,AMGN,0.02376990245542454,0.6155539697241159,-0.006877414888984856,-0.016453756985915557,-0.0036424902207198295,-0.005794936721570609,-0.004865891464548744,-0.017002146725743517,-0.1658521456363602
88,2011-08-18,Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research Meeting ,AMGN,-0.005413784071975569,0.24396019680740122,0.008777443078725744,-0.0009747298524821479,0.0320002538162536,0.007252094199658776,0.028382165816453586,0.010497403789432092,-0.06918251400615483
89,2011-08-22,Amgen Announces PDUFA Date for XGEVA Supplemental Biologics License Application ,AMGN,0.006348765408147772,-0.015598177386881407,0.010497403789432092,-0.005413784071975569,0.008777443078725744,-0.0009747298524821479,0.0320002538162536,0.025042853117152486,-0.15965898081767105
90,2011-09-14,S&P Likes Three Health Care ETFs,AMGN,0.006374042387237822,0.2262443438914028,0.015723086292513733,0.0003702864887382695,-0.022961883898626634,-0.0012635837558724328,0.015774084016563883,0.018096335706846878,-0.03200777543489719
91,2011-09-19,Amgen Announces FDA Approves New Indications for Prolia for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy ,AMGN,-0.003174503134166784,-0.4051944309832223,0.00799901402035097,0.018096335706846878,0.006374042387237822,0.015723086292513733,0.0003702864887382695,0.014859418380502865,0.13817325053948126
92,2011-10-13,Deutsche Bank Comments on Amgen's Restructuring Rumors,AMGN,0.006002664044450823,0.13886746837289765,-0.007882360864252314,-0.004880349338137968,0.01954876574801001,-0.009854430153993787,0.016092243009740326,0.008950494623636729,-0.4018739477344264
93,2011-10-13,Amgen Announces 2011 Fourth Quarter Dividend of $0.28/Share,AMGN,0.006002664044450823,0.13886746837289765,-0.007882360864252314,-0.004880349338137968,0.01954876574801001,-0.009854430153993787,0.016092243009740326,0.008950494623636729,-0.4018739477344264
94,2011-10-14,"Johnson & Johnson Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",AMGN,0.008950494623636729,-0.4018739477344264,0.006002664044450823,-0.007882360864252314,-0.004880349338137968,0.01954876574801001,-0.009854430153993787,-0.01826415278002036,-0.04901480846897566
95,2011-10-24,Amgen's Profit Drops,AMGN,0.00614458868694312,-0.30499125309293784,0.023048888986366256,-0.0008723435300045379,0.0006983265123039484,0.014883023701943277,-0.01826415278002036,-0.04206960049613173,0.7407877729653733
96,2011-10-24,Amgen Announces Buyback Authorization of $10B,AMGN,0.00614458868694312,-0.30499125309293784,0.023048888986366256,-0.0008723435300045379,0.0006983265123039484,0.014883023701943277,-0.01826415278002036,-0.04206960049613173,0.7407877729653733
97,2011-10-24,US Stock Futures Flat As Investors Await Earnings Reports,AMGN,0.00614458868694312,-0.30499125309293784,0.023048888986366256,-0.0008723435300045379,0.0006983265123039484,0.014883023701943277,-0.01826415278002036,-0.04206960049613173,0.7407877729653733
98,2011-10-24,Earnings Scheduled For October 24,AMGN,0.00614458868694312,-0.30499125309293784,0.023048888986366256,-0.0008723435300045379,0.0006983265123039484,0.014883023701943277,-0.01826415278002036,-0.04206960049613173,0.7407877729653733
99,2011-10-25,"Biogen Idec Earnings Preview: Analysts Expect Higher EPS, Revenue",AMGN,-0.04206960049613173,0.7407877729653733,0.00614458868694312,0.023048888986366256,-0.0008723435300045379,0.0006983265123039484,0.014883023701943277,0.008499935757245725,-0.1288183724777574
100,2011-10-27,"Pfizer Earnings Preview: Analysts Expect Higher EPS, Revenue",AMGN,0.01949080383685331,-0.11232393313197164,0.008499935757245725,-0.04206960049613173,0.00614458868694312,0.023048888986366256,-0.0008723435300045379,-0.014122929427917263,0.014638008287572113
101,2011-11-02,Piper Jaffray Maintains Overweight Rating and $72 PT on Amgen ,AMGN,-0.013323226816529976,-0.14627466673336165,-0.03020776301323902,0.0005235307865361083,-0.014122929427917263,0.01949080383685331,0.008499935757245725,0.016423035463995594,-0.2973384698765179
102,2011-11-07,UPDATE: Amgen Announces Plan to Launch Tender Offer of up to $5B and Launch of Senior Notes Offering ,AMGN,0.05909048083823376,4.6992510729011805,-0.009515430100153877,0.016423035463995594,-0.013323226816529976,-0.03020776301323902,0.0005235307865361083,-0.007359387822531982,-0.5634400346483975
103,2011-11-15,Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union,AMGN,-0.008063381297757632,0.3244371383906268,-0.009160114703298583,-0.0017253332840003743,0.007824974840843657,-0.008448348140926765,-0.007359387822531982,-0.010248971313870259,1.45010951569725
104,2011-11-15,"Financial Breakfast: Morning News Summary for November 15, 2011",AMGN,-0.008063381297757632,0.3244371383906268,-0.009160114703298583,-0.0017253332840003743,0.007824974840843657,-0.008448348140926765,-0.007359387822531982,-0.010248971313870259,1.45010951569725
105,2011-11-15,A Peek Into The Market Before The Trading Starts,AMGN,-0.008063381297757632,0.3244371383906268,-0.009160114703298583,-0.0017253332840003743,0.007824974840843657,-0.008448348140926765,-0.007359387822531982,-0.010248971313870259,1.45010951569725
106,2011-11-18,"PiperJaffray Reiterates ""Overweight"" On DaVita",AMGN,-0.006081237171339571,-0.43309349564289157,-0.0017851181490943224,-0.010248971313870259,-0.008063381297757632,-0.009160114703298583,-0.0017253332840003743,-0.010797341737036392,0.4436920625724219
107,2011-11-22,Amgen Announces Enbrel Patent Issued ,AMGN,0.01255218058990204,0.19880107351576415,-0.010797341737036392,-0.006081237171339571,-0.0017851181490943224,-0.010248971313870259,-0.008063381297757632,-0.012935808157323092,-0.3695470237472539
108,2011-12-02,Seven Stocks Insiders Are Buying,AMGN,0.0017242207016514577,-0.25779680927659254,0.0015538765227067763,0.03152862391193212,0.004293423867146373,0.022872715733810667,-0.005278387935895412,-0.010326642759307725,0.5753727152047381
109,2011-12-06,UPDATE: Amgen and FDA Agree to Modify Nplate Risk Evaluation and Mitigation Strategy,AMGN,0.006782241893598551,0.2761199471726854,-0.010326642759307725,0.0017242207016514577,0.0015538765227067763,0.03152862391193212,0.004293423867146373,0.007773033495638293,0.18498412698412703
110,2011-12-08,Amgen Announces Preliminary Results of Its Tender Offer,AMGN,0.0010286602638494013,1.2269938650306749,0.007773033495638293,0.006782241893598551,-0.010326642759307725,0.0017242207016514577,0.0015538765227067763,0.0032535113038962837,-0.8298314627016493
111,2011-12-08,Amgen Announces Preliminary Results of Its Tender Offer ,AMGN,0.0010286602638494013,1.2269938650306749,0.007773033495638293,0.006782241893598551,-0.010326642759307725,0.0017242207016514577,0.0015538765227067763,0.0032535113038962837,-0.8298314627016493
112,2011-12-13,Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate,AMGN,0.004723416945970449,-0.3274896326723138,-0.024406625854827224,0.0032535113038962837,0.0010286602638494013,0.007773033495638293,0.006782241893598551,0.0033081974499842293,-0.017008591969139064
113,2011-12-14,Amgen Announces Final Results of Its Tender Offer; Accepted 83.33M Shares at $60/Share,AMGN,0.0033081974499842293,-0.017008591969139064,0.004723416945970449,-0.024406625854827224,0.0032535113038962837,0.0010286602638494013,0.007773033495638293,0.01735512455485888,0.29083422523486746
114,2011-12-15,"Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012",AMGN,0.01735512455485888,0.29083422523486746,0.0033081974499842293,0.004723416945970449,-0.024406625854827224,0.0032535113038962837,0.0010286602638494013,0.02439422260572144,1.4632932966362264
115,2011-12-15,Amgen Announces 2012 First Quarter Dividend Boost of 29%,AMGN,0.01735512455485888,0.29083422523486746,0.0033081974499842293,0.004723416945970449,-0.024406625854827224,0.0032535113038962837,0.0010286602638494013,0.02439422260572144,1.4632932966362264
116,2011-12-15,Hearing Goldman Sach Note Saying Amgen Should Buy Dendreon,AMGN,0.01735512455485888,0.29083422523486746,0.0033081974499842293,0.004723416945970449,-0.024406625854827224,0.0032535113038962837,0.0010286602638494013,0.02439422260572144,1.4632932966362264
117,2011-12-19,Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars,AMGN,0.001998481698818555,-0.6253944508076015,0.02439422260572144,0.01735512455485888,0.0033081974499842293,0.004723416945970449,-0.024406625854827224,0.01645325981703727,-0.09086484462748035
118,2011-12-19,"End-of-Day Market Summary for December 19, 2011",AMGN,0.001998481698818555,-0.6253944508076015,0.02439422260572144,0.01735512455485888,0.0033081974499842293,0.004723416945970449,-0.024406625854827224,0.01645325981703727,-0.09086484462748035
119,2011-12-20,"Jefferies Reiterates Hold, $70 PT On Watson Pharmaceuticals",AMGN,0.01645325981703727,-0.09086484462748035,0.001998481698818555,0.02439422260572144,0.01735512455485888,0.0033081974499842293,0.004723416945970449,0.03237444558131597,0.4601024036019712
120,2011-12-29,Bank of America Raises PO on Amgen to $65,AMGN,0.011562277332856974,-0.10201742320036677,-0.006519759063664754,0.011461630303826187,0.005526161326946166,0.003167071724485604,0.03237444558131597,-0.008186391065675758,0.45011772047768983
121,2011-12-30,From Earlier: FDA to Review Potential New Use of XGEVA at Oncologic Drugs Advisory Committee Meeting  ,AMGN,-0.008186391065675758,0.45011772047768983,0.011562277332856974,-0.006519759063664754,0.011461630303826187,0.005526161326946166,0.003167071724485604,-0.0015573855136480352,0.9985524539817296
122,2012-01-09,Just What The Doctor Ordered: 4 ETFs For Biotech M&A,AMGN,-0.008647475405740734,0.6435624141764207,0.0054342792835220255,0.010194250501369018,-0.0054592327306054456,-0.0015573855136480352,-0.008186391065675758,0.022896917335470945,-0.18433790862674893
123,2012-01-10,Dako and Amgen to Collaborate in Development of a Companion Diagnostic for an Amgen Investigational Cancer Therapy,AMGN,0.022896917335470945,-0.18433790862674893,-0.008647475405740734,0.0054342792835220255,0.010194250501369018,-0.0054592327306054456,-0.0015573855136480352,0.011116522003945084,-0.19356149906511666
124,2012-01-24,"Benzinga's M&A Chatter for Tuesday January 24, 2012",AMGN,0.0060487318383057875,-0.2819022165892904,-0.025729343395575976,0.006219077678136564,-0.0011557465561211622,0.01689473946643738,0.006952515608942056,0.01495800085093646,0.23477727046003904
125,2012-01-26,"Benzinga's M&A Chatter for Thursday January 26, 2012",AMGN,-0.01632669062628156,0.09328195885898949,0.01495800085093646,0.0060487318383057875,-0.025729343395575976,0.006219077678136564,-0.0011557465561211622,0.0038186073087986827,0.4691479081400636
126,2012-01-26,Amgen to Acquire Micromet for $11 per Share Totaling $1.16B ,AMGN,-0.01632669062628156,0.09328195885898949,0.01495800085093646,0.0060487318383057875,-0.025729343395575976,0.006219077678136564,-0.0011557465561211622,0.0038186073087986827,0.4691479081400636
127,2012-01-26,Micromet Up 33% After Acquisition Announcement,AMGN,-0.01632669062628156,0.09328195885898949,0.01495800085093646,0.0060487318383057875,-0.025729343395575976,0.006219077678136564,-0.0011557465561211622,0.0038186073087986827,0.4691479081400636
128,2012-01-30,"Amid Rising Repurchases, Are Buyback ETFs Worth A Look?",AMGN,-0.00014579894214350464,-0.3975585455741384,0.0038186073087986827,-0.01632669062628156,0.01495800085093646,0.0060487318383057875,-0.025729343395575976,-0.005854298178742057,0.611053130168109
129,2012-02-06,Dendreon Rockets 17% After Critical Reveiw For Amgen's Cancer Drug,AMGN,-0.0023091981568659214,0.7987233526397186,-0.004883538474450666,-0.0031499615830840044,0.02811717168664818,-0.005854298178742057,-0.00014579894214350464,0.0007229730474764828,-0.42086097460234506
130,2012-02-06,Piper Jaffray Postive on Amgen After FDA Releases Briefing Documents on Xgeva,AMGN,-0.0023091981568659214,0.7987233526397186,-0.004883538474450666,-0.0031499615830840044,0.02811717168664818,-0.005854298178742057,-0.00014579894214350464,0.0007229730474764828,-0.42086097460234506
131,2012-02-08,Amgen to Discuss Application for New Use of XGEVA at FDA Oncologic Drugs Advisory Committee Meeting  ,AMGN,-0.016047441543745378,0.5897824030274361,0.0007229730474764828,-0.0023091981568659214,-0.004883538474450666,-0.0031499615830840044,0.02811717168664818,-0.017925370989385958,-0.1632303663962793
132,2012-02-08,Deutsche Bank: Xgeva Not Proceeding Well for Amgen,AMGN,-0.016047441543745378,0.5897824030274361,0.0007229730474764828,-0.0023091981568659214,-0.004883538474450666,-0.0031499615830840044,0.02811717168664818,-0.017925370989385958,-0.1632303663962793
133,2012-02-14,Amgen Names Michael Severino Corporate Chief Medical Officer  ,AMGN,-0.005278556257951816,-0.02990463215258854,0.017910323018679897,0.007779888369400245,-0.017925370989385958,-0.016047441543745378,0.0007229730474764828,0.0008843533816813576,-0.05299253329588283
134,2012-02-15,Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet ,AMGN,0.0008843533816813576,-0.05299253329588283,-0.005278556257951816,0.017910323018679897,0.007779888369400245,-0.017925370989385958,-0.016047441543745378,0.014580538134121523,0.34756172915791295
135,2012-02-17,"Friday Slide: Opportunity Or Red Flag For Biotech ETFs? (GILD, IBB, XBI)",AMGN,-0.01611267619686141,-0.08866308394930389,0.014580538134121523,0.0008843533816813576,-0.005278556257951816,0.017910323018679897,0.007779888369400245,-0.01608157538267352,0.1900295852033731
136,2012-03-02,Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet and Commencement of Subsequent Offering,AMGN,0.002071572241455266,-0.35451953714573203,-0.006175667901166082,-0.002053956991117989,0.010527553463030914,-0.004281875193307028,0.00579153969443813,-0.0073821754931592265,0.2834827227851391
137,2012-03-07,Amgen Completes Tender Offer for Outstanding Shares of Micromet,AMGN,0.006161563386198443,-0.4668670294858257,-0.010263577121949585,-0.0073821754931592265,0.002071572241455266,-0.006175667901166082,-0.002053956991117989,0.01269635848552264,0.17862693116372608
138,2012-04-02,Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio ,AMGN,0.002059618444158362,0.16882275166567284,0.009655813273297342,-0.005319410689106241,-0.0019168353279034323,0.004294669234421233,0.012901172913852399,-0.002642987838427091,0.06245979815903291
139,2012-04-04,From Earlier: UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis  ,AMGN,-0.0011775013105254084,-0.2479488945951024,-0.002642987838427091,0.002059618444158362,0.009655813273297342,-0.005319410689106241,-0.0019168353279034323,0.0025053356162787477,0.07098045747279591
140,2012-04-10,"Benzinga's M&A Chatter for Tuesday April 10, 2012",AMGN,-0.012384552522988868,0.430495378393992,-0.014701334766626495,0.0025053356162787477,-0.0011775013105254084,-0.002642987838427091,0.002059618444158362,0.008158505488786494,-0.2092935207854817
141,2012-04-10,Amgen to Acquire KAI for $315M,AMGN,-0.012384552522988868,0.430495378393992,-0.014701334766626495,0.0025053356162787477,-0.0011775013105254084,-0.002642987838427091,0.002059618444158362,0.008158505488786494,-0.2092935207854817
142,2012-04-10,Market Roundup,AMGN,-0.012384552522988868,0.430495378393992,-0.014701334766626495,0.0025053356162787477,-0.0011775013105254084,-0.002642987838427091,0.002059618444158362,0.008158505488786494,-0.2092935207854817
143,2012-04-10,Amgen Acquires KAI Pharmaceuticals,AMGN,-0.012384552522988868,0.430495378393992,-0.014701334766626495,0.0025053356162787477,-0.0011775013105254084,-0.002642987838427091,0.002059618444158362,0.008158505488786494,-0.2092935207854817
144,2012-04-10,Amgen To Acquire KAI Pharmaceuticals For $315M,AMGN,-0.012384552522988868,0.430495378393992,-0.014701334766626495,0.0025053356162787477,-0.0011775013105254084,-0.002642987838427091,0.002059618444158362,0.008158505488786494,-0.2092935207854817
145,2012-04-24,Baidu Down After Earnings; Amgen Flat and Panera Rising,AMGN,0.004978830939768031,0.38418350073355145,-0.0026285757897777096,0.019961184619689654,-0.00029788880528902606,-0.002969666553908179,0.0164502575255685,0.02273049779873393,0.19465563278367748
146,2012-04-25,"Benzinga's M&A Chatter for Wednesday April 25, 2012",AMGN,0.02273049779873393,0.19465563278367748,0.004978830939768031,-0.0026285757897777096,0.019961184619689654,-0.00029788880528902606,-0.002969666553908179,0.008548454756134527,-0.08305608162290357
147,2012-04-25,From Earlier: Amgen to Acquire Mustafa Nevzat; Company Valued at $700M,AMGN,0.02273049779873393,0.19465563278367748,0.004978830939768031,-0.0026285757897777096,0.019961184619689654,-0.00029788880528902606,-0.002969666553908179,0.008548454756134527,-0.08305608162290357
148,2012-05-15,"S&P Bullish On Biotech ETFs (FBT, IBB, XBI)",AMGN,0.006837809717719079,-0.070729668600649,-0.0031245756010916947,0.009844415150396912,0.006751299093155527,-0.015275992580313869,0.015658804496401224,0.0042443493746482375,-0.09759517447551525
149,2012-05-17,From Earlier: Amgen Announces Analysis Of Rilotumumab Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer ,AMGN,-0.00619857557863801,0.6371152154793316,0.0042443493746482375,0.006837809717719079,-0.0031245756010916947,0.009844415150396912,0.006751299093155527,-0.019705157193683598,0.03873428602127427
152,2012-05-21,"The Definitive Biotech ETF Guide (IBB, XBI, FBT)",AMGN,0.002458385093528914,-0.2674941815360745,-0.019705157193683598,-0.00619857557863801,0.0042443493746482375,0.006837809717719079,-0.0031245756010916947,-0.005914625738403401,0.2780013650591917
153,2012-05-22,Health Care SPDR In Focus Ahead Of Obamacare Decision,AMGN,-0.005914625738403401,0.2780013650591917,0.002458385093528914,-0.019705157193683598,-0.00619857557863801,0.0042443493746482375,0.006837809717719079,-0.007690959483369064,-0.16047586600615094
154,2012-06-01,"ETF Showdown: Calling On Convertibles (CWB, CVRT)",AMGN,-0.025460167493279173,-0.28834261767261204,-0.0010060671106878472,0.004474546679257507,0.0033310431683357677,-0.0007236632422732425,0.01052922304082915,0.014022095143776614,0.10271693596648723
155,2012-06-08,Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial ,AMGN,-0.0033287781479168776,0.0233335576944651,-0.012575089302426123,0.022352322059020713,-0.003639091103311176,0.014022095143776614,-0.025460167493279173,-0.015681434118278714,0.06825107978338552
156,2012-06-20,West Announces Technology Agreement With Amgen  ,AMGN,-0.0031498004088914566,-0.09163320387071294,0.013885271048089676,0.010240072697921487,0.01235406925276239,0.02324947619579576,0.0029145356300239733,-0.01566178388510775,0.46464719665676246
157,2012-06-25,"Ahead of Obamacare Ruling, S&P Likes Health Care SPDR",AMGN,-0.014766274100307508,-0.7947814196065128,0.011304852916067532,-0.01566178388510775,-0.0031498004088914566,0.013885271048089676,0.010240072697921487,0.0009802072373763515,-0.04930395929646947
158,2012-07-05,Small-Cap Corner: A Forgotten Biotech ETF,AMGN,-0.01104323561344478,0.060493665069257574,0.010758834254623428,0.019887296218177974,0.020862818913322645,-0.01312722175270109,0.01273443763991322,-0.006457674470078945,-0.039555541799498606
162,2012-07-16,"3 Unheralded ETFs Up More Than 10% in the Past 90 Days (PBE, TAGS)",AMGN,0.004028087963933613,-0.01826949828433644,0.015169736695315406,-0.0036797690940763017,0.015480758081036994,0.0017380118690313306,0.01286380256520303,0.019282995083236498,0.4385666603690408
164,2012-07-16,"3 Unheralded ETFs up 10%+ in the Past 90 Days (PBE, TAGS)",AMGN,0.004028087963933613,-0.01826949828433644,0.015169736695315406,-0.0036797690940763017,0.015480758081036994,0.0017380118690313306,0.01286380256520303,0.019282995083236498,0.4385666603690408
166,2012-07-19,Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes Collaboration   ,AMGN,0.00025077684933716426,0.0669631179701804,0.01091941166601429,0.019282995083236498,0.004028087963933613,0.015169736695315406,-0.0036797690940763017,-0.02348017516011036,0.3835703195227589
169,2012-07-25,"Financial Breakfast: Morning News Summary for July 25, 2012",AMGN,0.020686057170882233,0.18038339579129437,-0.01483306005822116,-0.0030860156635450497,-0.02348017516011036,0.00025077684933716426,0.01091941166601429,0.0170599087822334,0.19417139833526664
173,2012-08-03,Beyond SPLV: Low Volatility ETFs to Survive a Wild Market ,AMGN,0.014436746321710325,-0.11331511800520644,-0.00953281049064525,-0.009443336813685588,-0.010304249946576416,-0.005481374298044184,0.05839320704592876,0.0026762879371935444,-0.07313048963944291
177,2012-08-08,Amgen Ends Ganitumab Study; Says It Was Unlikely to Succeed,AMGN,-0.002451948237675694,-0.12330013780909543,-0.010432825115980982,0.0026762879371935444,0.014436746321710325,-0.00953281049064525,-0.009443336813685588,0.007373678020405894,0.0046860634101490994
180,2012-09-20,FDA Approves New Indication for Prolia ,AMGN,0.00722066317246739,0.0027720376997126817,-0.004022254571442785,-0.0006093494401937516,0.00897262261926901,-0.02352387984435733,0.0020446668278590874,-0.003281069197895392,0.706172094893446
181,2012-10-24,S&P Likes a Trio of Biotech ETFs ,AMGN,0.0020618577978575026,0.53489627335023,-0.005467427723787055,0.007342433702365758,-0.02928983387299544,0.006614073603723236,0.013175900627475201,0.006285784706982156,-0.16166959712560203
186,2012-11-13,More Mega-Cap ETFs Your Broker Forgot to Mention,AMGN,0.0071626897621068775,0.5244404264605025,0.004109314634595851,0.005074329648407705,-0.007030557613263877,-0.022339416767116704,0.010885880184124508,-0.020403098389057184,-0.12459867896362042
191,2012-12-12,These ETFs Are Awash in 2013 Takeover Targets,AMGN,0.0024457105462496465,-0.16671721531390715,0.0023402223833426383,0.01607790726775593,-0.0024849960537118854,-0.0052807897090855205,0.007698684205179607,-0.01131183019693871,-0.2403337346361677
195,2012-12-13,Amgen Appoints Robert A. Bradway Chairman of the Board Of Directors ,AMGN,-0.01131183019693871,-0.2403337346361677,0.0024457105462496465,0.0023402223833426383,0.01607790726775593,-0.0024849960537118854,-0.0052807897090855205,0.0005608566355379541,0.2525338149117311
196,2012-12-13,"UPDATE: Amgen Raises Qtr. Dividend from $0.36 to $0.47/Share, Adds $2B to Buyback Plan",AMGN,-0.01131183019693871,-0.2403337346361677,0.0024457105462496465,0.0023402223833426383,0.01607790726775593,-0.0024849960537118854,-0.0052807897090855205,0.0005608566355379541,0.2525338149117311
199,2012-12-19,From Earlier: Amgen Takes Third License for Rights to Use ImmunoGen's TAP Technology,AMGN,-0.008959747629476156,-0.10839287657321095,-0.0023466082404103306,0.003363477056441244,0.0005608566355379541,-0.01131183019693871,0.0024457105462496465,-0.0009037257703244927,-0.4126309366419201
202,2012-12-27,FDA Says Amgen to Pay $762M to Resolve Criminal Liability,AMGN,-0.008516578653682494,0.14784590501396844,-0.005835396951639926,0.002753347427604913,-0.014138548596616007,-0.0009037257703244927,-0.008959747629476156,-0.010562588099685466,-0.22542112342278875
203,2013-01-07,4 Health Care ETFs Your Broker Forgot to Mention,AMGN,-0.005057688666084803,-0.21557689376619416,0.004402786604571496,-0.006281817989663874,0.03422287944601976,0.011261930653109875,-0.010562588099685466,-0.00429179957592174,1.009365406287646
207,2013-01-16,Amgen Says Top-Line Results from Phase 3 Aranesp RED-HF Trial Did Not Meet Primary Endpoint,AMGN,-0.00893318352312733,0.23509453798244628,-0.02116858751742945,-0.0004598703764023826,-0.00967994988689469,-0.009699178178490753,0.005898850892445129,-0.004506083727384591,-0.19157058474554411
210,2013-01-16,Amgen To Build State-Of-The-Art Manufacturing Facility In Singapore,AMGN,-0.00893318352312733,0.23509453798244628,-0.02116858751742945,-0.0004598703764023826,-0.00967994988689469,-0.009699178178490753,0.005898850892445129,-0.004506083727384591,-0.19157058474554411
213,2013-01-22,A Peek Into The Market Before The Trading Starts,AMGN,0.014741822839154262,-0.3479703234851166,-0.022159074982147753,-0.004506083727384591,-0.00893318352312733,-0.02116858751742945,-0.0004598703764023826,-0.0026415121894169946,-0.18355703626435615
216,2013-01-23,"Earnings Scheduled For January 23, 2013",AMGN,-0.0026415121894169946,-0.18355703626435615,0.014741822839154262,-0.022159074982147753,-0.004506083727384591,-0.00893318352312733,-0.02116858751742945,-0.005417157753490831,0.052265853149770614
219,2013-02-21,"Benzinga's Small Cap Movers for Thursday February 21, 2013",AMGN,0.005670544492694329,-0.3591096222782274,0.0061804775832159375,0.006219748802464453,-0.013102388644268825,-0.0025899452918565213,0.004731463800278668,0.01985200426279543,0.20179766498949725
222,2013-03-08,"If Stocks Keep Soaring, Get to Know These Leveraged ETFs",AMGN,0.0005377874351688572,0.03516660514747838,-0.003430521337817183,-0.0018194834683291639,0.00765681980092392,0.001620024770044859,0.011250587197899842,-0.01677419299806271,0.8475801484651042
226,2013-03-14,Generic Drugs Will Hit Pharmaceuticals Hard in 2013,AMGN,0.00699146694606112,0.3187521583976056,-0.002288984417851192,0.00339008084964898,-0.01677419299806271,0.0005377874351688572,-0.003430521337817183,-0.004013581417343981,1.959933659217877
228,2013-03-14,Generics Will Hit Drug Companies Hard in 2013,AMGN,0.00699146694606112,0.3187521583976056,-0.002288984417851192,0.00339008084964898,-0.01677419299806271,0.0005377874351688572,-0.003430521337817183,-0.004013581417343981,1.959933659217877
231,2013-03-15,Exploring No Man's Land ETFs,AMGN,-0.004013581417343981,1.959933659217877,0.00699146694606112,-0.002288984417851192,0.00339008084964898,-0.01677419299806271,0.0005377874351688572,-0.015466764132522015,-0.6455316680920503
234,2013-03-19,Amgen Announces Phase 3 Talimogene Laherparepvec Trial In Melanoma Met Primary Endpoint of Durable Response Rate ,AMGN,0.0222370298436958,0.11231592667572587,-0.015466764132522015,-0.004013581417343981,0.00699146694606112,-0.002288984417851192,0.00339008084964898,0.017856702087952092,0.036600264279837535
235,2013-03-25,Moving Averages Indicate These Sector ETFs Could be Stretched,AMGN,0.0025888200232480063,0.06720003386458395,0.023857236781024804,0.002764927302044029,0.017856702087952092,0.0222370298436958,-0.015466764132522015,0.01910999349575171,-0.37983419935742335
240,2013-03-25,This Dead Money Sector is Leading the S&P This Year,AMGN,0.0025888200232480063,0.06720003386458395,0.023857236781024804,0.002764927302044029,0.017856702087952092,0.0222370298436958,-0.015466764132522015,0.01910999349575171,-0.37983419935742335
244,2013-03-27,Stocks Hitting 52-Week Highs,AMGN,0.01510218989693679,0.11234409977614335,0.01910999349575171,0.0025888200232480063,0.023857236781024804,0.002764927302044029,0.017856702087952092,0.023564716333474456,0.583187189144122
247,2013-03-28,Biotech Breakout Boosting ETFs,AMGN,0.023564716333474456,0.583187189144122,0.01510218989693679,0.01910999349575171,0.0025888200232480063,0.023857236781024804,0.002764927302044029,-0.0019512130003738193,-0.25552044744679303
251,2013-04-02,UPDATE: Piper Jaffray Says Affymax May Run Out of Cash as Early as the Second-Quarter,AMGN,0.03997673467635243,0.2124057857892041,-0.0019512130003738193,0.023564716333474456,0.01510218989693679,0.01910999349575171,0.0025888200232480063,-0.014943390754169616,0.06763907051604456
254,2013-04-10,Three Market-Based ETFs Trouncing SPY,AMGN,0.037871351985722335,0.6107370905052749,-0.007611384620610173,0.010188176362752266,-0.017378005379526384,0.010208598815151237,-0.014943390754169616,-0.0002770112030145988,-0.07939243778950766
256,2013-04-10,3 Market-Based ETFs Trouncing SPY,AMGN,0.037871351985722335,0.6107370905052749,-0.007611384620610173,0.010188176362752266,-0.017378005379526384,0.010208598815151237,-0.014943390754169616,-0.0002770112030145988,-0.07939243778950766
258,2013-04-11,Under The Hood: An Unheralded Biotech ETF,AMGN,-0.0002770112030145988,-0.07939243778950766,0.037871351985722335,-0.007611384620610173,0.010188176362752266,-0.017378005379526384,0.010208598815151237,0.03095504999220222,0.3401591387783758
261,2013-04-11,ETF Showdown: A Pharma Fight,AMGN,-0.0002770112030145988,-0.07939243778950766,0.037871351985722335,-0.007611384620610173,0.010188176362752266,-0.017378005379526384,0.010208598815151237,0.03095504999220222,0.3401591387783758
265,2013-04-19,"Weekly Preview: Earnings Season Continues, Apple In Focus",AMGN,0.036478555596362705,0.5510503175378603,-0.018092004074105494,-0.01271996469007286,0.02184772953013958,-0.027695570212588172,0.03095504999220222,0.018315512056304772,-0.2862660588479071
271,2013-04-19,Vertex News Lifts Biotech ETFs,AMGN,0.036478555596362705,0.5510503175378603,-0.018092004074105494,-0.01271996469007286,0.02184772953013958,-0.027695570212588172,0.03095504999220222,0.018315512056304772,-0.2862660588479071
275,2013-04-22,Biotech Mutual Funds Show ETFs Are The Place to Be,AMGN,0.018315512056304772,-0.2862660588479071,0.036478555596362705,-0.018092004074105494,-0.01271996469007286,0.02184772953013958,-0.027695570212588172,-0.005818989786233408,0.1133639910813824
279,2013-04-23,"Earnings Scheduled For April 23, 2013",AMGN,-0.005818989786233408,0.1133639910813824,0.018315512056304772,0.036478555596362705,-0.018092004074105494,-0.01271996469007286,0.02184772953013958,-0.06943966757125086,0.5625717087010034
282,2013-04-23,"Benzinga Market Primer: Tuesday, April 23",AMGN,-0.005818989786233408,0.1133639910813824,0.018315512056304772,0.036478555596362705,-0.018092004074105494,-0.01271996469007286,0.02184772953013958,-0.06943966757125086,0.5625717087010034
284,2013-04-23,"Benzinga Market Primer, Tuesday April 23",AMGN,-0.005818989786233408,0.1133639910813824,0.018315512056304772,0.036478555596362705,-0.018092004074105494,-0.01271996469007286,0.02184772953013958,-0.06943966757125086,0.5625717087010034
286,2013-04-24,"Benzinga Market Primer: Wednesday, April 24",AMGN,-0.06943966757125086,0.5625717087010034,-0.005818989786233408,0.018315512056304772,0.036478555596362705,-0.018092004074105494,-0.01271996469007286,0.0355477282183978,0.08403978372605292
288,2013-04-24,"Benzinga Market Primer, Wednesday April 24",AMGN,-0.06943966757125086,0.5625717087010034,-0.005818989786233408,0.018315512056304772,0.036478555596362705,-0.018092004074105494,-0.01271996469007286,0.0355477282183978,0.08403978372605292
291,2013-05-03,3 Sector ETFs Up 20% or More YTD,AMGN,0.008428875394582702,-0.10250702102883757,0.010044023228511056,0.0031664901848986737,-0.02306159880043024,-0.015777565449818898,-0.002577142480114536,-0.015495952237049027,0.0013737836290783623
293,2013-05-03,Three Sector ETFs Up 20% or More YTD,AMGN,0.008428875394582702,-0.10250702102883757,0.010044023228511056,0.0031664901848986737,-0.02306159880043024,-0.015777565449818898,-0.002577142480114536,-0.015495952237049027,0.0013737836290783623
294,2013-05-06,Transgenomic in Collaboration Agreement with Amgen,AMGN,-0.015495952237049027,0.0013737836290783623,0.008428875394582702,0.010044023228511056,0.0031664901848986737,-0.02306159880043024,-0.015777565449818898,-0.0035296341133262965,0.12690065165199504
295,2013-05-07,Amgen Announces Top-Line Results of Vectibix Phase 3 Head-to-Head Study Against Erbitux in Metastatic Colorectal Cancer,AMGN,-0.0035296341133262965,0.12690065165199504,-0.015495952237049027,0.008428875394582702,0.010044023228511056,0.0031664901848986737,-0.02306159880043024,0.005839864367135128,0.09032498055527372
298,2013-05-09,Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China,AMGN,-0.004853886511488104,-0.23677191241238138,0.005839864367135128,-0.0035296341133262965,-0.015495952237049027,0.008428875394582702,0.010044023228511056,0.020657869080938474,0.18055104031209357
301,2013-05-10,S&P Highlights Biotech ETFs,AMGN,0.020657869080938474,0.18055104031209357,-0.004853886511488104,0.005839864367135128,-0.0035296341133262965,-0.015495952237049027,0.008428875394582702,0.0015929779628447438,-0.12326598051702176
304,2013-05-29,A Peek Into The Market Before The Trading Starts,AMGN,-0.0170433623737124,-0.08042598912906085,0.002737953893087619,0.002745658323787481,0.010428002290153948,0.0027816282592973973,0.020160770604398026,0.007951196897525659,-0.19182789786590604
305,2013-05-29,"Amgen, Astellas Announce Strategic Alliance for Japan Market",AMGN,-0.0170433623737124,-0.08042598912906085,0.002737953893087619,0.002745658323787481,0.010428002290153948,0.0027816282592973973,0.020160770604398026,0.007951196897525659,-0.19182789786590604
308,2013-06-12,RBC Says Amgen's AMG-386 Will Need to See Increases in Overall Survival Benefits Before FDA Approval,AMGN,-0.01592986765250415,0.24950351174618546,-0.0038652700813534002,-0.005059973722467248,0.013539548807278035,0.03054993281233509,-0.027649450662077246,0.022206338802561287,0.1467281749108389
311,2013-06-12,UPDATE: Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer; Meets Primary Endpoint,AMGN,-0.01592986765250415,0.24950351174618546,-0.0038652700813534002,-0.005059973722467248,0.013539548807278035,0.03054993281233509,-0.027649450662077246,0.022206338802561287,0.1467281749108389
314,2013-06-13,"FDA Issues Approval for Xgeva, Marketed by Amgen",AMGN,0.022206338802561287,0.1467281749108389,-0.01592986765250415,-0.0038652700813534002,-0.005059973722467248,0.013539548807278035,0.03054993281233509,-0.011065358998300967,0.056894628308711725
317,2013-06-18,Interesting Similarities Among 2013's Top-Performing ETFs,AMGN,0.024424715272172826,0.07996755879967554,0.017039843409164535,-0.011065358998300967,0.022206338802561287,-0.01592986765250415,-0.0038652700813534002,-0.02285715897560403,0.14914388705316917
321,2013-07-01,Mid-Afternoon Market Update: Zynga Surges on News of New Executive; Markets Back Off of Highs,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
323,2013-07-01,UPDATE: Brean Capital Sees Onyx Buyout Price At $160,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
327,2013-07-01,"Mid-Day Market Update: Dow Surges Triple Digits, InterDigital Shares Tumble",AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
329,2013-07-01,"Benzinga's M&A Chatter for Monday July 1, 2013",AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
332,2013-07-01,Afternoon Market Gainers,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
338,2013-07-01,RBC Sees Positives for Pharmacyclics Amid News of Rejected Offer for Onyx from Amgen,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
341,2013-07-01,Onyx Rejects Amgen Bid but Open to Other Offers,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
343,2013-07-01,"Onyx Rejects Amgen Bid - But Open to Other Offers (ONXX, AMGN)",AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
344,2013-07-01,Morning Market Movers ,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
347,2013-07-01,Benzinga's Volume Movers,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
351,2013-07-01,"Benzinga Market Primer, Monday July 1",AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
352,2013-07-01,"Benzinga Market Primer: Monday, July 1",AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
355,2013-07-01,Benzinga's Top Pre-Market Gainers,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
358,2013-07-01,"Mid-Morning Market Update: Markets Open Higher, Onyx Rejects Amgen Bid",AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
360,2013-07-01,ETFs For an Onyx Takeover Battle,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
368,2013-07-01,News of Rejected $120/Share Bid from Amgen Moves Onyx Shares to New Highs; Leerink Says Deal Could Push Amgen to 'Critical Mass',AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
369,2013-07-01,Bernstein Believes Onyx Pharma Bid Would Need to be in $140-150/Share Range to Sufficiently Entice Management,AMGN,-0.011858677719609134,-0.07040248970529628,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0217744703621916,-0.014668173660174477,-0.18221160716108353
375,2013-07-02,"Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)",AMGN,-0.014668173660174477,-0.18221160716108353,-0.011858677719609134,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0026027741204190935,-0.4676618157310102
376,2013-07-02,Pfizer and Novartis Said to be Zeroing in on Onyx,AMGN,-0.014668173660174477,-0.18221160716108353,-0.011858677719609134,-0.0033338702285926614,-0.006124158936713475,0.033409045465794485,0.0024962757135447156,-0.0026027741204190935,-0.4676618157310102
379,2013-07-15,The Lancet Oncology Publishes Positive Phase 2 Results for XGEVA In Patients with Giant Cell Tumor Of Bone ,AMGN,0.0017260642326919484,-0.3173696267349414,0.009781058899082762,0.01175807683397112,0.037933186899951954,0.0015277423039716798,0.005530511849139552,-0.0038291730585463535,-0.2515693473883691
380,2013-07-15,Health Care ETFs Looking Healthy Ahead of Earnings,AMGN,0.0017260642326919484,-0.3173696267349414,0.009781058899082762,0.01175807683397112,0.037933186899951954,0.0015277423039716798,0.005530511849139552,-0.0038291730585463535,-0.2515693473883691
385,2013-07-16,"Benzinga's M&A Chatter for Tuesday July 16, 2013",AMGN,-0.0038291730585463535,-0.2515693473883691,0.0017260642326919484,0.009781058899082762,0.01175807683397112,0.037933186899951954,0.0015277423039716798,0.002498643650376664,0.1521865274041252
388,2013-07-18,"Benzinga's M&A Chatter for Thursday July 18, 2013",AMGN,0.004409855634086801,0.05150627231938465,0.002498643650376664,-0.0038291730585463535,0.0017260642326919484,0.009781058899082762,0.01175807683397112,0.04409651303753348,1.372403883833326
392,2013-07-22,"Benzinga's M&A Chatter for Monday July 22, 2013",AMGN,-0.00402185590739812,-0.47563639033163874,0.04409651303753348,0.004409855634086801,0.002498643650376664,-0.0038291730585463535,0.0017260642326919484,-0.0213860630710756,-0.10377655664834973
396,2013-07-26,"Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom Expected",AMGN,0.000821826470565501,-0.2500372522723886,0.0272984535093328,-0.00018778410679765045,-0.0213860630710756,-0.00402185590739812,0.04409651303753348,-0.0020985486442260948,-0.19427776673951913
400,2013-07-30,3 ETFs That Have Blown Past Their 200-Day Lines,AMGN,0.016731982720996186,0.9639968435588873,-0.0020985486442260948,0.000821826470565501,0.0272984535093328,-0.00018778410679765045,-0.0213860630710756,-0.026168937044243168,0.11305308623374022
401,2013-07-30,"Earnings Scheduled For July 30, 2013",AMGN,0.016731982720996186,0.9639968435588873,-0.0020985486442260948,0.000821826470565501,0.0272984535093328,-0.00018778410679765045,-0.0213860630710756,-0.026168937044243168,0.11305308623374022
403,2013-07-30,"Benzinga's M&A Chatter for Tuesday July 30, 2013",AMGN,0.016731982720996186,0.9639968435588873,-0.0020985486442260948,0.000821826470565501,0.0272984535093328,-0.00018778410679765045,-0.0213860630710756,-0.026168937044243168,0.11305308623374022
409,2013-07-31,"Benzinga Market Primer, Wednesday July 31",AMGN,-0.026168937044243168,0.11305308623374022,0.016731982720996186,-0.0020985486442260948,0.000821826470565501,0.0272984535093328,-0.00018778410679765045,0.010157729339334676,-0.459389946755708
411,2013-07-31,"Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into FOMC Decision",AMGN,-0.026168937044243168,0.11305308623374022,0.016731982720996186,-0.0020985486442260948,0.000821826470565501,0.0272984535093328,-0.00018778410679765045,0.010157729339334676,-0.459389946755708
415,2013-08-01,"Benzinga Market Primer: Thursday, August 1: Futures Up On Europe and Asia",AMGN,0.010157729339334676,-0.459389946755708,-0.026168937044243168,0.016731982720996186,-0.0020985486442260948,0.000821826470565501,0.0272984535093328,-0.003016549869821916,-0.12227693848593602
426,2013-08-02,"Three Soaring, But Overlooked Health Care ETFs",AMGN,-0.003016549869821916,-0.12227693848593602,0.010157729339334676,-0.026168937044243168,0.016731982720996186,-0.0020985486442260948,0.000821826470565501,-0.014945978847780483,-0.1252852795739825
430,2013-08-06,"Benzinga's M&A Chatter for Tuesday August 6, 2013",AMGN,-0.020571365871020486,0.9749959232483556,-0.014945978847780483,-0.003016549869821916,0.010157729339334676,-0.026168937044243168,0.016731982720996186,0.06823782481758944,1.728904056806297
433,2013-08-06,Buyback ETF Defies Logic,AMGN,-0.020571365871020486,0.9749959232483556,-0.014945978847780483,-0.003016549869821916,0.010157729339334676,-0.026168937044243168,0.016731982720996186,0.06823782481758944,1.728904056806297
437,2013-08-07,"Benzinga's M&A Chatter for Wednesday August 7, 2013",AMGN,0.06823782481758944,1.728904056806297,-0.020571365871020486,-0.014945978847780483,-0.003016549869821916,0.010157729339334676,-0.026168937044243168,-0.017971479377203226,-0.5200601097305148
439,2013-08-08,Bernstein Says Onyx Acquisition Could Boost Amgen Earnings 25% by 2020,AMGN,-0.017971479377203226,-0.5200601097305148,0.06823782481758944,-0.020571365871020486,-0.014945978847780483,-0.003016549869821916,0.010157729339334676,-0.006794962795899417,-0.40628743144136004
442,2013-08-15,Deutsche Bank Sees Decline in Onyx Pharma Shares as Overdone,AMGN,-0.008252054994527525,0.5055517161944252,-0.006983832108309995,-0.003234287203243924,-0.012952657013357682,-0.006794962795899417,-0.017971479377203226,-0.008037059288020343,-0.2271864863210723
445,2013-08-15,"Benzinga's M&A Chatter for Thursday August 15, 2013",AMGN,-0.008252054994527525,0.5055517161944252,-0.006983832108309995,-0.003234287203243924,-0.012952657013357682,-0.006794962795899417,-0.017971479377203226,-0.008037059288020343,-0.2271864863210723
448,2013-08-15,Benzinga's Top Pre-Market Losers,AMGN,-0.008252054994527525,0.5055517161944252,-0.006983832108309995,-0.003234287203243924,-0.012952657013357682,-0.006794962795899417,-0.017971479377203226,-0.008037059288020343,-0.2271864863210723
451,2013-08-19,"Benzinga's M&A Chatter for Monday August 19, 2013",AMGN,-0.004194066973523869,-0.3176922467727885,-0.008037059288020343,-0.008252054994527525,-0.006983832108309995,-0.003234287203243924,-0.012952657013357682,0.010816630631930835,0.07683825663049149
454,2013-08-21,"Benzinga's M&A Chatter for Wednesday August 21, 2013",AMGN,-0.00899644535690336,0.26181622204257615,0.010816630631930835,-0.004194066973523869,-0.008037059288020343,-0.008252054994527525,-0.006983832108309995,0.01567146781443851,-0.09661299278178792
457,2013-08-22,"Benzinga's M&A Chatter for Thursday August 22, 2013",AMGN,0.01567146781443851,-0.09661299278178792,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.008037059288020343,-0.008252054994527525,-0.006491618491550444,-0.2566308921563992
460,2013-08-26,"The Top 10 Financial Tweets For Monday, August 26",AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
464,2013-08-26,Mid-Day Market Update: Qihoo 360 Surges On Upbeat Results; Tyson Shares Decline,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
465,2013-08-26,A Look Ahead: This Week's ETFs to Watch,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
471,2013-08-26,Mid-Afternoon Market Update: Markets Sell off on Syrian Conflict Fears; 3D Systems Rises on Citi Report,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
475,2013-08-26,These ETFs House The Next Biotech Takeover Targets,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
476,2013-08-26,Amgen and Onyx Finally Ink a Deal Two Months In The Making,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
481,2013-08-26,"Stocks To Watch For August 26, 2013",AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
484,2013-08-26,US Stock Futures Down; Durable-Goods Data In Focus,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
485,2013-08-26,Amgen and Onyx Finally Ink Deal Two Months In The Making,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
489,2013-08-26,Benzinga's Volume Movers,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
491,2013-08-26,Mid-Morning Market Update: Markets Open Higher; Amgen To Acquire Onyx For $10.4B,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
498,2013-08-26,Benzinga's Top Pre-Market Gainers,AMGN,0.07717795890434931,6.348915601348343,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,-0.004194066973523869,-0.04061538514716001,-0.5399880568080522
504,2013-08-27,"Benzinga Market Primer: Tuesday, August 27: Investors Cautious With Tension Between The US and Syria On The Rise",AMGN,-0.04061538514716001,-0.5399880568080522,0.07717795890434931,-0.006491618491550444,0.01567146781443851,-0.00899644535690336,0.010816630631930835,0.0006413112725858205,-0.42748292664572085
512,2013-08-29,Verizon and Vodafone Trying to Strike a Deal--Again,AMGN,-0.0031135870584235725,-0.0997338240609904,0.0006413112725858205,-0.04061538514716001,0.07717795890434931,-0.006491618491550444,0.01567146781443851,0.000735183705179665,-0.03088042049934292
520,2013-09-03,"Amgen, Cytokinetics Announce Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil Did Not Meet Primary Endpoint",AMGN,0.019001211322823064,0.2466290018832391,0.000735183705179665,-0.0031135870584235725,0.0006413112725858205,-0.04061538514716001,0.07717795890434931,0.018106410458250677,-0.10695510302737321
521,2013-09-05,Biotech Breakout Highlights Flawed ETF Thinking,AMGN,-0.0007963994430683075,-0.08298937681845864,0.018106410458250677,0.019001211322823064,0.000735183705179665,-0.0031135870584235725,0.0006413112725858205,-0.017001539406669486,0.11728463383139642
525,2013-09-09,Sobi Acquires Full Rights to Develop and Commercialize Kineret from Amgen ,AMGN,0.0059451823409437665,-0.06656980583806626,-0.017001539406669486,-0.0007963994430683075,0.018106410458250677,0.019001211322823064,0.000735183705179665,-0.004566901770461151,0.11069053346540247
526,2013-09-09,Sobi Acquires Full Rights to Develop and Commercialize Kineretfrom Amgen ,AMGN,0.0059451823409437665,-0.06656980583806626,-0.017001539406669486,-0.0007963994430683075,0.018106410458250677,0.019001211322823064,0.000735183705179665,-0.004566901770461151,0.11069053346540247
527,2013-09-18,"Amgen, Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx ",AMGN,0.01546753427323111,-0.17035482640213662,-0.012374496821296321,0.018425215079874713,0.01410173752174737,0.013307139963926407,0.007286820594948784,-0.0028932393750549235,0.16133977159500268
529,2013-09-24,"Amgen, ShanghaiTech University Announce Amgen China R&amp;D Center",AMGN,-0.002346956560371538,-0.11636493568365891,-0.015404317812087398,-0.0028160727281756337,-0.0028932393750549235,0.01546753427323111,-0.012374496821296321,-0.020038280216321813,0.6406973087118659
530,2013-09-30,Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec,AMGN,-0.01121994995871578,0.5675188124935573,0.0030127945997731054,0.003289416766246722,-0.020038280216321813,-0.002346956560371538,-0.015404317812087398,0.023766716777513963,-0.0719100384703909
531,2013-09-30,US Stock Futures Signal Lower Start On Wall Street,AMGN,-0.01121994995871578,0.5675188124935573,0.0030127945997731054,0.003289416766246722,-0.020038280216321813,-0.002346956560371538,-0.015404317812087398,0.023766716777513963,-0.0719100384703909
534,2013-10-01,Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer,AMGN,0.023766716777513963,-0.0719100384703909,-0.01121994995871578,0.0030127945997731054,0.003289416766246722,-0.020038280216321813,-0.002346956560371538,-0.013265588608646683,-0.12421171969106493
537,2013-10-03,"Amgen, AstraZeneca Highlight Brodalumab Data to be Presented at EADV",AMGN,-0.017159001320458223,0.23737864077669912,-0.013265588608646683,0.023766716777513963,-0.01121994995871578,0.0030127945997731054,0.003289416766246722,0.016108780911026077,0.009546227278671271
538,2013-10-16,Amgen Announces Appointment Of Greg C. Garland To Board Of Directors,AMGN,0.02548429033860833,0.7987708872974757,-0.0012544598735374501,0.006221884909090258,0.008824762417121379,0.03424967809827062,-0.013734624588052968,0.01373821721853452,-0.24994352834876887
541,2013-10-22,"Earnings Scheduled For October 22, 2013",AMGN,0.022615288390619215,0.3660654393679661,-0.011138118866588886,-0.008027555629165128,0.01373821721853452,0.02548429033860833,-0.0012544598735374501,-0.004646636549029637,-0.08197615735057429
544,2013-11-12,Gilead Sciences Leads In Rising Short Interest Among Biotechs ,AMGN,8.841978727147648e-05,0.05172564057869966,-0.00035320692438389756,0.01963437450173955,-0.02029457565240711,-0.015720509329306354,-0.01824666319179824,0.007275401896671196,0.3345349078102342
546,2013-11-15,"Annaly Capital, VIVUS And Others Insiders Have Been Buying",AMGN,-0.003725665617312357,-0.2796327005420389,0.016559595497484203,0.007275401896671196,8.841978727147648e-05,-0.00035320692438389756,0.01963437450173955,0.009131733187856206,-0.010548015804844546
556,2014-01-15,"Amgen, Mass General, Broad Institute Collaborate on New Drugs for IFD",AMGN,0.006711157148044711,0.20596568550291194,0.011340107785181353,-0.013475640128372435,-0.0075700546839152505,0.02597515045038401,-0.004723939429861823,0.004387781348038855,-0.16687332767734775
557,2014-01-15,"Amgen, Mass General, Broad Institute Collaborate on New Drugs for IBD",AMGN,0.006711157148044711,0.20596568550291194,0.011340107785181353,-0.013475640128372435,-0.0075700546839152505,0.02597515045038401,-0.004723939429861823,0.004387781348038855,-0.16687332767734775
558,2014-01-16,Market Wrap For January 16: Markets End Two Day Winning Streak,AMGN,0.004387781348038855,-0.16687332767734775,0.006711157148044711,0.011340107785181353,-0.013475640128372435,-0.0075700546839152505,0.02597515045038401,0.001008065510935685,0.5705780980730064
562,2014-01-23,Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-2 Trial Of Evolocumab (AMG 145) In Statin Intolerant Patients With High Cholesterol,AMGN,-0.006191280119948517,-0.30502143053753294,0.042935232116900535,0.0008391264606459892,0.001008065510935685,0.004387781348038855,0.006711157148044711,-0.0348706286088456,0.41249858549281426
565,2014-01-24,Benzinga Weekly Preview:  Tech Sector To Steal The Spotlight,AMGN,-0.0348706286088456,0.41249858549281426,-0.006191280119948517,0.042935232116900535,0.0008391264606459892,0.001008065510935685,0.004387781348038855,-0.0064550206979322455,-0.17374672034288685
567,2014-01-24,Benzinga Weekly Preview: Tech Sector To Steal The Spotlight,AMGN,-0.0348706286088456,0.41249858549281426,-0.006191280119948517,0.042935232116900535,0.0008391264606459892,0.001008065510935685,0.004387781348038855,-0.0064550206979322455,-0.17374672034288685
569,2014-01-28,"Earnings Scheduled For January 28, 2014",AMGN,0.018393651243052034,0.05410384447568717,-0.0064550206979322455,-0.0348706286088456,-0.006191280119948517,0.042935232116900535,0.0008391264606459892,-0.01267602047147054,0.31775743917582666
572,2014-01-28,Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) In Combination With Statins In Patients With High Cholesterol,AMGN,0.018393651243052034,0.05410384447568717,-0.0064550206979322455,-0.0348706286088456,-0.006191280119948517,0.042935232116900535,0.0008391264606459892,-0.01267602047147054,0.31775743917582666
575,2014-01-30,Amgen Announces Positive Top-Line Results From Phase 3 RUTHERFORD-2 Trial Of Evolocumab (AMG 145) In Patients With Heterozygous Familial Hypercholesterolemia,AMGN,0.014433199191997703,-0.42044185397179956,-0.01267602047147054,0.018393651243052034,-0.0064550206979322455,-0.0348706286088456,-0.006191280119948517,-0.016047612226685826,0.4859233386528561
578,2014-02-24,France's Biosimilar Substitution May Lead to Erosion of Amgen,AMGN,0.01566439054463764,-0.1833284241531664,0.0029147830344311565,0.001135133645662867,-0.012726201268558945,0.008882663902646915,-0.002497016892027859,-0.011368142752488652,-0.12850753805092696
582,2014-03-11,US Stock Futures Edge Lower Ahead Of Wholesale Trade Data,AMGN,-0.00901128785561811,-0.29873491271161823,0.025683097718668835,-0.015540805475653507,-0.01584909807597057,0.0015079339866708175,0.01867557999436542,0.013760417080559861,0.03988400120518221
585,2014-03-11,"Bayer, Onyx Report Primary Endpoint of Phase 3 Study Results of NEXAVAR as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation was Not Met",AMGN,-0.00901128785561811,-0.29873491271161823,0.025683097718668835,-0.015540805475653507,-0.01584909807597057,0.0015079339866708175,0.01867557999436542,0.013760417080559861,0.03988400120518221
588,2014-03-18,Market Wrap For March 18: Markets Positive Despite Crimea Concerns,AMGN,0.029145679410736314,0.2647527291092031,0.0107720369089912,-0.011455280377973054,-0.016034228246807336,0.013760417080559861,-0.00901128785561811,-0.006981850565538128,-0.20152967194987104
592,2014-03-27,Biotech ETFs Come Back Down To Earth,AMGN,0.0181498295438145,0.18460898069618614,-0.00431061069676042,-0.005359465461958646,-0.013422623654905319,-0.032427952851664554,0.0037128211046673076,-0.014228105543638847,-0.2871261035709579
594,2014-03-27,Market Wrap For March 27: Markets Lower Following Mixed Economic Data,AMGN,0.0181498295438145,0.18460898069618614,-0.00431061069676042,-0.005359465461958646,-0.013422623654905319,-0.032427952851664554,0.0037128211046673076,-0.014228105543638847,-0.2871261035709579
598,2014-04-04,"UPDATE: Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response Rate Met in Phase 3 Study of Talimogene, Secondary Endpoint Not Met",AMGN,-0.04044138357849847,0.6524717583901458,-0.01468491977319808,-0.0007138798135708502,0.022133778632524193,0.023143942273566864,-0.014228105543638847,-0.0024352193071035533,-0.04071830031490409
601,2014-04-22,"Earnings Scheduled For April 22, 2014",AMGN,0.019483732319000024,0.6093532488054478,0.013511135748876635,-0.0006922046228344803,0.004695420939863304,0.014825453305060243,0.01232792939490257,-0.050125726369589674,1.5636002337814143
604,2014-04-23,"Market Wrap For April 23: S&P 500 Ends Winning Streak on Earnings, Home Sales",AMGN,-0.050125726369589674,1.5636002337814143,0.019483732319000024,0.013511135748876635,-0.0006922046228344803,0.004695420939863304,0.014825453305060243,0.003529857556943572,-0.4426033668314213
607,2014-04-23,"#PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure Off Beijing ",AMGN,-0.050125726369589674,1.5636002337814143,0.019483732319000024,0.013511135748876635,-0.0006922046228344803,0.004695420939863304,0.014825453305060243,0.003529857556943572,-0.4426033668314213
611,2014-04-23,"Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces 7-for-1 Stock Split",AMGN,-0.050125726369589674,1.5636002337814143,0.019483732319000024,0.013511135748876635,-0.0006922046228344803,0.004695420939863304,0.014825453305060243,0.003529857556943572,-0.4426033668314213
614,2014-06-02,Amgen Presents New Data On Talimogene Laherparepvec As Single Agent And Combination Therapy In Metastatic Melanoma At ASCO,AMGN,0.003965802458929524,0.21728318308983519,-8.608768703088909e-05,0.002853018190283274,-0.001898401344476719,0.013644565577354273,-0.004614088689233964,0.0057533211768050485,-0.09743907777615646
617,2014-06-16,"Benzinga's M&A Chatter for Monday June 16, 2014",AMGN,0.0011202694389913503,0.4822237474262183,-0.0014627222955704289,-0.0012035368464520246,-0.006490219384551965,0.006013666281088792,-0.012052058592593617,8.588571646317433e-05,-0.024773106130765
620,2014-07-03,"Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%",AMGN,0.015037606019395966,0.3568762957843814,0.005984799295716492,0.01638896089698516,-0.0018551790728874584,-0.004616374581363325,-0.002344667596649974,-0.021896458947243902,0.5665172659671998
622,2014-07-03,Benzinga's Top #PreMarket Losers,AMGN,0.015037606019395966,0.3568762957843814,0.005984799295716492,0.01638896089698516,-0.0018551790728874584,-0.004616374581363325,-0.002344667596649974,-0.021896458947243902,0.5665172659671998
624,2014-07-03,Morning Market Losers ,AMGN,0.015037606019395966,0.3568762957843814,0.005984799295716492,0.01638896089698516,-0.0018551790728874584,-0.004616374581363325,-0.002344667596649974,-0.021896458947243902,0.5665172659671998
626,2014-07-03,"Mid-Morning Market Update: Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%",AMGN,0.015037606019395966,0.3568762957843814,0.005984799295716492,0.01638896089698516,-0.0018551790728874584,-0.004616374581363325,-0.002344667596649974,-0.021896458947243902,0.5665172659671998
630,2014-07-10,Morgan Stanley Issues 2015 'Vintage Values' Stock List,AMGN,-0.00518504321436386,-0.00192627285088387,-0.003251350867331082,-0.001664402376529317,-0.021896458947243902,0.015037606019395966,0.005984799295716492,0.0068935641448024665,0.0343235572374645
635,2014-07-17,UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis(,AMGN,-0.0197095198386269,-0.3423209610726432,0.007273547982084683,-0.01781806562695254,-0.006596072844620826,0.0068935641448024665,-0.00518504321436386,0.025218870995171505,0.29374999999999996
638,2014-07-18,Biotech Enters Reporting Season With Large Caps Central To Sector Performance,AMGN,0.025218870995171505,0.29374999999999996,-0.0197095198386269,0.007273547982084683,-0.01781806562695254,-0.006596072844620826,0.0068935641448024665,0.0061708982407262525,-0.11528065332413162
642,2014-07-25,US Stock Futures Drop Ahead Of Durable Goods Orders Data,AMGN,0.004744162014047815,-0.05926017951983109,0.0020489572982533844,0.007431140169808392,0.017474669191637204,0.0061708982407262525,0.025218870995171505,-0.00154687493100647,-0.19706824259632205
645,2014-07-29,"Earnings Scheduled For July 29, 2014",AMGN,0.005381226759546109,0.63984375,-0.00154687493100647,0.004744162014047815,0.0020489572982533844,0.007431140169808392,0.017474669191637204,0.054334555533413376,1.1227401519520575
648,2014-07-30,Stocks Mixed Despite Better-Than-Expected GDP,AMGN,0.054334555533413376,1.1227401519520575,0.005381226759546109,-0.00154687493100647,0.004744162014047815,0.0020489572982533844,0.007431140169808392,-0.02015221649050969,-0.42836386831567386
649,2014-07-30,Stocks Mixed Despite Better Than Expected GDP,AMGN,0.054334555533413376,1.1227401519520575,0.005381226759546109,-0.00154687493100647,0.004744162014047815,0.0020489572982533844,0.007431140169808392,-0.02015221649050969,-0.42836386831567386
654,2014-07-30,Amgen Reports Stellar Earnings and Also Raises Guidance,AMGN,0.054334555533413376,1.1227401519520575,0.005381226759546109,-0.00154687493100647,0.004744162014047815,0.0020489572982533844,0.007431140169808392,-0.02015221649050969,-0.42836386831567386
656,2014-07-30,"Amgen Reports Stellar Earnings, Raises Guidance",AMGN,0.054334555533413376,1.1227401519520575,0.005381226759546109,-0.00154687493100647,0.004744162014047815,0.0020489572982533844,0.007431140169808392,-0.02015221649050969,-0.42836386831567386
658,2014-08-04,Benzinga's Top #PreMarket Gainers,AMGN,0.024691387550395794,0.40966825896493275,-0.014443855269326566,-0.02015221649050969,0.054334555533413376,0.005381226759546109,-0.00154687493100647,-0.005985235560657776,-0.4145415931414651
659,2014-08-04,"UPDATE: Amgen Announces Phase 3 ASPIRE Trial of Kyprolis Met Primary Endpoint, Helped Patients Live Longer without Worsening",AMGN,0.024691387550395794,0.40966825896493275,-0.014443855269326566,-0.02015221649050969,0.054334555533413376,0.005381226759546109,-0.00154687493100647,-0.005985235560657776,-0.4145415931414651
665,2014-08-04,Morning Market Movers ,AMGN,0.024691387550395794,0.40966825896493275,-0.014443855269326566,-0.02015221649050969,0.054334555533413376,0.005381226759546109,-0.00154687493100647,-0.005985235560657776,-0.4145415931414651
668,2014-08-28,Stocks Hitting 52-Week Highs,AMGN,0.00624004568885872,0.44798009802465466,0.004079249946086438,0.018399084551215417,0.014832000735046424,0.0021882170711333693,-0.0011303966559613743,0.004975299693988022,-0.3941841680129241
671,2014-09-17,Amgen's Poised To Break Even Higher,AMGN,0.009904410288426702,0.6427946141981742,0.009857135980268605,0.0005802296465051704,-0.00770029258406435,-0.0016519916839455862,0.01310113400780133,0.009310057219779733,-0.45180035017381814
673,2014-09-22,Amgen Submits Biologics License Application For Investigational BiTE Immunotherapy Blinatumomab,AMGN,-0.012707594663032507,-0.540107111422732,0.014012233384822714,0.009310057219779733,0.009904410288426702,0.009857135980268605,0.0005802296465051704,-0.01054975672765135,-0.2471454521863241
676,2014-10-09,UPDATE: Amgen's BiTE Received FDA Priority Review Designation,AMGN,-0.017776883740420413,-0.24040320353493505,0.029699412410685078,-0.011481522395539345,-0.011067311359842291,0.014212997464571941,-0.011670031325946573,-0.0013811152112969127,1.0906744228322123
679,2014-10-17,Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors,AMGN,0.024837334743826656,-0.07013660511004305,-0.0034380398746938212,-0.009833459721169002,-0.01018296718484879,-0.02787674460310008,-0.0013811152112969127,0.028573636995327556,-0.09898660137386928
682,2014-10-17,Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement,AMGN,0.024837334743826656,-0.07013660511004305,-0.0034380398746938212,-0.009833459721169002,-0.01018296718484879,-0.02787674460310008,-0.0013811152112969127,0.028573636995327556,-0.09898660137386928
685,2014-10-20,"Stocks To Watch For October 20, 2014",AMGN,0.028573636995327556,-0.09898660137386928,0.024837334743826656,-0.0034380398746938212,-0.009833459721169002,-0.01018296718484879,-0.02787674460310008,0.04785100306619028,0.35139949877713694
688,2014-10-21,Loeb Buys EBay Inc.; PayPal Not Threatened By Apple Inc.,AMGN,0.04785100306619028,0.35139949877713694,0.028573636995327556,0.024837334743826656,-0.0034380398746938212,-0.009833459721169002,-0.01018296718484879,-0.003123188077603367,-0.41661639520075067
690,2014-10-21,"Third Point's Notable Additions And Exit: Alibaba, eBay, Sony",AMGN,0.04785100306619028,0.35139949877713694,0.028573636995327556,0.024837334743826656,-0.0034380398746938212,-0.009833459721169002,-0.01018296718484879,-0.003123188077603367,-0.41661639520075067
692,2014-10-21,Third Point Notable Additions and Exit,AMGN,0.04785100306619028,0.35139949877713694,0.028573636995327556,0.024837334743826656,-0.0034380398746938212,-0.009833459721169002,-0.01018296718484879,-0.003123188077603367,-0.41661639520075067
694,2014-10-27,Amgen Beats Q3 Earnings Estimates,AMGN,0.0063834370761322035,-0.21545953670276774,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.028573636995327556,0.06066140110591478,1.785668064709407
696,2014-10-27,Amgen Beats 3Q Earnings Estimates,AMGN,0.0063834370761322035,-0.21545953670276774,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.028573636995327556,0.06066140110591478,1.785668064709407
698,2014-10-27,"#PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations",AMGN,0.0063834370761322035,-0.21545953670276774,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.028573636995327556,0.06066140110591478,1.785668064709407
699,2014-10-27,"#PreMarket Primer: Monday, October 27: ECB Stress Tests In Line With Expectations",AMGN,0.0063834370761322035,-0.21545953670276774,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.028573636995327556,0.06066140110591478,1.785668064709407
702,2014-10-27,"Earnings Scheduled For October 27, 2014",AMGN,0.0063834370761322035,-0.21545953670276774,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.028573636995327556,0.06066140110591478,1.785668064709407
703,2014-10-27,"Keep an Eye on These 7 Stocks for October 27, 2014",AMGN,0.0063834370761322035,-0.21545953670276774,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.028573636995327556,0.06066140110591478,1.785668064709407
713,2014-10-28,Amgen At All Time High As Deutsche Bank Ups Price Target,AMGN,0.06066140110591478,1.785668064709407,0.0063834370761322035,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.01075111683031138,-0.39175098079702664
715,2014-10-28,"#PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola",AMGN,0.06066140110591478,1.785668064709407,0.0063834370761322035,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.01075111683031138,-0.39175098079702664
724,2014-10-28,Amgen Rallies 2% After Announcing Growth And Capital Plans,AMGN,0.06066140110591478,1.785668064709407,0.0063834370761322035,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.01075111683031138,-0.39175098079702664
726,2014-10-28,Amgen Rallies 3% After Announcing Growth And Capital Plans,AMGN,0.06066140110591478,1.785668064709407,0.0063834370761322035,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.04785100306619028,0.01075111683031138,-0.39175098079702664
731,2014-10-29,UPDATE: Nomura Upgrades Amgen,AMGN,0.01075111683031138,-0.39175098079702664,0.06066140110591478,0.0063834370761322035,6.801659421595829e-05,0.025132368693973506,-0.003123188077603367,0.016993867498482196,-0.45337916206964834
733,2014-10-30,Ebola Vaccine Contenders,AMGN,0.016993867498482196,-0.45337916206964834,0.01075111683031138,0.06066140110591478,0.0063834370761322035,6.801659421595829e-05,0.025132368693973506,0.003713159017715739,1.062647172984862
741,2014-11-04,"Markets Mostly Lower As Americans Head To The Ballots, Oil Continues To Tumble",AMGN,-0.007118051360350264,-0.36141351007932965,-0.0038225760761764205,0.003713159017715739,0.016993867498482196,0.01075111683031138,0.06066140110591478,-0.009164104957032126,0.09247109438020984
743,2014-11-04,"Markets Mostly Lower As Americans Head To Vote, Oil Continues To Tumble",AMGN,-0.007118051360350264,-0.36141351007932965,-0.0038225760761764205,0.003713159017715739,0.016993867498482196,0.01075111683031138,0.06066140110591478,-0.009164104957032126,0.09247109438020984
746,2014-11-11,Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis,AMGN,-0.004108323515020662,-0.045936283969755465,0.021610705336469138,-0.0006236969242934265,0.00887144579045418,-0.009164104957032126,-0.007118051360350264,-0.003016827210166162,0.17017607852239935
749,2014-11-14,Jana Partners 13F Filing Shows Moves In Alibaba & Other Big Names,AMGN,-0.019707992287426812,0.23888476449723672,-0.006669070384047182,-0.003016827210166162,-0.004108323515020662,0.021610705336469138,-0.0006236969242934265,0.009259268281572197,-0.40910402379208555
750,2014-11-14,13F Filing From Jana Partners Shows Moves In Big Names,AMGN,-0.019707992287426812,0.23888476449723672,-0.006669070384047182,-0.003016827210166162,-0.004108323515020662,0.021610705336469138,-0.0006236969242934265,0.009259268281572197,-0.40910402379208555
753,2014-11-17,"Events for the Week of Nov. 17-21, 2014",AMGN,0.009259268281572197,-0.40910402379208555,-0.019707992287426812,-0.006669070384047182,-0.003016827210166162,-0.004108323515020662,0.021610705336469138,0.019479629633540663,0.177734375
756,2014-11-19,"#PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates Chaos In New York",AMGN,0.0024658101162848833,-0.22729302206914148,0.019479629633540663,0.009259268281572197,-0.019707992287426812,-0.006669070384047182,-0.003016827210166162,0.0002455021386673639,0.3244046390688844
760,2014-11-24,Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer,AMGN,0.008414798834710746,-0.4099273607748184,0.0007993684387239686,0.0002455021386673639,0.0024658101162848833,0.019479629633540663,0.009259268281572197,-0.011816517951248273,0.6253590480098481
763,2014-11-25,"#PreMarket Primer: Tuesday, November 25: Violent Protests In Ferguson Following Grand Jury Decision",AMGN,-0.011816517951248273,0.6253590480098481,0.008414798834710746,0.0007993684387239686,0.0002455021386673639,0.0024658101162848833,0.019479629633540663,0.015286128675749966,-0.4058739375578557
768,2014-12-11,Morgan Stanley: The Biotech Stock With The Most Upside In 2015,AMGN,0.004172075105712825,-0.0907111340324337,-0.023614214130341704,-0.013109029122845839,0.014180761730951508,0.016151628302907506,-0.00904379182195214,-0.009332671868188092,0.060845727249810855
770,2014-12-16,"Amgen Just Crashed 50% In Premarket, Here's How It Looked",AMGN,-0.001002699255565731,0.014565408847639016,-0.029964282904423878,-0.009332671868188092,0.004172075105712825,-0.023614214130341704,-0.013109029122845839,0.025338734853846523,-0.23924946581196582
776,2014-12-23,"BioTech Stocks Sell Off, ETFs Fall Over 5%",AMGN,-0.04260621802906717,0.7460790348393451,-0.033143203336994165,0.010031429151492688,0.030584373383182317,0.025338734853846523,-0.001002699255565731,0.01999721157699108,-0.686563165390527
781,2015-01-05,Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies,AMGN,-0.011883063500940816,0.5660934981192907,0.0037664294108119556,-0.008342239378103078,-0.013632093339868478,-0.003731735661850588,0.01736502545309282,-0.032216907859295874,0.2439771585422641
782,2015-01-05,Morning Market Losers,AMGN,-0.011883063500940816,0.5660934981192907,0.0037664294108119556,-0.008342239378103078,-0.013632093339868478,-0.003731735661850588,0.01736502545309282,-0.032216907859295874,0.2439771585422641
787,2015-01-12,Biotechs Presenting at the J.P. Morgan Healthcare Conference: Day Two,AMGN,0.0031463639810047628,-0.3161226608594363,-0.012304044410570758,-0.003602206097115701,0.03492444087212565,-0.032216907859295874,-0.011883063500940816,-0.006913505936781861,0.6923019957788721
789,2015-01-12,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2,AMGN,0.0031463639810047628,-0.3161226608594363,-0.012304044410570758,-0.003602206097115701,0.03492444087212565,-0.032216907859295874,-0.011883063500940816,-0.006913505936781861,0.6923019957788721
795,2015-01-13,Amgen's Decline May Be Linked To Comments Of Express Script's CEO,AMGN,-0.006913505936781861,0.6923019957788721,0.0031463639810047628,-0.012304044410570758,-0.003602206097115701,0.03492444087212565,-0.032216907859295874,0.0001287472330950834,-0.25030631892175736
797,2015-01-13,Amgen's Decline May Be Linked To Comments of Express Script's CEO,AMGN,-0.006913505936781861,0.6923019957788721,0.0031463639810047628,-0.012304044410570758,-0.003602206097115701,0.03492444087212565,-0.032216907859295874,0.0001287472330950834,-0.25030631892175736
799,2015-01-27,Amgen Beats Q4 Expectations,AMGN,-0.005258969815211012,-0.08677292354584709,-0.0005004805610862029,0.0015041212887203503,0.013915225223328775,-0.0013961846758586693,-0.005238721882783182,-0.026748135523564365,0.7129993394291276
803,2015-01-27,"Earnings Scheduled For January 27, 2015",AMGN,-0.005258969815211012,-0.08677292354584709,-0.0005004805610862029,0.0015041212887203503,0.013915225223328775,-0.0013961846758586693,-0.005238721882783182,-0.026748135523564365,0.7129993394291276
806,2015-02-11,FDA Advisory Committee To Review Amgen's Talimogene Laherparepvec,AMGN,0.003539217198708533,-0.026748770870856253,0.02245005960705493,-0.009180705226833674,-0.012780576579266234,0.012611477705853691,-0.005123873895184983,0.00045724217895326547,-0.2658113887013279
809,2015-02-18,Dan Loeb's Diversified Portfolio Looks Jinx-Proof,AMGN,0.00998439091239467,-0.15342951021665474,0.004952002926664534,0.001958339574485768,0.00045724217895326547,0.003539217198708533,0.02245005960705493,0.001733174836594742,0.18678553018587585
811,2015-03-09,Analyst: 'Mess Continues' With Amgen Neupogen Competitor,AMGN,0.0008393361689067458,-0.47817373026347954,-0.02957404391909546,0.002575785896423044,0.003973190841780605,-0.006702962336550433,0.012109997773648074,-0.009224955019570658,0.64384074941452
813,2015-03-09,Analyst: 'Mess Continues' With Amgen Inc. Neupogen Competitor,AMGN,0.0008393361689067458,-0.47817373026347954,-0.02957404391909546,0.002575785896423044,0.003973190841780605,-0.006702962336550433,0.012109997773648074,-0.009224955019570658,0.64384074941452
815,2015-03-20,CVS Says New Cholesterol Drug Types Could Be Costly,AMGN,0.005854254470787135,1.4065910663898205,0.015431791091055524,0.02127922550193917,0.00024550011185198173,0.05685204735646754,6.44040492063791e-05,-0.020929000769794537,-0.5708360064597482
822,2015-03-27,Expert Explains Why Investors Might Want To Stay Away From The IBB ETF,AMGN,0.012706171858173576,-0.2248847926267281,-0.0004356848619908593,-0.03246827899455318,-0.003182167381774903,-0.020929000769794537,0.005854254470787135,0.01057907989711615,-0.020829062282176403
824,2015-04-06,US Stock Futures Signal Lower Start On Wall Street,AMGN,-0.0038492673125110066,0.05654682939771827,-0.007765768199003209,-0.01720347140964451,-0.0271440819737776,0.01057907989711615,0.012706171858173576,0.012880143332794969,-0.07630975923658856
827,2015-04-21,Kinahan: Amgen Inc. To Trade Up 3% On Q1 Earnings News,AMGN,0.015002830505552067,0.3744793364482597,0.014610755336914583,-0.019715840483154334,0.00846037031525082,0.017838239676748247,0.0004926318036979627,0.0037990068079101214,0.41040371034046585
828,2015-04-21,2 Amgen Charts To Watch Before Earnings,AMGN,0.015002830505552067,0.3744793364482597,0.014610755336914583,-0.019715840483154334,0.00846037031525082,0.017838239676748247,0.0004926318036979627,0.0037990068079101214,0.41040371034046585
832,2015-04-21,"Amgen Tops Q1 Expectations, Shares Gain",AMGN,0.015002830505552067,0.3744793364482597,0.014610755336914583,-0.019715840483154334,0.00846037031525082,0.017838239676748247,0.0004926318036979627,0.0037990068079101214,0.41040371034046585
836,2015-04-21,"Earnings Scheduled For April 21, 2015",AMGN,0.015002830505552067,0.3744793364482597,0.014610755336914583,-0.019715840483154334,0.00846037031525082,0.017838239676748247,0.0004926318036979627,0.0037990068079101214,0.41040371034046585
839,2015-04-21,10 Stocks You Should Be Watching Today,AMGN,0.015002830505552067,0.3744793364482597,0.014610755336914583,-0.019715840483154334,0.00846037031525082,0.017838239676748247,0.0004926318036979627,0.0037990068079101214,0.41040371034046585
842,2015-05-06,"Goldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis Oncology",AMGN,-0.003073382788001955,0.2192806221646144,-0.016470083010368564,0.010912997668291124,0.015514897640874104,-0.019070650115786347,-0.009292869960018102,-0.006605917363022407,0.16246312488372716
844,2015-05-15,US Stock Futures Edge Higher Ahead Of Economic Data,AMGN,0.002346241161104823,-0.12250229990800365,0.02266576807922127,0.0009480154508136884,-0.012604918906524265,-0.007946232568079581,0.02811915046426061,0.00665177436072284,-0.09674578545668033
847,2015-05-26,"Amgen Inc., AstraZeneca End Development Pact; Shares Sink",AMGN,-0.02793755665574227,1.4928484107579463,-0.0015870919921590065,-0.00085350188507749,0.002567777851649078,0.0007340730516094407,0.00665177436072284,0.008993259792603236,-0.18193855282838434
849,2015-05-26,"Amgen, AstraZeneca End Development Pact; Shares Sink",AMGN,-0.02793755665574227,1.4928484107579463,-0.0015870919921590065,-0.00085350188507749,0.002567777851649078,0.0007340730516094407,0.00665177436072284,0.008993259792603236,-0.18193855282838434
851,2015-06-01,16 Biotech Stocks Moving Off The ASCO Conference,AMGN,0.004928187101149284,-0.35441632874974516,-0.006927179588419041,-0.019259653791784515,0.008993259792603236,-0.02793755665574227,-0.0015870919921590065,-0.0037577202058362014,-0.12372798091094117
854,2015-06-01,Top Gainers And Losers From The ASCO Conference,AMGN,0.004928187101149284,-0.35441632874974516,-0.006927179588419041,-0.019259653791784515,0.008993259792603236,-0.02793755665574227,-0.0015870919921590065,-0.0037577202058362014,-0.12372798091094117
856,2015-06-01,Amgen Presents Phase 3 Data At ASCO Showing Prolia Significantly Reduced Bone Fractures In Breast Cancer Patients Receiving Aromatase Inhibitors,AMGN,0.004928187101149284,-0.35441632874974516,-0.006927179588419041,-0.019259653791784515,0.008993259792603236,-0.02793755665574227,-0.0015870919921590065,-0.0037577202058362014,-0.12372798091094117
861,2015-06-02,Report: AstraZeneca PLC Might Bid On Juno Therapeutics Inc.,AMGN,-0.0037577202058362014,-0.12372798091094117,0.004928187101149284,-0.006927179588419041,-0.019259653791784515,0.008993259792603236,-0.02793755665574227,0.00441073043608764,-0.13483101073201986
863,2015-06-10,"FDA Panel Clears Product Path For Sanofi SA, Regeneron Pharmaceuticals Inc",AMGN,0.004844795234637322,1.1593637020968908,-0.010672550562987437,-0.004960448250142635,-0.005313189386728756,0.00610944393733881,0.00441073043608764,0.015493432152613007,-0.3916755960353603
865,2015-06-29,Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent,AMGN,-0.040627540525851824,0.352440713417564,-0.00466108633547313,-0.007067535469655217,-0.011132157108961871,-0.0032674089637938497,0.009332682450688967,0.012664916155146422,-0.1863191773950844
867,2015-07-09,US Stock Futures Jump Ahead Of Jobless Claims Data,AMGN,-0.006565459412720798,0.7323166910382286,-0.01982145622950615,0.005760814354564436,0.008090924190271798,-0.011162182485262795,0.009575345648926481,0.018439030721331573,-0.0409280563393869
869,2015-07-09,Benzinga's Top #PreMarket Losers,AMGN,-0.006565459412720798,0.7323166910382286,-0.01982145622950615,0.005760814354564436,0.008090924190271798,-0.011162182485262795,0.009575345648926481,0.018439030721331573,-0.0409280563393869
873,2015-07-21,"European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha, The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol",AMGN,-0.0038941181152204463,-0.0008913980092111196,0.00655322156493221,0.0014107653323220948,0.016142264248770966,0.007092581942891085,0.02285556839131697,0.003359690197775711,-0.21676579925650563
874,2015-07-21,"US Stock Futures Mixed; All Eyes On Apple, Microsoft Earnings",AMGN,-0.0038941181152204463,-0.0008913980092111196,0.00655322156493221,0.0014107653323220948,0.016142264248770966,0.007092581942891085,0.02285556839131697,0.003359690197775711,-0.21676579925650563
880,2015-07-27,"Benzinga's M&A Chatter for Monday July 27, 2015",AMGN,0.043823830559067245,0.3052803409889586,-0.033577163823760414,-0.0009132110386728121,0.003359690197775711,-0.0038941181152204463,0.00655322156493221,0.04349426369764697,0.48572222608212323
883,2015-07-27,A Big Day for Biotech and it's not Going so Well,AMGN,0.043823830559067245,0.3052803409889586,-0.033577163823760414,-0.0009132110386728121,0.003359690197775711,-0.0038941181152204463,0.00655322156493221,0.04349426369764697,0.48572222608212323
885,2015-07-28,Is More M&A On The Way For Large-Cap Biotechs?,AMGN,0.04349426369764697,0.48572222608212323,0.043823830559067245,-0.033577163823760414,-0.0009132110386728121,0.003359690197775711,-0.0038941181152204463,-0.007352278423826242,-0.4023218294051627
887,2015-07-30,"Even With Recent Declines, Investors Still Love Biotech ETFs",AMGN,0.0012830904685769973,-0.2089470492733212,-0.007352278423826242,0.04349426369764697,0.043823830559067245,-0.033577163823760414,-0.0009132110386728121,0.0285397226194255,0.8024776835389826
889,2015-07-30,"Thursday's After-Hours Movers: Earnings Shaking LinkedIn, Expedia, EA, Amgen & Boston Beer Co",AMGN,0.0012830904685769973,-0.2089470492733212,-0.007352278423826242,0.04349426369764697,0.043823830559067245,-0.033577163823760414,-0.0009132110386728121,0.0285397226194255,0.8024776835389826
891,2015-07-30,"Thursday's After-Hours Movers: Earnings Moving LinkedIn, Expedia, EA, Amgen & Boston Beer Co",AMGN,0.0012830904685769973,-0.2089470492733212,-0.007352278423826242,0.04349426369764697,0.043823830559067245,-0.033577163823760414,-0.0009132110386728121,0.0285397226194255,0.8024776835389826
893,2015-07-30,"Amgen Posts Upbeat Q2 Results, Lifts 2015 Guidance",AMGN,0.0012830904685769973,-0.2089470492733212,-0.007352278423826242,0.04349426369764697,0.043823830559067245,-0.033577163823760414,-0.0009132110386728121,0.0285397226194255,0.8024776835389826
899,2015-07-30,"Earnings Scheduled For July 30, 2015",AMGN,0.0012830904685769973,-0.2089470492733212,-0.007352278423826242,0.04349426369764697,0.043823830559067245,-0.033577163823760414,-0.0009132110386728121,0.0285397226194255,0.8024776835389826
902,2015-07-31,7 Must Watch Stocks for Today,AMGN,0.0285397226194255,0.8024776835389826,0.0012830904685769973,-0.007352278423826242,0.04349426369764697,0.043823830559067245,-0.033577163823760414,-0.005662965135994957,-0.5990616511647049
905,2015-07-31,Stocks Hitting 52-Week Highs,AMGN,0.0285397226194255,0.8024776835389826,0.0012830904685769973,-0.007352278423826242,0.04349426369764697,0.043823830559067245,-0.033577163823760414,-0.005662965135994957,-0.5990616511647049
908,2015-08-18,"Dan Loeb, Still Bullish On Amgen, Allergan and Dow Chemical, Sells Out Of Dollar General",AMGN,-0.012191952482189516,0.1431013676588897,0.012342430812166238,-0.005101775659486774,-0.007360069705395489,0.012220978221873402,-0.011957725234079786,-0.006856504856822543,0.3811031934547373
910,2015-08-21,"The Other Bearish Biotech ETF Is Looking Groovy, Too",AMGN,-0.03698377258986629,0.7779941577409932,-0.03253888948719452,-0.006856504856822543,-0.012191952482189516,0.012342430812166238,-0.005101775659486774,-0.048650165557150404,0.40092455383029435
912,2015-09-16,Mid-Morning Market Update: Markets Mixed; FedEx Earnings Miss Estimates,AMGN,-0.00630971541697789,0.5640184360596829,0.007549798613764924,-0.014424867796489549,0.00045681955479315306,0.013635380710192546,-0.02251538023616695,0.018057894960166188,-0.12104789970530938
914,2015-09-16,Morning Market Gainers,AMGN,-0.00630971541697789,0.5640184360596829,0.007549798613764924,-0.014424867796489549,0.00045681955479315306,0.013635380710192546,-0.02251538023616695,0.018057894960166188,-0.12104789970530938
919,2015-09-25,Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe,AMGN,-0.03470129502301322,0.49002614230506936,-0.01516630308920297,-0.0014386886524745401,-0.007886405401439922,-0.023241899592480575,-0.021571317453897842,-0.04540535202194507,0.43309113793695286
922,2015-10-02,US Stock Futures Up; All Eyes On Jobs Report,AMGN,0.01597415182818751,0.02728886417588061,0.013808040560751467,0.033627376680706034,0.011948198572852897,-0.04540535202194507,-0.03470129502301322,0.009335189347218664,-0.09085042156760692
926,2015-10-02,FDA Accepts Novartis/Sandoz Regulatory Submission for Proposed Biosimilar to Enbrel,AMGN,0.01597415182818751,0.02728886417588061,0.013808040560751467,0.033627376680706034,0.011948198572852897,-0.04540535202194507,-0.03470129502301322,0.009335189347218664,-0.09085042156760692
927,2015-10-06,Biotech Bears Spark Good Vibes For These ETFs,AMGN,-0.017941794424201074,0.08989947562455636,0.009335189347218664,0.01597415182818751,0.013808040560751467,0.033627376680706034,0.011948198572852897,0.0483644732705899,0.681282433766834
928,2015-10-06,Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary,AMGN,-0.017941794424201074,0.08989947562455636,0.009335189347218664,0.01597415182818751,0.013808040560751467,0.033627376680706034,0.011948198572852897,0.0483644732705899,0.681282433766834
932,2015-10-07,"Benzinga's M&A Chatter for Wednesday October 7, 2015",AMGN,0.0483644732705899,0.681282433766834,-0.017941794424201074,0.009335189347218664,0.01597415182818751,0.013808040560751467,0.033627376680706034,0.012495461035457733,-0.17043636908927318
935,2015-10-12,New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide,AMGN,0.02299626934017973,0.7764289655620111,-0.0020678051492709626,0.012495461035457733,0.0483644732705899,-0.017941794424201074,0.009335189347218664,-0.03561377065303972,-0.24284670199159508
938,2015-10-14,Biotech ETFs Get More Refined With Debut Of Cancer Immunotherapy Fund,AMGN,0.0015581315986510358,-0.22840802142908856,-0.03561377065303972,0.02299626934017973,-0.0020678051492709626,0.012495461035457733,0.0483644732705899,0.03200050337741023,0.022580846938137222
944,2015-10-23,10 S&P 100 Companies Paying The Highest And Lowest Taxes,AMGN,0.022585657977355345,-0.1035589979900976,0.014791168101925933,-0.00239266735842536,-0.026024676981541983,0.01218800060682712,0.00045892671066338764,0.01817026186516335,0.18847237032783748
950,2015-10-23,Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec),AMGN,0.022585657977355345,-0.1035589979900976,0.014791168101925933,-0.00239266735842536,-0.026024676981541983,0.01218800060682712,0.00045892671066338764,0.01817026186516335,0.18847237032783748
953,2015-10-27,"Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure",AMGN,0.0214399785785766,-0.10799245387199186,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.00239266735842536,-0.026024676981541983,0.004260011394765284,0.2583565459610029
956,2015-10-27,"Perhaps It's Time To Buy, Buy, Buy Biotech ETFs",AMGN,0.0214399785785766,-0.10799245387199186,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.00239266735842536,-0.026024676981541983,0.004260011394765284,0.2583565459610029
958,2015-10-28,"Amgen Posts Upbeat Q3 Results, Lifts Forecast",AMGN,0.004260011394765284,0.2583565459610029,0.0214399785785766,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.00239266735842536,-0.01284819689602923,-0.0017831888335485546
959,2015-10-28,"Lifelock, Yelp Surge Following Earnings Report; B-Dubs, GoPro Crash",AMGN,0.004260011394765284,0.2583565459610029,0.0214399785785766,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.00239266735842536,-0.01284819689602923,-0.0017831888335485546
962,2015-10-28,"Lifelock, Yelp Surges Following Earnings Report, B-Dubs, GoPro Crashing",AMGN,0.004260011394765284,0.2583565459610029,0.0214399785785766,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.00239266735842536,-0.01284819689602923,-0.0017831888335485546
965,2015-10-28,"Keep an Eye on These 10 Stocks for October 28, 2015",AMGN,0.004260011394765284,0.2583565459610029,0.0214399785785766,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.00239266735842536,-0.01284819689602923,-0.0017831888335485546
968,2015-10-28,"Earnings Scheduled For October 28, 2015",AMGN,0.004260011394765284,0.2583565459610029,0.0214399785785766,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.00239266735842536,-0.01284819689602923,-0.0017831888335485546
971,2015-10-29,"10 Stocks To Watch For October 29, 2015",AMGN,-0.01284819689602923,-0.0017831888335485546,0.004260011394765284,0.0214399785785766,0.01817026186516335,0.022585657977355345,0.014791168101925933,-0.014946052285346623,-0.05759517062954289
974,2015-11-03,11 Activist Investors Who Have Shaped The Market,AMGN,0.0009242773428939088,-0.2516679596586501,0.026109807532454843,-0.014946052285346623,-0.01284819689602923,0.004260011394765284,0.0214399785785766,-0.0035702305298271897,0.26871241965581594
976,2015-11-09,Amgen Issues Presentation of Results from Phase 3 Study Showing Clinical Equivalence of ABP 501 with Adalimumab,AMGN,-0.005173266941423282,-0.18594497607655502,-0.004713665922214227,-0.004077248904356234,-0.0035702305298271897,0.0009242773428939088,0.026109807532454843,-0.007892715401357053,0.05477187568878117
979,2015-11-10,"Benzinga's M&A Chatter for Tuesday November 10, 2015",AMGN,-0.007892715401357053,0.05477187568878117,-0.005173266941423282,-0.004713665922214227,-0.004077248904356234,-0.0035702305298271897,0.0009242773428939088,-0.009534909618465037,-0.3311740326681294
982,2015-11-19,European Commission Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma,AMGN,-0.008886171917960484,-0.31413401438268695,0.021065943578374435,0.02006449949705158,0.01946574428165504,0.0037752763759939523,-0.03261349677709657,0.002633290950259548,0.3365997060264576
985,2015-11-24,EC Approves Amgen's BLINCYTO for Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia,AMGN,0.0019080061746856725,-0.1154879570098839,0.016008913215068254,0.002633290950259548,-0.008886171917960484,0.021065943578374435,0.02006449949705158,0.007187575324790085,-0.4211554109031733
986,2015-12-01,"Benzinga's M&A Chatter for Tuesday December 1, 2015",AMGN,0.00546252732666086,-0.18560987058271305,-0.014799545755946442,-0.0026224056288244313,0.007187575324790085,0.0019080061746856725,0.016008913215068254,-0.009013758857977505,0.18221490325236722
989,2015-12-04,"Application for Amgen's Biosimilar Candidate to Humira, Submitted to EMA",AMGN,0.043841020959568544,-0.1225663518775455,-0.03656847748037906,-0.009013758857977505,0.00546252732666086,-0.014799545755946442,-0.0026224056288244313,-0.01938935339664738,-0.09033640235660179
990,2015-12-14,"M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down",AMGN,0.01907850779442466,-0.07489104035665572,-0.028308364312464862,0.011273685734339178,-0.009162407897998492,0.006633252227477238,-0.01938935339664738,0.02852419541042206,0.9296554700424369
993,2015-12-14,M&A In Smid Cap Biotechs Isn't Slowing Down,AMGN,0.01907850779442466,-0.07489104035665572,-0.028308364312464862,0.011273685734339178,-0.009162407897998492,0.006633252227477238,-0.01938935339664738,0.02852419541042206,0.9296554700424369
996,2015-12-15,Benzinga's Top #PreMarket Gainers,AMGN,0.02852419541042206,0.9296554700424369,0.01907850779442466,-0.028308364312464862,0.011273685734339178,-0.009162407897998492,0.006633252227477238,0.012052708021342173,-0.26874906813776656
999,2015-12-18,EC Approves Amgen's IMLYGIC as First Oncolytic Immunotherapy In Europe,AMGN,-0.01629203458285855,0.68324593177272,-0.019139623535963324,0.012052708021342173,0.02852419541042206,0.01907850779442466,-0.028308364312464862,0.0030229418487097703,-0.3867191263850972
1000,2015-12-21,"Benzinga's M&A Chatter for Monday December 21, 2015",AMGN,0.0030229418487097703,-0.3867191263850972,-0.01629203458285855,-0.019139623535963324,0.012052708021342173,0.02852419541042206,0.01907850779442466,0.018960056245889367,-0.18157060933776747
1003,2016-01-04,Mid-Afternoon Market Update: Netflix Drops Following Baird Downgrade; Lululemon Shares Rise,AMGN,-0.024579812975977444,1.8623233290162733,-0.0058787175803471925,-0.006993538630708174,0.016756574208908193,-0.011128276382875613,0.005100949887905548,-0.001073594300735059,-0.4729894554611268
1006,2016-01-04,Mid-Day Market Update: Baxalta Shares Surge Amid Report Of Shire Interest; Canadian Solar Shares Slide,AMGN,-0.024579812975977444,1.8623233290162733,-0.0058787175803471925,-0.006993538630708174,0.016756574208908193,-0.011128276382875613,0.005100949887905548,-0.001073594300735059,-0.4729894554611268
1007,2016-01-04,Benzinga's Top #PreMarket Gainers,AMGN,-0.024579812975977444,1.8623233290162733,-0.0058787175803471925,-0.006993538630708174,0.016756574208908193,-0.011128276382875613,0.005100949887905548,-0.001073594300735059,-0.4729894554611268
1011,2016-01-04,"Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter",AMGN,-0.024579812975977444,1.8623233290162733,-0.0058787175803471925,-0.006993538630708174,0.016756574208908193,-0.011128276382875613,0.005100949887905548,-0.001073594300735059,-0.4729894554611268
1015,2016-01-15,Write A Prescription For This Healthcare ETF,AMGN,-0.012144103662530603,0.09984067976633026,0.052935302081249525,-0.035346929194517984,0.02098974262286113,-0.02003845939071358,-0.014838332364762508,0.0,-0.29467246096893607
1021,2016-01-22,Amgen's Repatha) Approved in Japan as First PCSK9 Inhibitor for Treatment of High Cholesterol,AMGN,0.021599919406044776,-0.02068891741548995,-0.014449832782317262,0.024586978530996895,0.0,-0.012144103662530603,0.052935302081249525,-0.016978767448443066,0.04102855395101912
1022,2016-01-22,Amgen's Repatha Approved in Japan as First PCSK9 Inhibitor for Treatment of High Cholesterol,AMGN,0.021599919406044776,-0.02068891741548995,-0.014449832782317262,0.024586978530996895,0.0,-0.012144103662530603,0.052935302081249525,-0.016978767448443066,0.04102855395101912
1023,2016-01-25,FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501,AMGN,-0.016978767448443066,0.04102855395101912,0.021599919406044776,-0.014449832782317262,0.024586978530996895,0.0,-0.012144103662530603,0.002281368308055809,-0.23495834295187934
1026,2016-01-28,Earnings Recap For January 28,AMGN,-0.014089110203015287,0.1317058870559391,-0.02152440646227427,0.002281368308055809,-0.016978767448443066,0.021599919406044776,-0.014449832782317262,0.02952480995520257,0.6894854586129755
1028,2016-01-28,"Why Amazon, Microsoft, Xerox And Amgen Are Moving In After-Hours",AMGN,-0.014089110203015287,0.1317058870559391,-0.02152440646227427,0.002281368308055809,-0.016978767448443066,0.021599919406044776,-0.014449832782317262,0.02952480995520257,0.6894854586129755
1030,2016-01-28,"Why Amazon, Microsoft, Xerox And Amgen Are Moving After-Hours",AMGN,-0.014089110203015287,0.1317058870559391,-0.02152440646227427,0.002281368308055809,-0.016978767448443066,0.021599919406044776,-0.014449832782317262,0.02952480995520257,0.6894854586129755
1034,2016-01-28,"Earnings Scheduled For January 28, 2016",AMGN,-0.014089110203015287,0.1317058870559391,-0.02152440646227427,0.002281368308055809,-0.016978767448443066,0.021599919406044776,-0.014449832782317262,0.02952480995520257,0.6894854586129755
1037,2016-01-29,Maybe Some Good News For A Big Biotech ETF,AMGN,0.02952480995520257,0.6894854586129755,-0.014089110203015287,-0.02152440646227427,0.002281368308055809,-0.016978767448443066,0.021599919406044776,0.00013110049527886858,-0.35852475468331846
1043,2016-02-08,"Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts",AMGN,-0.014065213100566631,-0.28280041538151557,-0.0324862097301577,-0.0051760148015719265,0.0038637571415007788,-0.01728327590195733,0.00013110049527886858,0.0011191792606426443,-0.08994446005229828
1047,2016-02-08,Pharmaceuticals Turn To Politics To Protect Prices,AMGN,-0.014065213100566631,-0.28280041538151557,-0.0324862097301577,-0.0051760148015719265,0.0038637571415007788,-0.01728327590195733,0.00013110049527886858,0.0011191792606426443,-0.08994446005229828
1053,2016-02-10,The Generic Drug Battle,AMGN,0.0115250292337441,0.014817981050081919,0.0011191792606426443,-0.014065213100566631,-0.0324862097301577,-0.0051760148015719265,0.0038637571415007788,-0.01634084417954651,0.023610623610623716
1059,2016-03-08,Bet On Gender Equality With This New ETF,AMGN,-0.018193141103175492,-0.06548127363669631,0.009111183320945626,0.0009599993846158839,-0.011187205277721546,-0.006065039419070661,0.04294329055560109,-0.02579023686437676,0.9827681864168925
1065,2016-03-16,"Jury In Repatha Patent Case Ruled In Favor Of Amgen, Against Regeneron, Sanofi",AMGN,0.005376503424704859,1.0119636147913784,-0.009749499531724104,0.0003456377572745861,0.025101320798029736,0.0009227956195472231,-0.02579023686437676,0.0010419417425548971,-0.19738889707929952
1068,2016-03-16,The Plot Thickens At Amgen; Piper Still Overweight,AMGN,0.005376503424704859,1.0119636147913784,-0.009749499531724104,0.0003456377572745861,0.025101320798029736,0.0009227956195472231,-0.02579023686437676,0.0010419417425548971,-0.19738889707929952
1071,2016-03-16,"Jury In Repatha Patent Case Ruled In Favor Of Amgen, Against Regeneron And Sanofi",AMGN,0.005376503424704859,1.0119636147913784,-0.009749499531724104,0.0003456377572745861,0.025101320798029736,0.0009227956195472231,-0.02579023686437676,0.0010419417425548971,-0.19738889707929952
1075,2016-03-16,Chardan Downgrades Regeneron To Sell,AMGN,0.005376503424704859,1.0119636147913784,-0.009749499531724104,0.0003456377572745861,0.025101320798029736,0.0009227956195472231,-0.02579023686437676,0.0010419417425548971,-0.19738889707929952
1077,2016-03-17,A Rare Opportunity With A Biotechnology ETF,AMGN,0.0010419417425548971,-0.19738889707929952,0.005376503424704859,-0.009749499531724104,0.0003456377572745861,0.025101320798029736,0.0009227956195472231,0.00957469303565528,0.3883707165744841
1078,2016-03-17,"The Market In 5 Minutes: Thursday, March 17, 2016",AMGN,0.0010419417425548971,-0.19738889707929952,0.005376503424704859,-0.009749499531724104,0.0003456377572745861,0.025101320798029736,0.0009227956195472231,0.00957469303565528,0.3883707165744841
1084,2016-04-13,"SunTrust: Medivation M&A Chatter Highlights The Value, Company Is 'Unique' In Industry",AMGN,0.009205475020666265,0.3970471158717521,0.014131447243405981,-0.00044765779728228594,-0.005845765410936954,-0.014280350751702753,0.04387105118425816,0.0003752101065621627,-0.3765735895974719
1086,2016-04-13,"SunTrust: Medivation M&A Chatter Highlights Value, Company's 'Unique' Industry Position",AMGN,0.009205475020666265,0.3970471158717521,0.014131447243405981,-0.00044765779728228594,-0.005845765410936954,-0.014280350751702753,0.04387105118425816,0.0003752101065621627,-0.3765735895974719
1090,2016-04-20,2 Winners From AACR Flying Under The Radar,AMGN,0.004071099541757661,-0.11834385443743034,0.0024743737142629563,0.009804206610174004,6.235586773972734e-05,0.0003752101065621627,0.009205475020666265,0.009769047310246526,-0.01090847828833763
1096,2016-04-26,Big Biotech In The Earnings Spotlight,AMGN,-0.003731706499636611,0.3509991856167387,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,0.004071099541757661,0.0024743737142629563,-0.011360248052844635,0.2656496336826486
1102,2016-04-28,Goldman Sees Potential Medivation Buyout Value Near $70/Share,AMGN,-0.002732843313731581,0.2288331196189779,-0.011360248052844635,-0.003731706499636611,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,-0.014075935569819564,0.6059747771384276
1104,2016-04-28,Why Medivation Will Likely Reject Sanofi's $52.50/Share Buyout Offer,AMGN,-0.002732843313731581,0.2288331196189779,-0.011360248052844635,-0.003731706499636611,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,-0.014075935569819564,0.6059747771384276
1106,2016-04-28,What's Next For Medivation After Sanofi's Bid?,AMGN,-0.002732843313731581,0.2288331196189779,-0.011360248052844635,-0.003731706499636611,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,-0.014075935569819564,0.6059747771384276
1107,2016-04-28,Biotech Boom May Continue Through Earnings Season,AMGN,-0.002732843313731581,0.2288331196189779,-0.011360248052844635,-0.003731706499636611,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,-0.014075935569819564,0.6059747771384276
1111,2016-04-28,Medivation Will Likely Reject Sanofi's $52.50/Share Buyout Offer: Here's Why,AMGN,-0.002732843313731581,0.2288331196189779,-0.011360248052844635,-0.003731706499636611,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,-0.014075935569819564,0.6059747771384276
1113,2016-04-28,What's Likely Next For Medivation After Sanofi's Bid,AMGN,-0.002732843313731581,0.2288331196189779,-0.011360248052844635,-0.003731706499636611,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,-0.014075935569819564,0.6059747771384276
1117,2016-04-28,"Earnings Scheduled For April 28, 2016",AMGN,-0.002732843313731581,0.2288331196189779,-0.011360248052844635,-0.003731706499636611,0.0016544566467624477,-0.007058148697005273,0.009769047310246526,-0.014075935569819564,0.6059747771384276
1120,2016-05-05,"Benzinga's M&A Chatter for Thursday May 5, 2016",AMGN,0.0004541565633506828,-0.23717359926518833,-0.013879322762284207,-0.0166047672488987,0.00435899246976823,-0.014075935569819564,-0.002732843313731581,-0.0068718635603287614,0.2921647888535306
1123,2016-05-09,"Benzinga's M&A Chatter for Monday May 9, 2016",AMGN,0.014491630374478648,-0.00489217252396168,-0.0068718635603287614,0.0004541565633506828,-0.013879322762284207,-0.0166047672488987,0.00435899246976823,0.011775371036978566,-0.1354804187150931
1126,2016-05-10,The Market In 5 Minutes,AMGN,0.011775371036978566,-0.1354804187150931,0.014491630374478648,-0.0068718635603287614,0.0004541565633506828,-0.013879322762284207,-0.0166047672488987,-0.019460825961402972,0.0606576402321084
1128,2016-05-10,The Market In 5 Minutes: Better Late Than Never,AMGN,0.011775371036978566,-0.1354804187150931,0.014491630374478648,-0.0068718635603287614,0.0004541565633506828,-0.013879322762284207,-0.0166047672488987,-0.019460825961402972,0.0606576402321084
1131,2016-05-10,Report: Medivation Committed Toward Selling Itself,AMGN,0.011775371036978566,-0.1354804187150931,0.014491630374478648,-0.0068718635603287614,0.0004541565633506828,-0.013879322762284207,-0.0166047672488987,-0.019460825961402972,0.0606576402321084
1133,2016-05-10,Report: Medivation Committed Towards Selling Itself,AMGN,0.011775371036978566,-0.1354804187150931,0.014491630374478648,-0.0068718635603287614,0.0004541565633506828,-0.013879322762284207,-0.0166047672488987,-0.019460825961402972,0.0606576402321084
1134,2016-05-10,Report: Medivation Committed To Selling Itself,AMGN,0.011775371036978566,-0.1354804187150931,0.014491630374478648,-0.0068718635603287614,0.0004541565633506828,-0.013879322762284207,-0.0166047672488987,-0.019460825961402972,0.0606576402321084
1137,2016-05-25,"Benzinga's M&A Chatter for Wednesday May 25, 2016",AMGN,0.018661919903232294,0.18291359938008522,0.022907080500406574,-0.005859863220796124,0.010156601741154958,-0.014320699355153454,0.00479654557643272,-0.00012859431252554288,-0.40761848612885265
1140,2016-05-27,Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma Treatment,AMGN,0.007650136450500611,-0.24582550038703965,-0.00012859431252554288,0.018661919903232294,0.022907080500406574,-0.005859863220796124,0.010156601741154958,0.0077195721058684885,1.3492668621700878
1144,2016-06-21,Watch These 7 Huge Put Purchases In Tuesday Trade,AMGN,-0.008164612294814244,-0.19329333948623284,0.006884421533479346,-0.01759710340123133,0.0026336589241104935,-0.007124819783595249,-0.0005882084559803991,0.0026099291802874625,0.7047135992677904
1147,2016-06-22,Biotechs Are Ripping Following IPAB Ruling,AMGN,0.0026099291802874625,0.7047135992677904,-0.008164612294814244,0.006884421533479346,-0.01759710340123133,0.0026336589241104935,-0.007124819783595249,0.01642078676814518,-0.32878459094874835
1151,2016-06-29,Regeneron Is 'One Of The Stronger Growers In Biotech',AMGN,0.011319232106677957,-0.1326816927322907,0.026559565214905545,-0.012768773476556583,-0.03822163234174247,0.01642078676814518,0.0026099291802874625,0.013657737813113524,-0.07700670891782235
1155,2016-07-07,Here's Why Valeant Is Happy To Relinquish Its European Brodalumab Rights,AMGN,0.0034608925686572256,-0.36434533124673973,0.011537848390668515,-6.483478597563153e-05,0.013999229403576452,0.013657737813113524,0.011319232106677957,0.02880136349719753,0.5352262935456076
1158,2016-07-11,Amgen Gets FDA Approval For Its PCSK9 Inhibitor,AMGN,-0.005710902427508269,-0.34125350795135645,0.02880136349719753,0.0034608925686572256,0.011537848390668515,-6.483478597563153e-05,0.013999229403576452,0.011112728166705388,-0.023329411287377755
1159,2016-07-11,Amgen Gets FDA Approval For PCSK9 Inhibitor,AMGN,-0.005710902427508269,-0.34125350795135645,0.02880136349719753,0.0034608925686572256,0.011537848390668515,-6.483478597563153e-05,0.013999229403576452,0.011112728166705388,-0.023329411287377755
1162,2016-07-14,Can Strong JP Morgan Earnings Distract from Bearish UK Rate Decision?,AMGN,0.013829750302603916,-0.0917601604874062,-0.008891198992933336,0.011112728166705388,-0.005710902427508269,0.02880136349719753,0.0034608925686572256,0.003318391648971186,0.3005971858638743
1164,2016-07-25,"The Market In 5 Minutes: Yahoo, Outerwall Highlight Merger Monday",AMGN,0.005372405372405353,0.08178691409374506,0.009013560785846142,0.005758349794945161,0.004676992257178991,-0.0027005938843998045,-0.002143398733482349,0.006664342544396407,0.06606528892010788
1166,2016-07-26,Wait On The DNC Before Going Long Biotech ETFs,AMGN,0.006664342544396407,0.06606528892010788,0.005372405372405353,0.009013560785846142,0.005758349794945161,0.004676992257178991,-0.0027005938843998045,0.017951641506908977,0.4565820502150091
1168,2016-07-27,"Earnings Scheduled For July 27, 2016",AMGN,0.017951641506908977,0.4565820502150091,0.006664342544396407,0.005372405372405353,0.009013560785846142,0.005758349794945161,0.004676992257178991,0.003515433101749954,0.23625065473072704
1169,2016-07-27,"12 Must Watch Stocks for July 27, 2016",AMGN,0.017951641506908977,0.4565820502150091,0.006664342544396407,0.005372405372405353,0.009013560785846142,0.005758349794945161,0.004676992257178991,0.003515433101749954,0.23625065473072704
1174,2016-08-02,18 Biggest Mid-Day Gainers For Tuesday,AMGN,-5.770065964327831e-05,0.8446765027016434,0.012381732380047916,0.00437884343094308,0.003515433101749954,0.017951641506908977,0.006664342544396407,-0.0041343148344583636,-0.4063135528911823
1175,2016-08-02,Mid-Day Market Update: Dow Drops Over 100 Points; Avon Shares Surge Following Earnings Beat,AMGN,-5.770065964327831e-05,0.8446765027016434,0.012381732380047916,0.00437884343094308,0.003515433101749954,0.017951641506908977,0.006664342544396407,-0.0041343148344583636,-0.4063135528911823
1180,2016-08-02,Benzinga's Volume Movers,AMGN,-5.770065964327831e-05,0.8446765027016434,0.012381732380047916,0.00437884343094308,0.003515433101749954,0.017951641506908977,0.006664342544396407,-0.0041343148344583636,-0.4063135528911823
1183,2016-08-02,Mid-Afternoon Market Update: Crude Oil Down 1.5%; RetailMeNot Shares Gain On Strong Results,AMGN,-5.770065964327831e-05,0.8446765027016434,0.012381732380047916,0.00437884343094308,0.003515433101749954,0.017951641506908977,0.006664342544396407,-0.0041343148344583636,-0.4063135528911823
1186,2016-08-02,Mid-Morning Market Update: Markets Open Lower; Pfizer Tops Q2 Views,AMGN,-5.770065964327831e-05,0.8446765027016434,0.012381732380047916,0.00437884343094308,0.003515433101749954,0.017951641506908977,0.006664342544396407,-0.0041343148344583636,-0.4063135528911823
1189,2016-08-02,Collaboration Deal With Amgen Sends Advaxis Shares Sharply Higher,AMGN,-5.770065964327831e-05,0.8446765027016434,0.012381732380047916,0.00437884343094308,0.003515433101749954,0.017951641506908977,0.006664342544396407,-0.0041343148344583636,-0.4063135528911823
1191,2016-08-02,Collaboration Deal With Amgen Sends Advaxis Up 30%,AMGN,-5.770065964327831e-05,0.8446765027016434,0.012381732380047916,0.00437884343094308,0.003515433101749954,0.017951641506908977,0.006664342544396407,-0.0041343148344583636,-0.4063135528911823
1193,2016-08-12,"Notable Stocks Trading Ex-Dividend Monday, August 15",AMGN,0.003421906102422545,-0.13048347955945494,0.00700806531748599,-0.004939660494276965,-0.0015085159042478313,-0.007601300580229564,0.005733798147499192,0.01488179367386877,0.49436453413482173
1195,2016-08-12,"10 Notable Stocks Trading Ex-Dividend Monday, August 15",AMGN,0.003421906102422545,-0.13048347955945494,0.00700806531748599,-0.004939660494276965,-0.0015085159042478313,-0.007601300580229564,0.005733798147499192,0.01488179367386877,0.49436453413482173
1197,2016-08-26,FDA Rejection Of Amgen Drug Does Nothing To Change Baird's Outlook On The Stock,AMGN,0.010221666526537332,0.1149096729933683,-0.0035706463917456466,-0.02041293062140792,0.0002867351469710844,0.004204765372390229,-0.006466627804195713,-0.0026747509502630384,-0.14121628550917853
1198,2016-09-16,3 Pharma Companies Receive Positive EU Opinions,AMGN,0.0018535170611928553,0.3777146961250384,0.014694011083057124,0.004961538910457586,-0.015926475815031482,0.032962905878087145,-0.02585272357813151,-0.00913490906679737,-0.44721098230022593
1202,2016-09-28,"Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News",AMGN,-0.011186762682326656,-0.312196545041572,-0.01094902124385333,-0.007265717048334008,-0.004669206853161523,0.010181337952986258,0.002710730280260032,-0.025101746337131914,0.15248280667737157
1203,2016-09-29,Arrowhead's Landmark Deal With Amgen Sends Shares Shooting Higher,AMGN,-0.025101746337131914,0.15248280667737157,-0.011186762682326656,-0.01094902124385333,-0.007265717048334008,-0.004669206853161523,0.010181337952986258,0.008219919371320827,0.05141955835962153
1204,2016-09-29,15 Biggest Mid-Day Gainers For Thursday,AMGN,-0.025101746337131914,0.15248280667737157,-0.011186762682326656,-0.01094902124385333,-0.007265717048334008,-0.004669206853161523,0.010181337952986258,0.008219919371320827,0.05141955835962153
1205,2016-09-29,15 Stocks Moving In Thursday's Pre-Market Session,AMGN,-0.025101746337131914,0.15248280667737157,-0.011186762682326656,-0.01094902124385333,-0.007265717048334008,-0.004669206853161523,0.010181337952986258,0.008219919371320827,0.05141955835962153
1206,2016-09-29,Mid-Morning Market Update: Markets Edge Lower; PepsiCo Beats Q3 Expectations,AMGN,-0.025101746337131914,0.15248280667737157,-0.011186762682326656,-0.01094902124385333,-0.007265717048334008,-0.004669206853161523,0.010181337952986258,0.008219919371320827,0.05141955835962153
1207,2016-09-30,Alder BioPharma Could Lead The Migraine Market; Brean Assumes With Buy Rating,AMGN,0.008219919371320827,0.05141955835962153,-0.025101746337131914,-0.011186762682326656,-0.01094902124385333,-0.007265717048334008,-0.004669206853161523,0.0031770869775857857,-0.3712871287128713
1208,2016-10-05,Court Date For Litigation With Amgen And Other Expectations For AbbVie,AMGN,-0.0018503046549155355,-0.3017586502716614,0.0012553545700699775,0.0031770869775857857,0.008219919371320827,-0.025101746337131914,-0.011186762682326656,-0.0020330677458456625,-0.025238046483055165
1209,2016-10-27,"Earnings Scheduled For October 27, 2016",AMGN,0.009937684166704708,0.23928886925795045,0.006903019136664801,-0.005417144181255051,0.001577410006714297,-0.018513751751151775,0.0026070197724890054,-0.09584596281692936,4.438712168463572
1210,2016-10-28,The Market In 5 Minutes: Busy Earnings Week Comes To A Close,AMGN,-0.09584596281692936,4.438712168463572,0.009937684166704708,0.006903019136664801,-0.005417144181255051,0.001577410006714297,-0.018513751751151775,-0.02768971053557001,-0.5252353699294436
1211,2016-10-28,"12 Stocks To Watch For October 28, 2016",AMGN,-0.09584596281692936,4.438712168463572,0.009937684166704708,0.006903019136664801,-0.005417144181255051,0.001577410006714297,-0.018513751751151775,-0.02768971053557001,-0.5252353699294436
1212,2016-11-08,The Market In 5 Minutes: Election Day Has Finally Arrived,AMGN,-0.005459343692764906,-0.287116206762534,0.02813887960460959,0.0013312042987505546,-0.025090278400064725,-0.01463469162344655,-0.002833749379463235,0.05756584289530475,2.214774430966335
1213,2016-11-09,Biotech Is Getting A Big Boost Following Clinton's Loss,AMGN,0.05756584289530475,2.214774430966335,-0.005459343692764906,0.02813887960460959,0.0013312042987505546,-0.025090278400064725,-0.01463469162344655,0.03517284406627397,-0.24250852171553583
1214,2016-12-05,What Is The ASH Conference And Why Should Biotech Investors Care?,AMGN,0.008888068850450015,0.09615329940579431,0.01137715162630304,-0.011661092438392529,-0.013219079529954825,0.006410615896468741,-0.0024750917288104413,-0.0012387067906156624,-0.3777720140059655
1215,2016-12-12,"Chardan Upgrades Regeneron; Cites Fovista Failure, Stock's Recent Underperformance",AMGN,0.01610276398311772,-0.28620102214650767,0.020343177357621922,-0.004249595337729395,-0.027014001309138447,-0.0012387067906156624,0.008888068850450015,0.01790635125600315,0.3016827286184707
1216,2016-12-13,Amgen Shares Are Nearing A Unique Inflection Point,AMGN,0.01790635125600315,0.3016827286184707,0.01610276398311772,0.020343177357621922,-0.004249595337729395,-0.027014001309138447,-0.0012387067906156624,0.002156952611456875,-0.25808248427599967
1217,2016-12-19,Here's Oppenheimer's List Of The 29 Best Stocks For 2017,AMGN,-0.010912431962707525,-0.5258935313365215,-0.006782193555312177,0.011432806186355782,0.002156952611456875,0.01790635125600315,0.01610276398311772,-0.0035199010866696634,-0.13212555577676022
1218,2016-12-27,Regeneron Eyes A Comeback In 2017,AMGN,0.0054896080548398896,-0.10540627736553443,0.008130784902806942,0.0012998330516138523,-0.007132140948733823,-0.0035199010866696634,-0.010912431962707525,-0.00465100320331413,-0.07058217413704271
1219,2017-01-06,15 Biggest Mid-Day Gainers For Friday,AMGN,0.02484006522397464,1.876282069907313,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,0.0007451458841853942,0.013139532829350875,-0.5709090541755477
1220,2017-01-06,"5 Key Takeaways In Regeneron's Praluent Suit, Steps Forward",AMGN,0.02484006522397464,1.876282069907313,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,0.0007451458841853942,0.013139532829350875,-0.5709090541755477
1221,2017-01-06,Low Odds Court Ruling Against Regeneron Get Reversed On Appeal,AMGN,0.02484006522397464,1.876282069907313,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,0.0007451458841853942,0.013139532829350875,-0.5709090541755477
1222,2017-01-06,18 Stocks Moving In Friday's Pre-Market Session,AMGN,0.02484006522397464,1.876282069907313,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,0.0007451458841853942,0.013139532829350875,-0.5709090541755477
1223,2017-01-06,Regeneron Falls As Court Grants Permanent Injunction For Infringement Of Amgen's Repatha Patents,AMGN,0.02484006522397464,1.876282069907313,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,0.0007451458841853942,0.013139532829350875,-0.5709090541755477
1224,2017-01-06,The Medicines Co. Is A Top Pick For 2017,AMGN,0.02484006522397464,1.876282069907313,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,0.0007451458841853942,0.013139532829350875,-0.5709090541755477
1225,2017-01-09,Why The Amgen/Regeneron Patent Saga Is Far From Over,AMGN,0.013139532829350875,-0.5709090541755477,0.02484006522397464,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,-0.0005038672358914642,-0.21736469148009507
1226,2017-01-09,Legal Experts Weigh In On The Amgen/Regeneron Patent Case,AMGN,0.013139532829350875,-0.5709090541755477,0.02484006522397464,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.010623813011258587,-0.0005038672358914642,-0.21736469148009507
1227,2017-01-10,Catalyst Alert: Amgen/Regeneron Patent Case Appeal Could Be Decided By April,AMGN,-0.0005038672358914642,-0.21736469148009507,0.013139532829350875,0.02484006522397464,0.0007193189671133027,0.014197724194681127,0.03091419392238648,-0.013479668303703063,0.4502767416676694
1228,2017-01-18,Orphan Drugs Among 2015's Top 10 Best-Selling Medications,AMGN,0.006266303439107945,-0.285559047255426,-0.008455075501019538,0.0048916577334394695,-0.008044622149303793,-0.013479668303703063,-0.0005038672358914642,-0.012646810102186046,0.057263832935953385
1229,2017-01-31,"President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'",AMGN,0.014569612257023579,-0.1083173690932312,-0.01737076450249264,0.02732388588550383,-0.007268205749831336,0.014817460390804671,-0.005696724649079887,0.019083687047154685,0.17112762211679056
1230,2017-02-02,"Earnings Scheduled For February 2, 2017",AMGN,-0.0005637461049302628,0.13264370158989003,0.019083687047154685,0.014569612257023579,-0.01737076450249264,0.02732388588550383,-0.007268205749831336,0.04981788328022985,0.6571287173257749
1231,2017-02-03,Amgen Follows Up Positive Clinical News With Earnings Beat; Jefferies Sees 24% Upside,AMGN,0.04981788328022985,0.6571287173257749,-0.0005637461049302628,0.019083687047154685,0.014569612257023579,-0.01737076450249264,0.02732388588550383,-0.005670143166078168,-0.40417560339912584
1232,2017-02-03,18 Biggest Mid-Day Gainers For Friday,AMGN,0.04981788328022985,0.6571287173257749,-0.0005637461049302628,0.019083687047154685,0.014569612257023579,-0.01737076450249264,0.02732388588550383,-0.005670143166078168,-0.40417560339912584
1233,2017-02-03,25 Stocks Moving In Friday's Pre-Market Session,AMGN,0.04981788328022985,0.6571287173257749,-0.0005637461049302628,0.019083687047154685,0.014569612257023579,-0.01737076450249264,0.02732388588550383,-0.005670143166078168,-0.40417560339912584
1234,2017-02-03,10 Stocks You Should Be Watching Today,AMGN,0.04981788328022985,0.6571287173257749,-0.0005637461049302628,0.019083687047154685,0.014569612257023579,-0.01737076450249264,0.02732388588550383,-0.005670143166078168,-0.40417560339912584
1235,2017-02-06,FDA Watch: February's Notable PDUFA Dates,AMGN,-0.005670143166078168,-0.40417560339912584,0.04981788328022985,-0.0005637461049302628,0.019083687047154685,0.014569612257023579,-0.01737076450249264,0.0014405956370719952,-0.18338193748291265
1236,2017-02-09,"Regeneron Gets 'Encouraging' Judicial Decision, Could Still Lose Appeal",AMGN,-0.003866156125581943,0.22556821434705454,0.007792899267740738,0.0014405956370719952,-0.005670143166078168,0.04981788328022985,-0.0005637461049302628,0.0025079183007494787,-0.31536413322744894
1237,2017-02-09,Stay Of Court Injunction A Mild Positive For Regeneron,AMGN,-0.003866156125581943,0.22556821434705454,0.007792899267740738,0.0014405956370719952,-0.005670143166078168,0.04981788328022985,-0.0005637461049302628,0.0025079183007494787,-0.31536413322744894
1238,2017-02-21,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,AMGN,-0.0008652313358404884,-0.05143324749091438,0.006856045381791409,0.0018627568674378647,0.022255169073285286,0.0023261204077811293,0.0055173626969160505,-0.0030613414155383767,-0.345427788490815
1239,2017-03-10,Benzinga's Option Alert Recap From March 10,AMGN,0.014084495569212763,0.8317167604678082,0.006412652776633498,0.002254835201064953,-0.011590381157174257,-0.004106377801113892,0.0119614899669378,-0.002149656842111991,-0.4484637175855306
1240,2017-03-17,Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher,AMGN,-0.06384964501732049,2.9799148709763235,-0.013636721452005562,0.013768546174145246,-0.005136420283853971,-0.002149656842111991,0.014084495569212763,0.003736781637387665,-0.7563792988202266
1241,2017-03-17,Amgen's Repatha Results Not Good Enough For The Street,AMGN,-0.06384964501732049,2.9799148709763235,-0.013636721452005562,0.013768546174145246,-0.005136420283853971,-0.002149656842111991,0.014084495569212763,0.003736781637387665,-0.7563792988202266
1242,2017-04-05,The Market In 5 Minutes,AMGN,-0.0128986190137802,0.581807627042958,0.00286762567663823,-0.0010969569355293585,-0.001885991550332311,0.008095295129237012,-0.010017529127463565,6.164817576981285e-05,-0.14626090393247326
1243,2017-04-06,Your Cheat Sheet For Q1 Biotech Earnings,AMGN,6.164817576981285e-05,-0.14626090393247326,-0.0128986190137802,0.00286762567663823,-0.0010969569355293585,-0.001885991550332311,0.008095295129237012,0.006964579299032714,-0.2710799550294293
1244,2017-04-25,Which Leveraged ETFs Will Be Hot This Week?,AMGN,0.00956272146708792,0.008861193688543434,0.01701854166633532,-0.010058920259210513,0.0048367630596162225,6.213965356116624e-05,-0.005305095829656992,-0.0005467675397285987,0.18306227687425625
1245,2017-04-26,"Earnings Scheduled For April 26, 2017",AMGN,-0.0005467675397285987,0.18306227687425625,0.00956272146708792,0.01701854166633532,-0.010058920259210513,0.0048367630596162225,6.213965356116624e-05,-0.01148164864176282,0.3649143815111964
1246,2017-04-26,"15 Stocks To Watch For April 26, 2017",AMGN,-0.0005467675397285987,0.18306227687425625,0.00956272146708792,0.01701854166633532,-0.010058920259210513,0.0048367630596162225,6.213965356116624e-05,-0.01148164864176282,0.3649143815111964
1247,2017-05-22,Amgen News Has Major Readthrough For Radius Health,AMGN,-0.022298958968953952,1.6817599813758584,-0.009179417447935267,0.005730149868115708,-0.018313782593359695,0.00012493986209127783,0.005657970621625097,0.0068619320454543775,-0.4817483397716915
1248,2017-05-23,The Current State Of The Breast Cancer Treatment Space,AMGN,0.0068619320454543775,-0.4817483397716915,-0.022298958968953952,-0.009179417447935267,0.005730149868115708,-0.018313782593359695,0.00012493986209127783,0.003439985160940351,-0.25530429927414855
1249,2017-05-30,Tracking The Busy June PDUFA Calendar,AMGN,-0.007483289436160501,-0.005454678576658378,-0.002702353591481632,0.005368673983856098,0.003439985160940351,0.0068619320454543775,-0.022298958968953952,0.009035144563253494,0.43236279309456327
1250,2017-06-12,Pegfilgrastim To Help Chemotherapy Patients Fails To Clear Regulatory Hurdle; Coherus Receives CRL,AMGN,0.00499813844562369,0.06305667025545669,0.00866874159848341,0.006124178870419383,0.013351812702283361,-0.004306804321841495,0.006723441078032577,-0.0027293534503942674,-0.40886177926113476
1251,2017-06-13,Amgen Shares Could Gain $2-$4 As Competitor Coherus Receives CRL,AMGN,-0.0027293534503942674,-0.40886177926113476,0.00499813844562369,0.00866874159848341,0.006124178870419383,0.013351812702283361,-0.004306804321841495,0.004074984555868966,0.010357448796822766
1252,2017-06-26,"Stocks To Watch For June 26, 2017",AMGN,0.006782531905476841,-0.7885931029682987,-0.007594086063464456,0.014415178810349039,0.03042866686694956,0.007268836058247574,0.016438620992867525,-0.016237672474953335,-0.03163681854095335
1253,2017-07-06,Merck Falls As FDA Puts Hold On 3 Keytruda Myeloma Studies,AMGN,-0.014576039950576658,-0.09314487632508839,0.00844929070067213,0.0033094694745994246,-0.00208583696474518,-0.008502360502579132,0.018846838930633103,-0.0016887732025936408,0.01811876558603487
1254,2017-07-24,Two Ways To Trade This Week's Healthcare Earnings,AMGN,0.004716829158645908,-0.06415672785732984,0.0049629526072976216,0.0007817236562459584,0.009578256089864068,0.0004511667324640367,0.0015241533270062835,-0.0009389370261859709,0.3356238264551956
1255,2017-07-25,"Earnings Scheduled For July 25, 2017",AMGN,-0.0009389370261859709,0.3356238264551956,0.004716829158645908,0.0049629526072976216,0.0007817236562459584,0.009578256089864068,0.0004511667324640367,-0.027641331137921443,0.6290081359176836
1256,2017-09-01,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,AMGN,0.005287405460226102,-0.38858579509742297,0.023726051633028433,0.008244797151931937,0.0026197438825925623,0.012018061121138901,-0.0012355982973523139,-0.011023164660727613,-0.19408692791644389
1257,2017-09-28,"Biotech Investors, Here's Your PDUFA Primer For October",AMGN,0.0031372004060101766,0.057536832601469134,-0.003879497354522976,-0.0037038762287142646,0.0028532697265963858,-0.004714994599236966,-0.0081308971417976,0.005337961077504394,0.17090302301214644
1258,2017-10-04,25 Stocks Moving In Wednesday's Pre-Market Session,AMGN,0.007263856532260249,0.09648659358076883,0.00032069972244741507,0.0038616195965028854,0.005337961077504394,0.0031372004060101766,-0.003879497354522976,-0.009226452345286518,1.714328735770644
1259,2017-10-04,15 Biggest Mid-Day Gainers For Wednesday,AMGN,0.007263856532260249,0.09648659358076883,0.00032069972244741507,0.0038616195965028854,0.005337961077504394,0.0031372004060101766,-0.003879497354522976,-0.009226452345286518,1.714328735770644
1260,2017-10-05,Amgen 'Disappointed' In Court Decision To Reverse Praluent Sales Ban,AMGN,-0.009226452345286518,1.714328735770644,0.007263856532260249,0.00032069972244741507,0.0038616195965028854,0.005337961077504394,0.0031372004060101766,-0.005512577601902269,-0.5489948076154973
1261,2017-10-10,A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Fed Speakers,AMGN,0.0017794818161351866,0.3400894972361148,-0.0019372110040082324,-0.005512577601902269,-0.009226452345286518,0.007263856532260249,0.00032069972244741507,-0.008827257846577674,0.6073462973875468
1262,2017-10-10,"5 Stocks To Watch For October 10, 2017",AMGN,0.0017794818161351866,0.3400894972361148,-0.0019372110040082324,-0.005512577601902269,-0.009226452345286518,0.007263856532260249,0.00032069972244741507,-0.008827257846577674,0.6073462973875468
1263,2017-10-23,The Week Ahead: Earnings Season Starts In Earnest,AMGN,-0.013281754568337356,-0.1912430800201308,-0.0063001051025836086,-0.011595716988041738,0.0004836297785097976,0.023584532476956577,-0.006065498548933679,-0.0008860236952372702,0.3417081518357188
1264,2017-10-24,Healthcare ETFs Set To Soar As Q3 Earnings Unfold,AMGN,-0.0008860236952372702,0.3417081518357188,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,0.0004836297785097976,0.023584532476956577,-0.015911769683349397,0.17470578004522008
1265,2017-10-25,11 Stocks Moving In Wednesday's After-Hours Session,AMGN,-0.015911769683349397,0.17470578004522008,-0.0008860236952372702,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,0.0004836297785097976,-0.005521165445988463,0.480197409006786
1266,2017-10-25,"Earnings Scheduled For October 25, 2017",AMGN,-0.015911769683349397,0.17470578004522008,-0.0008860236952372702,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,0.0004836297785097976,-0.005521165445988463,0.480197409006786
1267,2017-10-25,"12 Stocks To Watch For October 25, 2017",AMGN,-0.015911769683349397,0.17470578004522008,-0.0008860236952372702,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,0.0004836297785097976,-0.005521165445988463,0.480197409006786
1268,2017-10-26,Amgen Price Target Trimmed After Major Product Sales Disappoint In Q3,AMGN,-0.005521165445988463,0.480197409006786,-0.015911769683349397,-0.0008860236952372702,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,-0.007024784556242336,-0.4200883554221889
1269,2017-10-26,Amgen Stock Falls After 'Boring' Q3 Beat,AMGN,-0.005521165445988463,0.480197409006786,-0.015911769683349397,-0.0008860236952372702,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,-0.007024784556242336,-0.4200883554221889
1270,2017-10-26,It's A Bad Day For Biotechs,AMGN,-0.005521165445988463,0.480197409006786,-0.015911769683349397,-0.0008860236952372702,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,-0.007024784556242336,-0.4200883554221889
1271,2017-10-26,"15 Stocks To Watch For October 26, 2017",AMGN,-0.005521165445988463,0.480197409006786,-0.015911769683349397,-0.0008860236952372702,-0.013281754568337356,-0.0063001051025836086,-0.011595716988041738,-0.007024784556242336,-0.4200883554221889
1272,2017-10-31,Attention Biotech Investors: Here Are November PDUFA Catalysts On The Horizon,AMGN,0.0036086932585004394,0.1394856515602949,-0.003936633787584798,-0.007024784556242336,-0.005521165445988463,-0.015911769683349397,-0.0008860236952372702,0.0011414259806477034,-0.05907245579027043
1273,2017-11-08,A Big Biotech ETF Is About To Get Cheaper,AMGN,0.0005764372223513448,-0.3531368053985987,0.01569104720410186,-0.015221719475762563,0.005974485810010144,-0.01715901880867632,0.0011414259806477034,0.002419413852875474,0.0008485574523311445
1274,2017-11-27,"The Week Ahead For Nov. 27: All The Earnings, Conferences, And FDA Actions To Watch",AMGN,-0.002409904197523405,1.150530106021204,0.0009413510771256739,0.0007068801035525762,0.006220291653213916,-0.007117359277696078,-0.004509194931118565,0.003240384753893988,0.23654713734244925
1275,2017-12-04,A Peek Into The Markets: U.S. Stock Futures Jump Ahead Of Factory Orders Data,AMGN,0.008408776377120564,0.3030177881353433,0.008767034171756283,0.01991510615770986,0.011570818045160358,0.003240384753893988,-0.002409904197523405,-0.00011214478040943998,-0.18738538860338227
1276,2017-12-04,"7 Stocks To Watch For December 4, 2017",AMGN,0.008408776377120564,0.3030177881353433,0.008767034171756283,0.01991510615770986,0.011570818045160358,0.003240384753893988,-0.002409904197523405,-0.00011214478040943998,-0.18738538860338227
1277,2017-12-11,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,AMGN,0.008095194836149622,-0.43829991307736116,0.008335514805563049,-0.012824873557263694,-0.013712460492745326,-0.00011214478040943998,0.008408776377120564,-0.0032236400946354937,0.17059765208110989
1278,2018-01-19,Here's Why Nektar Stock Skyrocketed Almost 500% In A Year,AMGN,0.009009095563247138,0.18392816622905128,-0.0022340258326202234,0.013312636478303164,0.0027020078505677336,0.016926587123743397,-0.0049216742885040965,0.01611351495718938,-0.019850505161131293
1279,2018-01-23,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,AMGN,-0.0017676375003385925,-0.02600703949941341,0.01611351495718938,0.009009095563247138,-0.0022340258326202234,0.013312636478303164,0.0027020078505677336,-0.007083720909482283,-0.20678578598674968
1280,2018-01-24,Argus: Bioverativ Shares Fully Valued After Sanofi Buyout Offer,AMGN,-0.007083720909482283,-0.20678578598674968,-0.0017676375003385925,0.01611351495718938,0.009009095563247138,-0.0022340258326202234,0.013312636478303164,-0.0028852487620238954,-0.10680840293596561
1281,2018-01-29,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines",AMGN,0.010152620225582387,0.1646302578884269,0.031197211301618566,-0.0028852487620238954,-0.007083720909482283,-0.0017676375003385925,0.01611351495718938,-0.03398979954534864,-0.12591716494732463
1282,2018-02-01,Amgen Q4 Earnings Preview,AMGN,-0.0026337250895500652,-0.12818265386835415,-0.027291141772429195,-0.03398979954534864,0.010152620225582387,0.031197211301618566,-0.0028852487620238954,0.007814239226944242,0.7236948578995119
1283,2018-02-01,"Earnings Scheduled For February 1, 2018",AMGN,-0.0026337250895500652,-0.12818265386835415,-0.027291141772429195,-0.03398979954534864,0.010152620225582387,0.031197211301618566,-0.0028852487620238954,0.007814239226944242,0.7236948578995119
1284,2018-02-02,"Jobs Jump In January, But Persistent Yield Climb Keeps Choking Stock Market",AMGN,0.007814239226944242,0.7236948578995119,-0.0026337250895500652,-0.027291141772429195,-0.03398979954534864,0.010152620225582387,0.031197211301618566,-0.06555817809302511,-0.015164878937035886
1285,2018-02-08,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,AMGN,-0.024510762087817328,0.05442902881536815,0.0046417416122424004,0.010872721851437284,-0.06555817809302511,0.007814239226944242,-0.0026337250895500652,0.0019635740015380154,0.011133603238866474
1286,2018-02-28,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,AMGN,-0.010872576243299847,-0.09411694344211641,-0.014376732051493035,0.009803495558588615,0.023129455877890504,0.0001098953373117606,-0.003005971776173455,-0.0026117028186730673,1.5875440140845072
1287,2018-03-02,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",AMGN,0.00976590430708546,0.6257718280630731,-0.0026117028186730673,-0.010872576243299847,-0.014376732051493035,0.009803495558588615,0.023129455877890504,0.027285518502648154,-0.20547199916298287
1288,2018-03-05,7 Biotech Stocks With Clinical Trial Outcomes In March,AMGN,0.027285518502648154,-0.20547199916298287,0.00976590430708546,-0.0026117028186730673,-0.010872576243299847,-0.014376732051493035,0.009803495558588615,0.0011570040850505947,0.21456037082395074
1289,2018-03-26,"The Week Ahead: Apple Holds A Special Event, Roku's Lockup Expires And More",AMGN,0.033996321817741926,-0.068990639350053,-0.03776701419650119,-0.030342964297386477,-0.002417074863647284,-0.002848318479241052,-0.03022749771704447,-0.02306085556344306,-0.060230964406819854
1290,2018-03-26,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",AMGN,0.033996321817741926,-0.068990639350053,-0.03776701419650119,-0.030342964297386477,-0.002417074863647284,-0.002848318479241052,-0.03022749771704447,-0.02306085556344306,-0.060230964406819854
1291,2018-03-29,"Biotech Stock Roundup: Protagonist Therapeutics, Verona, Amgen And More",AMGN,0.00011730068779347569,-0.17072526892364548,-0.004031644701182668,-0.02306085556344306,0.033996321817741926,-0.03776701419650119,-0.030342964297386477,-0.025985236183049043,0.26261340124144517
1292,2018-04-03,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,AMGN,0.013068278839864167,-0.2911466868355813,-0.025985236183049043,0.00011730068779347569,-0.004031644701182668,-0.02306085556344306,0.033996321817741926,0.03150628440133718,0.12528156490812092
1293,2018-04-20,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",AMGN,-0.007922326056214568,0.3036926059751477,-0.012449285175721192,0.001315116681919859,0.020422169008972757,-0.000582911400772046,0.002689390793439772,0.0180695715513286,0.20621239775569533
1294,2018-04-25,"Benzinga's Biotech Pulse: Takeda Sweetens Shire Offer Again, Menlo's Woes Abound, Earnings Fail to Boost Amgen",AMGN,0.016808324004645936,0.06934888595252198,-0.015573230830663198,0.0180695715513286,-0.007922326056214568,-0.012449285175721192,0.001315116681919859,0.0030887640547323514,-0.21547573394690867
1295,2018-04-30,"The Week Ahead: Tesla And Apple Earnings, Dropbox Quiet Period Expires, Fed Rate Decision And More",AMGN,-0.016792567091227117,0.48824645331573735,0.011917802699373148,0.0030887640547323514,0.016808324004645936,-0.015573230830663198,0.0180695715513286,-0.029802904537991726,0.3299526145149223
1296,2018-04-30,Playmakers: The Investor Picks From CNBC's 2018 Stock Draft,AMGN,-0.016792567091227117,0.48824645331573735,0.011917802699373148,0.0030887640547323514,0.016808324004645936,-0.015573230830663198,0.0180695715513286,-0.029802904537991726,0.3299526145149223
1297,2018-05-01,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Action Dates,AMGN,-0.029802904537991726,0.3299526145149223,-0.016792567091227117,0.011917802699373148,0.0030887640547323514,0.016808324004645936,-0.015573230830663198,0.0008861489994154148,-0.1487060882610326
1298,2018-05-02,Esperion Shares Plunge After Cholesterol-Lowering Drug's Phase 3 Results Stir Safety Concerns,AMGN,0.0008861489994154148,-0.1487060882610326,-0.029802904537991726,-0.016792567091227117,0.011917802699373148,0.0030887640547323514,0.016808324004645936,-0.017942375423370405,0.016447609956678155
1299,2018-05-07,What's In Store For Radius Health In Q1 Earnings?,AMGN,0.0004762352595857333,-0.0741107871720117,0.009555581124621959,-0.017942375423370405,0.0008861489994154148,-0.029802904537991726,-0.016792567091227117,0.0025586646047004447,0.23990805466339182
1300,2018-05-17,"Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More",AMGN,0.004890601064416522,-0.09053002966883172,0.016255591671556546,-0.02057311880598167,0.011904250237561476,0.01827025011143557,0.006660931624234978,0.009447713251281575,0.48880268030329743
1301,2018-05-18,"Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved",AMGN,0.009447713251281575,0.48880268030329743,0.004890601064416522,0.016255591671556546,-0.02057311880598167,0.011904250237561476,0.01827025011143557,0.0009640705048454823,-0.2428046902759683
1302,2018-05-22,"Benzinga's Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict",AMGN,0.01070978812569745,0.07254027842953237,0.0009640705048454823,0.009447713251281575,0.004890601064416522,0.016255591671556546,-0.02057311880598167,0.008858631502390413,-0.18255733401392793
1303,2018-05-25,Novartis Gets Approval For Remicade Biosimilar In Europe,AMGN,0.0015733950471830127,-0.24060181886760823,-0.01100372162582619,0.008858631502390413,0.01070978812569745,0.0009640705048454823,0.009447713251281575,-0.004488155265442884,0.314569536423841
1304,2018-06-05,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",AMGN,-0.020006569691997877,0.7316860970941361,0.01018661027522616,0.02199127503369258,-0.0034400697530696522,0.015779858894674925,-0.004488155265442884,0.010015004276920036,-0.44405647106109325
1305,2018-06-28,"Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut",AMGN,-0.0010350667277613246,-0.029089519279768994,-0.0057423900217059565,-0.00415457152674481,0.0011346007867312213,-0.004516582172493178,-0.0027880673956964808,0.006817678994508913,0.13992039539867918
1306,2018-06-29,"Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos",AMGN,0.006817678994508913,0.13992039539867918,-0.0010350667277613246,-0.0057423900217059565,-0.00415457152674481,0.0011346007867312213,-0.004516582172493178,0.003792302438190287,-0.2058168981659121
1307,2018-07-13,"Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering",AMGN,0.009429148363000017,-0.008836982104001079,0.004814843358812659,-0.012979687115223348,0.007828048319095782,0.01654371713412517,0.019481118230800787,-0.005257362729949588,-0.18243727598566306
1308,2018-07-19,AbbVie's Stock Hit By Citron Tweet,AMGN,-0.005394035112731066,0.14595180070403457,-0.005775605823240437,-0.004926222102139111,-0.005257362729949588,0.009429148363000017,0.004814843358812659,-0.006622710174197022,-0.11302772526780092
1309,2018-07-26,"Nasdaq, Tech Names Might Come Under Pressure Following Facebook's Weak Results",AMGN,0.005232010457465908,0.4113372816403722,0.008568484750207217,0.007527448041911633,-0.002729999203788691,-0.006622710174197022,-0.005394035112731066,-0.00829678072264628,0.44587065378376467
1310,2018-07-26,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",AMGN,0.005232010457465908,0.4113372816403722,0.008568484750207217,0.007527448041911633,-0.002729999203788691,-0.006622710174197022,-0.005394035112731066,-0.00829678072264628,0.44587065378376467
1311,2018-07-26,"Earnings Scheduled For July 26, 2018",AMGN,0.005232010457465908,0.4113372816403722,0.008568484750207217,0.007527448041911633,-0.002729999203788691,-0.006622710174197022,-0.005394035112731066,-0.00829678072264628,0.44587065378376467
1312,2018-07-27,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",AMGN,-0.00829678072264628,0.44587065378376467,0.005232010457465908,0.008568484750207217,0.007527448041911633,-0.002729999203788691,-0.006622710174197022,-0.009405574521431204,-0.27205989951709675
1313,2018-09-06,New Class of Migraine Drug Creates Four-Way Pharma Development Race,AMGN,-0.008091182375785655,-0.006467661691542337,0.005184972231760732,-0.015414821418150315,-0.0026950241900464134,0.0030037378061633646,0.005689052818230733,0.0007648054916487013,0.4488955655705782
1314,2018-09-07,"The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Walle, Advaxis Offering",AMGN,0.0007648054916487013,0.4488955655705782,-0.008091182375785655,0.005184972231760732,-0.015414821418150315,-0.0026950241900464134,0.0030037378061633646,0.03158445229078666,0.6553895779731962
1315,2018-09-11,"The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet",AMGN,-0.014963080849392574,-0.2145309455321518,0.03158445229078666,0.0007648054916487013,-0.008091182375785655,0.005184972231760732,-0.015414821418150315,0.00015025766082166214,-0.36990549320732424
1316,2018-09-17,Teva's Preventive Migraine Treatment Approved By FDA,AMGN,0.001146586791703097,-0.22126826930756327,-0.011580395124371923,0.017193123835448354,0.00015025766082166214,-0.014963080849392574,0.03158445229078666,0.007619481595691813,0.01651197374493618
1317,2018-09-21,"The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Gets BARDA Funding",AMGN,0.0,2.2871910112359553,0.009350540061188628,0.004250027649680632,0.007619481595691813,0.001146586791703097,-0.011580395124371923,0.010287529793656214,-0.6387749521465682
1318,2018-09-25,"The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering",AMGN,-0.0036194954542119184,-0.03247539742619232,0.010287529793656214,0.0,0.009350540061188628,0.004250027649680632,0.007619481595691813,0.0017922677318926716,-0.15397856192786163
1319,2018-10-12,Equillium's IPO: What You Need To Know,AMGN,0.018261450810786117,-0.22601197604790424,-0.03653068740676091,-0.023300837267917207,0.00209162510150529,0.00759730704790873,0.002703114037473364,-0.0091192143674651,-0.3528811041653772
1320,2018-10-16,"The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist",AMGN,0.03451130559387994,0.08148821194586575,-0.0091192143674651,0.018261450810786117,-0.03653068740676091,-0.023300837267917207,0.00209162510150529,0.0021249275543862023,0.0876409462745964
1321,2018-10-25,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",AMGN,0.0011709472408505395,0.16216216216216206,-0.04938262445614594,-0.0019190810695831617,-0.018731430327158405,-0.00453844764183442,-0.0002464685821428336,-0.011270467842226961,-0.08092381162590045
1322,2018-10-30,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",AMGN,0.004729315644298904,0.055124689907298574,0.011882972004471082,-0.011270467842226961,0.0011709472408505395,-0.04938262445614594,-0.0019190810695831617,0.01962115901592587,0.12384299361480977
1323,2018-10-30,"Earnings Scheduled For October 30, 2018",AMGN,0.004729315644298904,0.055124689907298574,0.011882972004471082,-0.011270467842226961,0.0011709472408505395,-0.04938262445614594,-0.0019190810695831617,0.01962115901592587,0.12384299361480977
1324,2018-10-30,"14 Stocks To Watch For October 30, 2018",AMGN,0.004729315644298904,0.055124689907298574,0.011882972004471082,-0.011270467842226961,0.0011709472408505395,-0.04938262445614594,-0.0019190810695831617,0.01962115901592587,0.12384299361480977
1325,2018-10-31,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",AMGN,0.01962115901592587,0.12384299361480977,0.004729315644298904,0.011882972004471082,-0.011270467842226961,0.0011709472408505395,-0.04938262445614594,0.0005706079845277934,-0.37738383615943627
1326,2018-11-01,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,AMGN,0.0005706079845277934,-0.37738383615943627,0.01962115901592587,0.004729315644298904,0.011882972004471082,-0.011270467842226961,0.0011709472408505395,-0.0302747473409285,0.30736037916032966
1327,2018-12-04,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",AMGN,-0.02547669335429048,-0.038212772284588525,-0.025546145906888862,0.029055637598379924,0.00471636935004538,0.021917905807419702,0.014410647836341939,0.0063209008550353385,-0.11434902476102138
1328,2018-12-17,A Peek Into The Markets: US Stock Futures Edge Lower; Crude Oil Rises Over 1%,AMGN,-0.010360882690381823,-0.02076275450306908,-0.027641364591135642,0.005702406069386434,0.0011723916781398724,0.010768033826366485,0.01384267811220985,-0.015677401833044446,0.08388710008905931
1329,2018-12-17,"6 Stocks To Watch For December 17, 2018",AMGN,-0.010360882690381823,-0.02076275450306908,-0.027641364591135642,0.005702406069386434,0.0011723916781398724,0.010768033826366485,0.01384267811220985,-0.015677401833044446,0.08388710008905931
1330,2018-12-19,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",AMGN,-0.008605200235962451,0.26264892709288,-0.015677401833044446,-0.010360882690381823,-0.027641364591135642,0.005702406069386434,0.0011723916781398724,-0.0028571927886932302,-0.04735445762627022
1331,2018-12-21,When Larger Firms Walk Away From Partnerships With Smaller Ones: How Bad Is The Damage?,AMGN,-0.0256811989739254,1.057117334874678,-0.0028571927886932302,-0.008605200235962451,-0.015677401833044446,-0.010360882690381823,-0.027641364591135642,-0.010043982282420982,-0.7183708396127615
1332,2018-12-31,Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates,AMGN,0.0206573964714849,0.11596367305751776,0.00210172184354418,0.013148189996918802,0.05302689770314162,-0.010043982282420982,-0.0256811989739254,-0.014229294908401524,0.0883608217592593
1333,2019-01-03,"The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen",AMGN,-0.015216433184160216,0.32062743012860984,-0.014229294908401524,0.0206573964714849,0.00210172184354418,0.013148189996918802,0.05302689770314162,0.03418387737900064,0.0552354110571478
1334,2019-01-08,"The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase",AMGN,0.012823660144825055,0.08501236603462492,0.013456739106313176,0.03418387737900064,-0.015216433184160216,-0.014229294908401524,0.0206573964714849,-0.001196361298865578,-0.12783028903139526
1335,2019-01-16,"The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen",AMGN,-0.002457476270551706,0.15476606755717182,0.01321270359703619,-0.018847319323243128,-0.010459797100668355,0.011528845776176855,-0.001196361298865578,0.015234666844237355,-0.26108284883720934
1336,2019-01-17,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",AMGN,0.015234666844237355,-0.26108284883720934,-0.002457476270551706,0.01321270359703619,-0.018847319323243128,-0.010459797100668355,0.011528845776176855,0.009706679120702777,0.26833866076551094
1337,2019-01-25,"The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug",AMGN,-0.010946698963320234,0.8335285260163963,-0.002927225137464129,-0.002079452793829706,-0.009319348401485184,0.009706679120702777,0.015234666844237355,-0.03431114549936076,-0.04503148097454146
1338,2019-01-29,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",AMGN,0.0008338283803643876,-0.23985953848358899,-0.03431114549936076,-0.010946698963320234,-0.002927225137464129,-0.002079452793829706,-0.009319348401485184,-0.037739070252398976,1.5420634172401875
1339,2019-01-29,"Earnings Scheduled For January 29, 2019",AMGN,0.0008338283803643876,-0.23985953848358899,-0.03431114549936076,-0.010946698963320234,-0.002927225137464129,-0.002079452793829706,-0.009319348401485184,-0.037739070252398976,1.5420634172401875
1340,2019-01-29,"12 Stocks To Watch For January 29, 2019",AMGN,0.0008338283803643876,-0.23985953848358899,-0.03431114549936076,-0.010946698963320234,-0.002927225137464129,-0.002079452793829706,-0.009319348401485184,-0.037739070252398976,1.5420634172401875
1341,2019-01-30,"15 Stocks To Watch For January 30, 2019",AMGN,-0.037739070252398976,1.5420634172401875,0.0008338283803643876,-0.03431114549936076,-0.010946698963320234,-0.002927225137464129,-0.002079452793829706,0.012171300112781003,-0.45631776093755794
1342,2019-01-30,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",AMGN,-0.037739070252398976,1.5420634172401875,0.0008338283803643876,-0.03431114549936076,-0.010946698963320234,-0.002927225137464129,-0.002079452793829706,0.012171300112781003,-0.45631776093755794
1343,2019-02-26,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",AMGN,0.0014224819391648325,-0.23615911518883936,0.0123200599048785,0.010781567928282776,-0.007596746985845115,-0.0002675465156481982,-0.007273961781491756,0.007049546282234642,-0.22410530645824767
1344,2019-02-28,Major Shareholders Team To Scuttle Bristol-Myers Squibb's $74B Celgene Buyout: What's Next?,AMGN,-0.007000198062011687,0.4718481603223412,0.007049546282234642,0.0014224819391648325,0.0123200599048785,0.010781567928282776,-0.007596746985845115,0.0056818454341480695,-0.13212304589006552
1345,2019-03-21,"The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering",AMGN,0.004028841471811484,-0.03607012233572959,-0.0019321950369833862,0.0009409757770446614,0.00036600399465158695,0.01853420360468827,0.0021886424907535673,-0.027046695553767486,0.37149461380784166
1346,2019-03-27,The Precision Biosciences IPO: What You Need To Know,AMGN,-0.010357332446451317,-0.1426391420456954,0.009003834684930379,-0.0005893982756806082,-0.027046695553767486,0.004028841471811484,-0.0019321950369833862,0.0071382593788844595,-0.06773459903095025
1347,2019-04-05,"The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership",AMGN,0.016014158644904297,0.21132202250965904,-0.0030583065760858563,0.0025464522376168475,0.003441729251648873,0.009422029846297253,0.012416546876617085,-0.002712112143711254,-0.24661396939860403
1348,2019-04-10,"The Daily Biotech Pulse: Amgen's Bone-Building Osteoporosis Drug Clears FDA Muster, PhaseBio Offering",AMGN,0.004715686523572904,-0.11716330236035455,-0.009749957895561878,-0.002712112143711254,0.016014158644904297,-0.0030583065760858563,0.0025464522376168475,-0.009180388838387454,0.2597386886039197
1349,2019-04-10,Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug,AMGN,0.004715686523572904,-0.11716330236035455,-0.009749957895561878,-0.002712112143711254,0.016014158644904297,-0.0030583065760858563,0.0025464522376168475,-0.009180388838387454,0.2597386886039197
1350,2019-04-30,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,AMGN,-0.010211484751421085,0.4884507042253521,-0.0016531738045889588,0.005485207334641862,0.012226674760475564,-0.00812201034660387,0.019278707597392142,-0.017733460035850412,0.5415341912692404
1351,2019-04-30,"Earnings Scheduled For April 30, 2019",AMGN,-0.010211484751421085,0.4884507042253521,-0.0016531738045889588,0.005485207334641862,0.012226674760475564,-0.00812201034660387,0.019278707597392142,-0.017733460035850412,0.5415341912692404
1352,2019-04-30,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",AMGN,-0.010211484751421085,0.4884507042253521,-0.0016531738045889588,0.005485207334641862,0.012226674760475564,-0.00812201034660387,0.019278707597392142,-0.017733460035850412,0.5415341912692404
1353,2019-04-30,"15 Stocks To Watch For April 30, 2019",AMGN,-0.010211484751421085,0.4884507042253521,-0.0016531738045889588,0.005485207334641862,0.012226674760475564,-0.00812201034660387,0.019278707597392142,-0.017733460035850412,0.5415341912692404
1354,2019-05-03,"The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",AMGN,0.0045892576402104535,-0.023059057730590582,0.0020436430990129484,-0.017733460035850412,-0.010211484751421085,-0.0016531738045889588,0.005485207334641862,-0.0014098374874158548,-0.07114960095092548
1355,2019-05-14,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",AMGN,0.001252783892931042,-0.25105285010973366,-0.02473062504279211,-0.005900416539794229,0.004182219004225329,-0.009892364097726869,-0.018016544967914716,0.012275779737121573,0.1326179067833524
1356,2019-05-15,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",AMGN,0.012275779737121573,0.1326179067833524,0.001252783892931042,-0.02473062504279211,-0.005900416539794229,0.004182219004225329,-0.009892364097726869,0.008906679158741326,-0.05034612964128382
1357,2019-05-16,5 ASCO Abstracts That Moved Stocks,AMGN,0.008906679158741326,-0.05034612964128382,0.012275779737121573,0.001252783892931042,-0.02473062504279211,-0.005900416539794229,0.004182219004225329,-5.921902155126002e-05,-0.165525366320595
1358,2019-05-20,Medicines Company Rallies On Positive LDL Cholesterol Study Results,AMGN,-0.008945914272880384,-0.053957469337333475,-5.921902155126002e-05,0.008906679158741326,0.012275779737121573,0.001252783892931042,-0.02473062504279211,0.007720314845023557,0.04896702886722948
1359,2019-05-22,Amgen To Buy Danish Collaborator Nuevolution For $167M,AMGN,0.009487787710913187,0.16280620637531684,0.007720314845023557,-0.008945914272880384,-5.921902155126002e-05,0.008906679158741326,0.012275779737121573,0.004728629024148612,0.10973045306824702
1360,2019-06-04,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-tender Offer",AMGN,0.013750438102694273,-0.211539793585925,0.03395332881600366,-0.013843028467680929,-0.0008273500744282458,0.001954289345931226,-0.014187245270295912,-0.0010305473643297258,-0.4275674251076166
1361,2019-06-11,"The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering",AMGN,-0.005467864168194669,0.10634025054987095,0.00039890099617378993,0.006076381166141509,-0.0005727695282702339,-0.0010305473643297258,0.013750438102694273,0.005612590329838518,-0.18376696343677068
1362,2019-06-14,"The Daily Biotech Pulse:  Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA",AMGN,-0.003565439500595291,-0.03222341568206233,0.006321063032600938,0.005612590329838518,-0.005467864168194669,0.00039890099617378993,0.006076381166141509,0.013119185199269356,0.1818966580342829
1363,2019-06-28,"The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO",AMGN,0.0014129156898516904,0.7108993937183754,0.004640543408853004,-0.00688574490370264,-0.0021101315565708045,-0.012185301090892664,0.01646036202957002,0.011233050655299115,-0.4458595331983374
1364,2019-07-09,"The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering",AMGN,-0.003566556425664724,-0.1581694990558703,-0.019899151777180712,-0.013999042968992015,0.010394058793788075,0.0015562360503673656,0.011233050655299115,0.0037445289950932548,-0.21902625676210585
1365,2019-07-09,Judge Rules Against Trump Proposal Forcing Pharma Companies To Disclose Drug Prices In Commercials,AMGN,-0.003566556425664724,-0.1581694990558703,-0.019899151777180712,-0.013999042968992015,0.010394058793788075,0.0015562360503673656,0.011233050655299115,0.0037445289950932548,-0.21902625676210585
1366,2019-07-12,"Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",AMGN,-0.01724747843490304,0.23932190286866017,-0.023426669221763397,0.0037445289950932548,-0.003566556425664724,-0.019899151777180712,-0.013999042968992015,0.006802925367104029,-0.27444471673312987
1367,2019-07-12,"The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study",AMGN,-0.01724747843490304,0.23932190286866017,-0.023426669221763397,0.0037445289950932548,-0.003566556425664724,-0.019899151777180712,-0.013999042968992015,0.006802925367104029,-0.27444471673312987
1368,2019-07-30,"15 Stocks To Watch For July 30, 2019",AMGN,0.002101471756678741,0.009922433766495375,0.004220292088022326,0.007064375663589306,-0.00944428596102087,-0.0013634569695170073,0.0006823391014920688,0.057409952880801196,2.5696972719565108
1369,2019-07-30,"Earnings Scheduled For July 30, 2019",AMGN,0.002101471756678741,0.009922433766495375,0.004220292088022326,0.007064375663589306,-0.00944428596102087,-0.0013634569695170073,0.0006823391014920688,0.057409952880801196,2.5696972719565108
1370,2019-07-30,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",AMGN,0.002101471756678741,0.009922433766495375,0.004220292088022326,0.007064375663589306,-0.00944428596102087,-0.0013634569695170073,0.0006823391014920688,0.057409952880801196,2.5696972719565108
1371,2019-07-31,"Easing Up: Fed Expected To Cut Rates, But Apple's Strong Results Front And Center Early",AMGN,0.057409952880801196,2.5696972719565108,0.002101471756678741,0.004220292088022326,0.007064375663589306,-0.00944428596102087,-0.0013634569695170073,-0.003108453263418909,-0.5131468648709064
1372,2019-07-31,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster",AMGN,0.057409952880801196,2.5696972719565108,0.002101471756678741,0.004220292088022326,0.007064375663589306,-0.00944428596102087,-0.0013634569695170073,-0.003108453263418909,-0.5131468648709064
1373,2019-07-31,"12 Stocks To Watch For July 31, 2019",AMGN,0.057409952880801196,2.5696972719565108,0.002101471756678741,0.004220292088022326,0.007064375663589306,-0.00944428596102087,-0.0013634569695170073,-0.003108453263418909,-0.5131468648709064
1374,2019-08-13,Stocks That Hit 52-Week Highs Of Tuesday,AMGN,0.001652299112552269,-0.4729463266442123,0.04856053367937707,0.05949363079258663,0.009207924472197426,-0.004987636313069421,0.016308607000872444,-0.028338475011641995,-0.1932013461263068
1375,2019-08-26,Amgen's Proposed $13.4B Acquisition Of Celgene's Otezla: What You Need To Know,AMGN,0.03179628058886319,0.17241379310344818,-0.0213352174906275,-0.002549649406598631,0.003789872662045557,-0.013737985839129885,0.009705021886892151,0.0052577889650655685,-0.1526016178967342
1376,2019-08-26,16 Healthcare Stocks Moving In Monday's Pre-Market Session,AMGN,0.03179628058886319,0.17241379310344818,-0.0213352174906275,-0.002549649406598631,0.003789872662045557,-0.013737985839129885,0.009705021886892151,0.0052577889650655685,-0.1526016178967342
1377,2019-08-29,"The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings",AMGN,-0.0026022057584421665,-0.36885440582693374,0.00498801937108917,0.0052577889650655685,0.03179628058886319,-0.0213352174906275,-0.002549649406598631,0.007923614140724622,0.09604448904499074
1378,2019-09-09,Amgen's KRAS Inhibitor Shows Lukewarm Response In Lung Cancer Study,AMGN,-0.025947158855645802,0.8229480737018426,0.00038543373651100943,0.006446207687989647,0.0038924700012088476,-0.014859495128985878,0.007923614140724622,-0.027033729515231975,0.11786731599742728
1379,2019-09-09,27 Healthcare Stocks Moving In Monday's Pre-Market Session,AMGN,-0.025947158855645802,0.8229480737018426,0.00038543373651100943,0.006446207687989647,0.0038924700012088476,-0.014859495128985878,0.007923614140724622,-0.027033729515231975,0.11786731599742728
1380,2019-09-09,30 Stocks Moving in Monday's Pre-Market Session,AMGN,-0.025947158855645802,0.8229480737018426,0.00038543373651100943,0.006446207687989647,0.0038924700012088476,-0.014859495128985878,0.007923614140724622,-0.027033729515231975,0.11786731599742728
1381,2019-09-19,"The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO",AMGN,0.0031276637477974933,-0.21835809885130153,-0.008540295940774656,0.013602708081120296,-0.0071109774962431205,0.007577149656125659,-0.009395420067804361,0.0065934823080286975,3.503438047728192
1382,2019-09-25,"The Daily Biotech Pulse: PhaseBio Leaps On Trial Results, Pacira Set To Join SmallCap 600 Index, Positive Readout For Amgen's Blood Cancer Drug",AMGN,-0.0024930917620614723,-0.23362755651237888,-0.006118337818019182,0.00416369352119994,0.0065934823080286975,0.0031276637477974933,-0.008540295940774656,-0.0034683016594087013,0.05500309006123949
1383,2019-09-30,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,AMGN,-0.0073356789158196545,0.4078404790148562,-0.002252148590320413,-0.0034683016594087013,-0.0024930917620614723,-0.006118337818019182,0.00416369352119994,-0.0016535161635274909,-0.06471933555350484
1384,2019-10-07,Pfenex Gets FDA Seal of Approval For Amgen's Forteo Biosimilar,AMGN,0.008078094568176875,0.019043647484014548,0.01541892843920345,0.0180224956518813,-0.020601674400501757,-0.0016535161635274909,-0.0073356789158196545,-0.005528109123338343,-0.07579684445050694
1385,2019-10-18,"The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe",AMGN,-0.004126372368854159,0.47986674391657,0.0017221786272174633,-0.007084841682501786,0.008723970799400682,0.010408172232690083,0.010670616713844616,0.0010358048125702624,-0.23460898502495842
1386,2019-10-28,More Earnings And A Fed Decision In Week Four Of The WeTrader Competition,AMGN,0.009652802370264446,0.2506999621642074,-4.937251042036461e-05,-0.0012786289060089384,-0.00737214029439448,0.00936291940423617,0.0010358048125702624,0.019413707118890677,1.6984511132623425
1387,2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",AMGN,0.019413707118890677,1.6984511132623425,0.009652802370264446,-4.937251042036461e-05,-0.0012786289060089384,-0.00737214029439448,0.00936291940423617,0.0090435364073993,-0.14943946188340806
1388,2019-10-29,"Earnings Scheduled For October 29, 2019",AMGN,0.019413707118890677,1.6984511132623425,0.009652802370264446,-4.937251042036461e-05,-0.0012786289060089384,-0.00737214029439448,0.00936291940423617,0.0090435364073993,-0.14943946188340806
1389,2019-10-30,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",AMGN,0.0090435364073993,-0.14943946188340806,0.019413707118890677,0.009652802370264446,-4.937251042036461e-05,-0.0012786289060089384,-0.00737214029439448,0.011238781134960352,-0.14174245419797016
1390,2019-11-01,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",AMGN,0.022039696357773586,0.13197985134222012,0.011238781134960352,0.0090435364073993,0.019413707118890677,0.009652802370264446,-4.937251042036461e-05,-0.016242316458265238,-0.2818884818884819
1391,2019-11-01,Stocks That Hit 52-Week Highs On Friday,AMGN,0.022039696357773586,0.13197985134222012,0.011238781134960352,0.0090435364073993,0.019413707118890677,0.009652802370264446,-4.937251042036461e-05,-0.016242316458265238,-0.2818884818884819
1392,2019-11-04,Stocks That Hit 52-Week Highs On Monday,AMGN,-0.016242316458265238,-0.2818884818884819,0.022039696357773586,0.011238781134960352,0.0090435364073993,0.019413707118890677,0.009652802370264446,0.003125029125603085,0.13806393108138737
1393,2019-11-05,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",AMGN,0.003125029125603085,0.13806393108138737,-0.016242316458265238,0.022039696357773586,0.011238781134960352,0.0090435364073993,0.019413707118890677,0.0061371247346606594,-0.15664010624169988
1394,2019-11-12,Stocks That Hit 52-Week Highs On Tuesday,AMGN,0.002763713789226019,0.9823352635050941,-0.0018541226426149748,0.014312451003447135,0.007347597742716205,0.0061371247346606594,0.003125029125603085,-0.007410247794652047,-0.13736365317064148
1395,2019-11-13,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",AMGN,-0.007410247794652047,-0.13736365317064148,0.002763713789226019,-0.0018541226426149748,0.014312451003447135,0.007347597742716205,0.0061371247346606594,0.0012830652577797697,0.17843977711101577
1396,2019-11-19,Medicines Company Shares Soar On Rumored Buyout Interest From Novartis,AMGN,0.017356220530885702,0.13936146461263665,-0.0008603612709916497,0.010800956334515055,0.0012830652577797697,-0.007410247794652047,0.002763713789226019,0.004498983144531232,0.38121178868161154
1397,2019-11-20,Stocks That Hit 52-Week Highs On Wednesday,AMGN,0.004498983144531232,0.38121178868161154,0.017356220530885702,-0.0008603612709916497,0.010800956334515055,0.0012830652577797697,-0.007410247794652047,0.01024341778588389,-0.2454388105439378
1398,2019-11-21,Stocks That Hit 52-Week Highs On Thursday,AMGN,0.01024341778588389,-0.2454388105439378,0.004498983144531232,0.017356220530885702,-0.0008603612709916497,0.010800956334515055,0.0012830652577797697,0.012817239981606665,-0.2573233557703155
1399,2019-11-21,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",AMGN,0.01024341778588389,-0.2454388105439378,0.004498983144531232,0.017356220530885702,-0.0008603612709916497,0.010800956334515055,0.0012830652577797697,0.012817239981606665,-0.2573233557703155
1400,2019-11-22,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",AMGN,0.012817239981606665,-0.2573233557703155,0.01024341778588389,0.004498983144531232,0.017356220530885702,-0.0008603612709916497,0.010800956334515055,0.016468536625786623,0.33539240506329104
1401,2019-11-22,Stocks That Hit 52-Week Highs On Friday,AMGN,0.012817239981606665,-0.2573233557703155,0.01024341778588389,0.004498983144531232,0.017356220530885702,-0.0008603612709916497,0.010800956334515055,0.016468536625786623,0.33539240506329104
1402,2019-11-25,Stocks That Hit 52-Week Highs On Monday,AMGN,0.016468536625786623,0.33539240506329104,0.012817239981606665,0.01024341778588389,0.004498983144531232,0.017356220530885702,-0.0008603612709916497,-0.0006395358387175643,0.25153560324562063
1403,2019-11-26,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",AMGN,-0.0006395358387175643,0.25153560324562063,0.016468536625786623,0.012817239981606665,0.01024341778588389,0.004498983144531232,0.017356220530885702,0.0006399451065479678,-0.521388754241396
1404,2019-11-29,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,AMGN,0.0007675721186761741,-0.40144322066084315,0.0006399451065479678,-0.0006395358387175643,0.016468536625786623,0.012817239981606665,0.01024341778588389,-0.0052829467070888425,0.727580372250423
1405,2019-12-10,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",AMGN,0.0043811302204626035,-0.19979656298517057,-0.004064021727749001,0.0015425762060539139,-0.00200969175087673,0.004768739514334541,-0.0030409225762652037,0.0007269193397234641,0.1735465310764701
1406,2019-12-12,Stocks That Hit 52-Week Highs On Thursday,AMGN,0.00846119349313268,0.055527050909298215,0.0007269193397234641,0.0043811302204626035,-0.004064021727749001,0.0015425762060539139,-0.00200969175087673,0.003178173925143968,0.1024574669187146
1407,2019-12-12,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",AMGN,0.00846119349313268,0.055527050909298215,0.0007269193397234641,0.0043811302204626035,-0.004064021727749001,0.0015425762060539139,-0.00200969175087673,0.003178173925143968,0.1024574669187146
1408,2019-12-13,Stocks That Hit 52-Week Highs On Friday,AMGN,0.003178173925143968,0.1024574669187146,0.00846119349313268,0.0007269193397234641,0.0043811302204626035,-0.004064021727749001,0.0015425762060539139,0.02728719041475869,0.49304330785812267
1409,2019-12-13,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",AMGN,0.003178173925143968,0.1024574669187146,0.00846119349313268,0.0007269193397234641,0.0043811302204626035,-0.004064021727749001,0.0015425762060539139,0.02728719041475869,0.49304330785812267
1410,2019-12-16,Stocks That Hit 52-Week Highs On Tuesday,AMGN,0.02728719041475869,0.49304330785812267,0.003178173925143968,0.00846119349313268,0.0007269193397234641,0.0043811302204626035,-0.004064021727749001,-0.0014802032329138681,-0.21823730148313425
1411,2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",AMGN,-0.0014802032329138681,-0.21823730148313425,0.02728719041475869,0.003178173925143968,0.00846119349313268,0.0007269193397234641,0.0043811302204626035,-0.003706062983534486,0.2410073452256034
1412,2019-12-17,Stocks That Hit 52-Week Highs On Tuesday,AMGN,-0.0014802032329138681,-0.21823730148313425,0.02728719041475869,0.003178173925143968,0.00846119349313268,0.0007269193397234641,0.0043811302204626035,-0.003706062983534486,0.2410073452256034
1413,2019-12-18,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",AMGN,-0.003706062983534486,0.2410073452256034,-0.0014802032329138681,0.02728719041475869,0.003178173925143968,0.00846119349313268,0.0007269193397234641,-0.000413455623298975,-0.2996245814590591
1414,2019-12-19,"Micron Yesterday, Nike Today: Earnings Keep Rolling In As Week Winds Down",AMGN,-0.000413455623298975,-0.2996245814590591,-0.003706062983534486,-0.0014802032329138681,0.02728719041475869,0.003178173925143968,0.00846119349313268,0.005044700685197023,1.4587598995557274
1415,2019-12-20,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",AMGN,0.005044700685197023,1.4587598995557274,-0.000413455623298975,-0.003706062983534486,-0.0014802032329138681,0.02728719041475869,0.003178173925143968,-0.00012340977541080989,-0.6688270877523765
1416,2020-01-14,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",AMGN,0.013000154159322985,0.11709239672720018,-0.005624084023678311,-0.0028040512851854604,0.002980344921146738,0.0007562154906008978,-0.009405026482900647,0.007083458807260357,-0.14219999106783976
1417,2020-01-17,9 Takeaways From The JPMorgan Healthcare Conference,AMGN,0.004116502447496062,0.23833724888526642,-0.004965071256529896,0.007083458807260357,0.013000154159322985,-0.005624084023678311,-0.0028040512851854604,-0.01610828229990091,0.19800216818956162
1418,2020-01-27,"Going Viral: Stocks On Their Back As Virus Spreads Heading Into Key Earnings, Fed Week",AMGN,-0.011702718466194084,-0.4335345325604095,-0.04020597113294855,-0.007222764484611677,-0.003577433612497072,-0.01610828229990091,0.004116502447496062,0.008477157823878034,-0.26012800675200454
1419,2020-01-28,Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later,AMGN,0.008477157823878034,-0.26012800675200454,-0.011702718466194084,-0.04020597113294855,-0.007222764484611677,-0.003577433612497072,-0.01610828229990091,0.010274093550361574,-0.048861637910547095
1420,2020-01-30,12 Stocks Moving In Thursday's After Hours,AMGN,-0.00440250328634284,0.29009045025236113,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,-0.007222764484611677,-0.04466047165707232,1.3120932754880692
1421,2020-01-30,"Earnings Scheduled For January 30, 2020",AMGN,-0.00440250328634284,0.29009045025236113,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,-0.007222764484611677,-0.04466047165707232,1.3120932754880692
1422,2020-01-30,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",AMGN,-0.00440250328634284,0.29009045025236113,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,-0.007222764484611677,-0.04466047165707232,1.3120932754880692
1423,2020-01-31,54 Stocks Moving In Friday's Mid-Day Session,AMGN,-0.04466047165707232,1.3120932754880692,-0.00440250328634284,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,0.003841837279370486,-0.5702055655145839
1424,2020-01-31,"Amgen Analysts Sidelined After Q4 Report, Say Valuation Reflects Growth Potential",AMGN,-0.04466047165707232,1.3120932754880692,-0.00440250328634284,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,0.003841837279370486,-0.5702055655145839
1425,2020-01-31,"The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO",AMGN,-0.04466047165707232,1.3120932754880692,-0.00440250328634284,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,0.003841837279370486,-0.5702055655145839
1426,2020-01-31,"12 Stocks To Watch For January 31, 2020",AMGN,-0.04466047165707232,1.3120932754880692,-0.00440250328634284,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,0.003841837279370486,-0.5702055655145839
1427,2020-01-31,"A Peek Into The Markets: US Stock Futures Drop Ahead Of Earnings, Economic Data",AMGN,-0.04466047165707232,1.3120932754880692,-0.00440250328634284,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,0.003841837279370486,-0.5702055655145839
1428,2020-01-31,33 Stocks Moving in Friday's Pre-Market Session,AMGN,-0.04466047165707232,1.3120932754880692,-0.00440250328634284,0.010274093550361574,0.008477157823878034,-0.011702718466194084,-0.04020597113294855,0.003841837279370486,-0.5702055655145839
1429,2020-02-03,82 Biggest Movers From Friday,AMGN,0.003841837279370486,-0.5702055655145839,-0.04466047165707232,-0.00440250328634284,0.010274093550361574,0.008477157823878034,-0.011702718466194084,0.022731258752286765,0.07792157168472746
1430,2020-03-30,Why Amgen's Stock Is Trading Higher Today,AMGN,0.05149554493880526,-0.21861345761724438,-0.0011083754725007555,0.02770008303935989,-0.04546811495013925,0.08825922439968759,-0.012324062238364464,-0.027580849483465508,-0.09009009009009006
1431,2020-04-02,Why Amgen's Stock Is Trading Higher Today,AMGN,0.05596295349222924,0.4073656246588304,-0.024268558700989984,-0.027580849483465508,0.05149554493880526,-0.0011083754725007555,0.02770008303935989,-0.016612530345716414,-0.4100793835492462
1432,2020-04-30,"Earnings Scheduled For April 30, 2020",AMGN,0.014977283917611883,0.6951947936168317,-0.008330933671134577,-0.019634463600536,0.02602837416443604,0.01630172602960589,0.013956170762396747,-0.03444513467561572,-0.46614076606188093
1433,2020-04-30,12 Stocks Moving In Thursday's After-Hours Session,AMGN,0.014977283917611883,0.6951947936168317,-0.008330933671134577,-0.019634463600536,0.02602837416443604,0.01630172602960589,0.013956170762396747,-0.03444513467561572,-0.46614076606188093
1434,2020-04-30,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",AMGN,0.014977283917611883,0.6951947936168317,-0.008330933671134577,-0.019634463600536,0.02602837416443604,0.01630172602960589,0.013956170762396747,-0.03444513467561572,-0.46614076606188093
1435,2020-05-01,"8 Stocks To Watch For May 1, 2020",AMGN,-0.03444513467561572,-0.46614076606188093,0.014977283917611883,-0.008330933671134577,-0.019634463600536,0.02602837416443604,0.01630172602960589,-0.00030309795618244095,-0.33151638536809613
1436,2020-05-14,5 ASCO Abstracts Moving Biopharma Stocks,AMGN,0.004855751892111737,0.4492519736555154,-0.0016020239769095612,-0.022781457063021038,0.03372782231086391,0.006385859799030502,-0.01377902845044976,0.016160387414095867,-0.0635627652210552
1437,2020-05-21,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",AMGN,-0.013560328860311,-0.35995800355354546,0.0019346529702555237,-0.024700942749529387,-0.029184028161542086,0.016160387414095867,0.004855751892111737,0.007340589969543343,-0.018170347003154563
1438,2020-06-04,Coronavirus Vaccine Frontrunner Moderna Appoints Former Amgen Executive As CFO,AMGN,-0.0005428953386981128,-0.3463188089058872,-0.01215789600937578,-0.01405855956252311,-0.012146423963079744,0.02485185592352357,-0.0030248840703437363,0.021685842836908886,0.5524072216649949
1439,2020-06-08,4 Analysts On Why The Rumored AstraZeneca-Gilead Deal Is Unlikely To Materialize,AMGN,0.000354464990571568,-0.3887632584935121,0.021685842836908886,-0.0005428953386981128,-0.01215789600937578,-0.01405855956252311,-0.012146423963079744,-0.0037650673252189737,0.05862144902003963
1440,2020-07-01,"The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes",AMGN,0.08165874236031256,1.5398995751255309,0.01856968018939842,-0.005497294465728109,-0.009655030391584551,0.0111821752005421,-0.013743319478740745,0.012229438088160682,-0.4923811551446212
1441,2020-07-01,Why Amgen's Stock Is Trading Higher Today,AMGN,0.08165874236031256,1.5398995751255309,0.01856968018939842,-0.005497294465728109,-0.009655030391584551,0.0111821752005421,-0.013743319478740745,0.012229438088160682,-0.4923811551446212
1442,2020-07-01,Stocks That Hit 52-Week Highs On Wednesday,AMGN,0.08165874236031256,1.5398995751255309,0.01856968018939842,-0.005497294465728109,-0.009655030391584551,0.0111821752005421,-0.013743319478740745,0.012229438088160682,-0.4923811551446212
1443,2020-07-02,Stocks That Hit 52-Week Highs On Thursday,AMGN,0.012229438088160682,-0.4923811551446212,0.08165874236031256,0.01856968018939842,-0.005497294465728109,-0.009655030391584551,0.0111821752005421,-0.007705868814670391,0.0366686638705811
1444,2020-07-02,"The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts",AMGN,0.012229438088160682,-0.4923811551446212,0.08165874236031256,0.01856968018939842,-0.005497294465728109,-0.009655030391584551,0.0111821752005421,-0.007705868814670391,0.0366686638705811
1445,2020-07-06,Stocks That Hit 52-Week Highs On Monday,AMGN,-0.007705868814670391,0.0366686638705811,0.012229438088160682,0.08165874236031256,0.01856968018939842,-0.005497294465728109,-0.009655030391584551,-0.012097678095856046,-0.3162929141139753
1446,2020-07-07,"The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold",AMGN,-0.012097678095856046,-0.3162929141139753,-0.007705868814670391,0.012229438088160682,0.08165874236031256,0.01856968018939842,-0.005497294465728109,-0.00616243502308067,-0.15731856798681265
1447,2020-07-14,"The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits",AMGN,0.012198132389087402,-0.06320952493967802,0.004015256187949179,-0.010410980724867458,0.00027850806730311817,-0.00616243502308067,-0.012097678095856046,0.0008693178018714942,-0.30325549972554156
1448,2020-07-28,"Earnings Scheduled For July 28, 2020",AMGN,0.0063868270547240424,0.05144500626246695,0.022864674669457852,-0.016888640209991923,-0.018444988643953164,-0.0036059314580946245,-0.011649862924087762,-0.025149879172368772,0.4500573546280773
1449,2020-07-28,"The Daily Biotech Pulse: Spectrum's Positive Dementia Readout, Pfizer, BioNTech Start Late-Stage Coronavirus Trial, resTORbio Receives COVID-19 Funding",AMGN,0.0063868270547240424,0.05144500626246695,0.022864674669457852,-0.016888640209991923,-0.018444988643953164,-0.0036059314580946245,-0.011649862924087762,-0.025149879172368772,0.4500573546280773
1450,2020-07-29,"The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More",AMGN,-0.025149879172368772,0.4500573546280773,0.0063868270547240424,0.022864674669457852,-0.016888640209991923,-0.018444988643953164,-0.0036059314580946245,-0.010890129100250778,-0.40140566525694465
1451,2020-08-25,"Apple Stock Split Causes Dow Jones Industrial Average Shuffle; Salesforce, Amgen and Honeywell To Make Entry",AMGN,0.05369948990165363,3.0836261419536193,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,-0.006213671936651344,0.007896260567701097,-0.5111152829273635
1452,2020-08-25,44 Stocks Moving In Tuesday's Mid-Day Session,AMGN,0.05369948990165363,3.0836261419536193,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,-0.006213671936651344,0.007896260567701097,-0.5111152829273635
1453,2020-08-25,33 Stocks Moving in Tuesday's Pre-Market Session,AMGN,0.05369948990165363,3.0836261419536193,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,-0.006213671936651344,0.007896260567701097,-0.5111152829273635
1454,2020-08-25,How Does Amgen's Debt Look?,AMGN,0.05369948990165363,3.0836261419536193,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,-0.006213671936651344,0.007896260567701097,-0.5111152829273635
1456,2020-08-25,3 ETFs For The New Look Dow Jones Industrial Average,AMGN,0.05369948990165363,3.0836261419536193,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,-0.006213671936651344,0.007896260567701097,-0.5111152829273635
1457,2020-08-25,"Shuffling The Deck: Major Indices Get Another Boost From $DJI Shakeup, China And Virus Optimism",AMGN,0.05369948990165363,3.0836261419536193,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,-0.006213671936651344,0.007896260567701097,-0.5111152829273635
1458,2020-08-26,61 Biggest Movers From Yesterday,AMGN,0.007896260567701097,-0.5111152829273635,0.05369948990165363,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,0.010512579321979798,0.25705599999999995
1459,2020-08-26,September Outlook: Rally Faces Potential New Challenge From Pre-Election Nerves,AMGN,0.007896260567701097,-0.5111152829273635,0.05369948990165363,-0.008710699653838638,-0.004565783192819861,-0.007318528958202952,-0.004182134917154801,0.010512579321979798,0.25705599999999995
1460,2020-08-31,"Puzzle Re-Arranged: Splits To Apple And Tesla, New Additions To $DJI Grab Early Focus",AMGN,0.0007901762115742894,-0.6842363534396809,0.0012260628920846006,0.010512579321979798,0.007896260567701097,0.05369948990165363,-0.008710699653838638,-0.009711070694765067,-0.2922864402180616
1461,2020-09-02,3 Pharma Stocks That Are COVID-19 Resistant,AMGN,0.02894039276054894,0.0009062391077030441,-0.009711070694765067,0.0007901762115742894,0.0012260628920846006,0.010512579321979798,0.007896260567701097,-0.0395552074512151,0.09266610948600085
1462,2020-09-17,"The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO",AMGN,0.0012916997596681412,0.20461875886982317,-0.002375641984461385,0.0064841996645081945,0.014555294314734457,0.01067989320106788,-0.020075762151945842,-0.001451345735335674,1.1571525472135948
1463,2020-10-05,7 Stocks Moving In Monday's After-Hours Session,AMGN,0.04319310904674012,0.1345212998687404,-0.039077613182677995,0.004839552819301485,0.023600430006315953,0.005141033645804427,0.013165476515917929,-0.01296814451237216,-0.14756512288328716
1464,2020-10-09,A Peek Into The Markets: US Stock Futures Climb; AMD In Talks To Buy Xilinx,AMGN,-0.014119733838153348,-0.25200722421901545,-0.06822683981653888,0.019707855466681856,-0.01296814451237216,0.04319310904674012,-0.039077613182677995,0.011871655765572697,-0.31111642361941194
1465,2020-10-26,"FAANGs In Focus: Amazon, Facebook, Apple, Alphabet, All Set To Report Later This Week",AMGN,-0.009993045420262359,0.4671133922630928,-0.0035969392218269114,-0.004323679431400662,-0.009216811380656664,0.0016904238297321683,-0.021253927609276135,-0.006358579002705644,-0.37339250429205406
1466,2020-10-28,17 Stocks Moving In Wednesday's After-Hours Session,AMGN,-0.031683463642104726,0.4857320099255582,-0.006358579002705644,-0.009993045420262359,-0.0035969392218269114,-0.004323679431400662,-0.009216811380656664,0.006655042869417427,0.04178844815588034
1467,2020-10-28,"Earnings Scheduled For October 28, 2020",AMGN,-0.031683463642104726,0.4857320099255582,-0.006358579002705644,-0.009993045420262359,-0.0035969392218269114,-0.004323679431400662,-0.009216811380656664,0.006655042869417427,0.04178844815588034
1468,2020-10-28,"The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts",AMGN,-0.031683463642104726,0.4857320099255582,-0.006358579002705644,-0.009993045420262359,-0.0035969392218269114,-0.004323679431400662,-0.009216811380656664,0.006655042869417427,0.04178844815588034
1469,2020-11-13,"The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations",AMGN,0.007726896840474673,-0.27524403248297924,-0.01474925324484122,-0.0037665795811709923,0.02808516368581615,0.014374019763210066,-0.0012935089369708885,-0.002949175620580391,0.17095806688925363
1470,2020-11-20,"The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger",AMGN,-0.006676427320786438,0.13888353815926346,-0.013566951526814863,-0.020134195099853258,-0.017831440847519642,-0.002949175620580391,0.007726896840474673,-0.004256839019376235,-0.31242811717745755
1471,2020-12-08,"The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings",AMGN,0.010995812915894465,-0.05590365729013913,-0.012041384371019759,0.010136186381621615,0.0015448806247329028,0.006575531293487646,0.013691209751713451,0.0039747185447345235,0.040244763473758605
1472,2020-12-09,Why Nano-Cap Xenetic Biosciences Is Skyrocketing,AMGN,0.0039747185447345235,0.040244763473758605,0.010995812915894465,-0.012041384371019759,0.010136186381621615,0.0015448806247329028,0.006575531293487646,-0.007352518546179798,-0.2949773755656109
1473,2020-12-14,3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover,AMGN,0.009058953461007047,0.4384687763086219,-0.0033310631160583526,-0.007352518546179798,0.0039747185447345235,0.010995812915894465,-0.012041384371019759,0.004663108596850263,-0.11639756257100564
1474,2020-12-17,"The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut",AMGN,0.012256974582946834,-0.030396662933065532,-0.009065982585558685,0.004663108596850263,0.009058953461007047,-0.0033310631160583526,-0.007352518546179798,-0.011892349883339093,1.3458014659018485
1475,2020-12-18,"The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data",AMGN,-0.011892349883339093,1.3458014659018485,0.012256974582946834,-0.009065982585558685,0.004663108596850263,0.009058953461007047,-0.0033310631160583526,-0.005164378114443147,-0.6074988537757475
1476,2020-12-22,"The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes",AMGN,-0.02780346083959251,0.5452106948169941,-0.005164378114443147,-0.011892349883339093,0.012256974582946834,-0.009065982585558685,0.004663108596850263,0.008823901770032672,-0.5062437003023854
1477,2021-01-07,Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing,AMGN,0.0033011856966260744,-0.29482262703739215,0.02410433796574285,0.004852959116215638,-0.014178647454779258,0.012105487277535243,0.001322178055813028,0.01910094658629702,-0.05162776644761691
1478,2021-01-13,"The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations",AMGN,0.004860664323543151,-0.20276601749929435,-0.004124920736884752,-0.0038577036658378194,0.01910094658629702,0.0033011856966260744,0.02410433796574285,0.016488571275111497,0.8367202435743115
1479,2021-01-19,"Piclidenoson From Can-Fite Biopharma Shows New, Promising Developments For Psoriasis Treatment",AMGN,0.011324335394251372,-0.23896749789857108,0.01584865627982812,0.016488571275111497,0.004860664323543151,-0.004124920736884752,-0.0038577036658378194,0.016473950533573145,0.2739656680012885
1480,2021-01-28,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",AMGN,-0.013184100153490363,0.6077087000833874,-0.02915721303588159,0.00583440498212906,0.014201284389462332,0.0058326452885284485,-0.0013076677216189436,-0.02550967276064331,-0.2714000307361303
1481,2021-01-29,"The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO",AMGN,-0.02550967276064331,-0.2714000307361303,-0.013184100153490363,-0.02915721303588159,0.00583440498212906,0.014201284389462332,0.0058326452885284485,-0.00414183264533341,-0.4269405188778739
1482,2021-02-02,"Earnings Scheduled For February 2, 2021",AMGN,0.0002496170631851591,0.12454566367609843,-0.00414183264533341,-0.02550967276064331,-0.013184100153490363,-0.02915721303588159,0.00583440498212906,-0.014179489647561438,0.8325832583258326
1483,2021-02-02,"The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment",AMGN,0.0002496170631851591,0.12454566367609843,-0.00414183264533341,-0.02550967276064331,-0.013184100153490363,-0.02915721303588159,0.00583440498212906,-0.014179489647561438,0.8325832583258326
1484,2021-02-03,"The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision",AMGN,-0.014179489647561438,0.8325832583258326,0.0002496170631851591,-0.00414183264533341,-0.02550967276064331,-0.013184100153490363,-0.02915721303588159,0.0005905317568601909,-0.37049026611894986
1485,2021-02-03,"Amgen Shares Dip On Light 2021 Outlook, Paused Studies",AMGN,-0.014179489647561438,0.8325832583258326,0.0002496170631851591,-0.00414183264533341,-0.02550967276064331,-0.013184100153490363,-0.02915721303588159,0.0005905317568601909,-0.37049026611894986
1486,2021-02-04,Citius Pharmaceuticals Says It Is Addressing Several Unmet Needs In The Medical Field,AMGN,0.0005905317568601909,-0.37049026611894986,-0.014179489647561438,0.0002496170631851591,-0.00414183264533341,-0.02550967276064331,-0.013184100153490363,-0.003793956211744054,-0.14111430294002913
1487,2021-02-17,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",AMGN,0.011896609722359841,-0.21936474902135672,-0.018422618323834627,0.009232574242058034,-0.007013241169035567,0.0076485253428135724,-0.0038725053566774914,-0.013072344856039808,0.23479751174304941
1488,2021-02-22,How Does Amgen's Debt Look?,AMGN,-0.000949511956605531,-0.055310540157798904,-0.003612553718514433,-0.013072344856039808,0.011896609722359841,-0.018422618323834627,0.009232574242058034,0.004277075349299109,0.25029981154702763
1489,2021-02-26,"AstraZeneca/Amgen's Tezepelumab Reduces Asthma Exacerbations, Phase 3 Trial Shows",AMGN,-0.011427491115784338,0.24711107901198903,-0.010739663301052582,-0.01062547932620761,0.004277075349299109,-0.000949511956605531,-0.003612553718514433,0.009425530391539372,-0.36930650065151294
1490,2021-02-26,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",AMGN,-0.011427491115784338,0.24711107901198903,-0.010739663301052582,-0.01062547932620761,0.004277075349299109,-0.000949511956605531,-0.003612553718514433,0.009425530391539372,-0.36930650065151294
1491,2021-03-03,"The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study",AMGN,-0.007754045560030787,0.08436137071651095,-0.0059460918780237515,0.009425530391539372,-0.011427491115784338,-0.010739663301052582,-0.01062547932620761,-0.009064919285551754,0.3701830996705737
1492,2021-03-04,Amgen Pays $1.9B For Five Prime Therapeutics Acquisition,AMGN,-0.009064919285551754,0.3701830996705737,-0.007754045560030787,-0.0059460918780237515,0.009425530391539372,-0.011427491115784338,-0.010739663301052582,0.026226777157741132,-0.15535364830863851
1493,2021-03-05,"The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study",AMGN,0.026226777157741132,-0.15535364830863851,-0.009064919285551754,-0.007754045560030787,-0.0059460918780237515,0.009425530391539372,-0.011427491115784338,0.00035135896141591516,0.026379373117532134
1494,2021-03-19,"Though Potential Bidders Moved Away, Amgen's Bid For Five Prime Outlasted 15 Suitors",AMGN,0.006218770851012412,3.11018249485815,0.0006140897371973431,0.016436349109526516,0.018477792270577886,0.02430981255366471,-0.0035039031059656,0.015247799537674078,-0.8363926639607939
1495,2021-03-31,Amgen Bets On Regenerative Immunology With Rodeo Therapeutics Acquisition,AMGN,-0.003763752472796922,0.8049014653865589,-0.020434484714640377,0.008304939006286371,0.02684248025898106,0.003177775497572144,0.0017547128895798458,0.0014469620328396715,-0.39054844760491614
1496,2021-03-31,"The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO",AMGN,-0.003763752472796922,0.8049014653865589,-0.020434484714640377,0.008304939006286371,0.02684248025898106,0.003177775497572144,0.0017547128895798458,0.0014469620328396715,-0.39054844760491614
1497,2021-04-06,Is Silicon Valley Replacing Big Pharma In Neuroscience?,AMGN,-0.011586421500387245,-0.08536202645146829,0.011437994279861474,0.0014469620328396715,-0.003763752472796922,-0.020434484714640377,0.008304939006286371,-0.0039341814599122005,-0.223812558207931
1498,2021-04-16,"The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs",AMGN,0.0022733940225654337,0.17005451548831507,0.022073614388842255,-0.0013202186542663474,0.004057211420116058,-4.0208864161561664e-05,0.008384596706519476,0.0010166492681402683,-0.15299599089825555
1499,2021-04-20,"The SPY, QQQ And DIA All Plunged Today. Here's Why.",AMGN,0.012384391701246944,-0.3265532386678607,0.0010166492681402683,0.0022733940225654337,0.022073614388842255,-0.0013202186542663474,0.004057211420116058,-0.0013892194961787618,0.3763059583359716
1500,2021-04-20,"Can-Fite Starts Preclinical Studies Required By FDA, EMA For Two Lead Drug Candidates Registration Filing",AMGN,0.012384391701246944,-0.3265532386678607,0.0010166492681402683,0.0022733940225654337,0.022073614388842255,-0.0013202186542663474,0.004057211420116058,-0.0013892194961787618,0.3763059583359716
1501,2021-04-20,"Amgen's Bemarituzumab Scores Breakthrough Therapy Tag For Gastric, GEJ Cancers",AMGN,0.012384391701246944,-0.3265532386678607,0.0010166492681402683,0.0022733940225654337,0.022073614388842255,-0.0013202186542663474,0.004057211420116058,-0.0013892194961787618,0.3763059583359716
1502,2021-04-21,Corporate America Helped Pour $61M Into Biden Inaugural Committee: Here Are The Companies That Donated,AMGN,-0.0013892194961787618,0.3763059583359716,0.012384391701246944,0.0010166492681402683,0.0022733940225654337,0.022073614388842255,-0.0013202186542663474,-0.014413878114377887,0.5507453073242548
1503,2021-04-23,"Bristol Myers' Psoriasis Med Deucravacitinib Superior To Amgen's Otezla, New Data Shows",AMGN,0.0077632349371374865,-0.28000118669712526,-0.014413878114377887,-0.0013892194961787618,0.012384391701246944,0.0010166492681402683,0.0022733940225654337,-0.005874793429471947,-0.2654415097449421
1504,2021-04-27,"Earnings Scheduled For April 27, 2021",AMGN,-0.001526298698944828,0.22561283446457625,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,0.012384391701246944,-0.07219861972187303,2.4559018719392194
1505,2021-04-27,15 Stocks Moving In Tuesday's After-Hours Session,AMGN,-0.001526298698944828,0.22561283446457625,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,0.012384391701246944,-0.07219861972187303,2.4559018719392194
1506,2021-04-27,"The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout",AMGN,-0.001526298698944828,0.22561283446457625,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,0.012384391701246944,-0.07219861972187303,2.4559018719392194
1507,2021-04-27,"Tech Time: Microsoft, Advanced Micro Devices, Alphabet Reporting After Close Today",AMGN,-0.001526298698944828,0.22561283446457625,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,0.012384391701246944,-0.07219861972187303,2.4559018719392194
1508,2021-04-28,Here's Why Amgen Stock Is Moving Today,AMGN,-0.07219861972187303,2.4559018719392194,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,-0.008449022992257804,-0.4631827091169147
1509,2021-04-28,"Boeing, Microsoft Fall In Another Mixed Day Of Trading For The Market",AMGN,-0.07219861972187303,2.4559018719392194,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,-0.008449022992257804,-0.4631827091169147
1510,2021-04-28,"The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping",AMGN,-0.07219861972187303,2.4559018719392194,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,-0.008449022992257804,-0.4631827091169147
1511,2021-04-28,25 Stocks Moving in Wednesday's Pre-Market Session,AMGN,-0.07219861972187303,2.4559018719392194,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,-0.008449022992257804,-0.4631827091169147
1512,2021-04-28,41 Stocks Moving In Wednesday's Mid-Day Session,AMGN,-0.07219861972187303,2.4559018719392194,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,-0.008449022992257804,-0.4631827091169147
1513,2021-04-28,Return On Capital Employed Overview: Amgen,AMGN,-0.07219861972187303,2.4559018719392194,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,-0.008449022992257804,-0.4631827091169147
1514,2021-04-28,Amgen Shares Drop On Light First Quarter Earnings Hit By Lower Prices,AMGN,-0.07219861972187303,2.4559018719392194,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,-0.0013892194961787618,-0.008449022992257804,-0.4631827091169147
1515,2021-04-29,Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales,AMGN,-0.008449022992257804,-0.4631827091169147,-0.07219861972187303,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,0.021004593145051986,-0.156041841417082
1516,2021-04-29,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",AMGN,-0.008449022992257804,-0.4631827091169147,-0.07219861972187303,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,0.021004593145051986,-0.156041841417082
1517,2021-04-29,60 Biggest Movers From Yesterday,AMGN,-0.008449022992257804,-0.4631827091169147,-0.07219861972187303,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,-0.014413878114377887,0.021004593145051986,-0.156041841417082
1518,2021-04-30,Intel And Apple Lead The Dow Jones Lower To Close The Week,AMGN,0.021004593145051986,-0.156041841417082,-0.008449022992257804,-0.07219861972187303,-0.001526298698944828,-0.005874793429471947,0.0077632349371374865,0.02395260296240309,0.04875909848285542
1519,2021-05-03,"Tesla, AMD And Amazon Lead The Nasdaq Lower Monday",AMGN,0.02395260296240309,0.04875909848285542,0.021004593145051986,-0.008449022992257804,-0.07219861972187303,-0.001526298698944828,-0.005874793429471947,0.008069038039145271,-0.00886361735931096
1520,2021-05-03,Astellas Walks Away From $450M Research & Discovery Partnership With Cytokinetics,AMGN,0.02395260296240309,0.04875909848285542,0.021004593145051986,-0.008449022992257804,-0.07219861972187303,-0.001526298698944828,-0.005874793429471947,0.008069038039145271,-0.00886361735931096
1521,2021-05-11,"EXCLUSIVE: Sree Batchu On The Power Of The Los Angeles MedTech Ecosystem, Why You Should Care",AMGN,-0.0012665758857459686,-0.43452045393269445,-0.006254723147941066,0.01157972047425404,0.007820460852077105,0.008044982846715953,0.008069038039145271,-0.005826424188181467,0.05409388409691829
1522,2021-05-14,"The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts",AMGN,0.0042746889087073026,-0.30180441486276066,0.004943540295778037,-0.005826424188181467,-0.0012665758857459686,-0.006254723147941066,0.01157972047425404,0.003978029716307674,-0.1594367675354207
1523,2021-05-17,Supreme Court Rebuffs Novartis Appeal Over Amgen's Arthritis Drug Enbrel: Report,AMGN,0.003978029716307674,-0.1594367675354207,0.0042746889087073026,0.004943540295778037,-0.005826424188181467,-0.0012665758857459686,-0.006254723147941066,-0.006022588077992941,-0.10030173759234207
1524,2021-05-20,Sorrento Reports Encouraging Data From Sofusa-Administered Enbrel In Rheumatoid Arthritis,AMGN,0.01327267525689435,-0.16026390197926488,-0.008889372897662784,-0.006022588077992941,0.003978029716307674,0.0042746889087073026,0.004943540295778037,-0.0036519048961082268,-0.022223219897638535
1525,2021-05-26,Tesla And Comcast Lead The QQQ Higher Wednesday,AMGN,-0.014256226534514194,0.1873481592225752,-0.023208924742927572,-0.012987399540416389,-0.0036519048961082268,0.01327267525689435,-0.008889372897662784,-0.013582083746949691,-0.029117809081608548
1526,2021-05-28,"Amgen's First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer",AMGN,0.011176731901757497,-0.12477371592229336,-0.013582083746949691,-0.014256226534514194,-0.023208924742927572,-0.012987399540416389,-0.0036519048961082268,-0.01832399235505089,0.17296946871237617
1527,2021-06-01,Baidu And JD.com Lead The Nasdaq Higher Tuesday,AMGN,-0.01832399235505089,0.17296946871237617,0.011176731901757497,-0.013582083746949691,-0.014256226534514194,-0.023208924742927572,-0.012987399540416389,0.006764384420361758,-0.4034108853563533
1528,2021-06-04,"Amgen's Stomach Cancer Drug Acquired in Five Prime Buyout Extends Patients' Lives, Mid-Stage Study Shows",AMGN,0.004708439020971067,-0.06709439968168707,0.0024665235220706627,0.006764384420361758,-0.01832399235505089,0.011176731901757497,-0.013582083746949691,0.0014354939959289048,0.1482646478647971
1529,2021-06-07,What Does Amgen's Debt Look Like?,AMGN,0.0014354939959289048,0.1482646478647971,0.004708439020971067,0.0024665235220706627,0.006764384420361758,-0.01832399235505089,0.011176731901757497,-0.0015599079770628466,-0.2394837032222119
1530,2021-06-07,Price Over Earnings Overview: Amgen,AMGN,0.0014354939959289048,0.1482646478647971,0.004708439020971067,0.0024665235220706627,0.006764384420361758,-0.01832399235505089,0.011176731901757497,-0.0015599079770628466,-0.2394837032222119
1531,2021-06-07,Amgen's Sotorasib is First KRAS Inhibitor to Show Overall Survival Benefit in Lung Cancer With KRAS Mutations,AMGN,0.0014354939959289048,0.1482646478647971,0.004708439020971067,0.0024665235220706627,0.006764384420361758,-0.01832399235505089,0.011176731901757497,-0.0015599079770628466,-0.2394837032222119
1532,2021-06-14,"IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings",AMGN,-0.006508186946098005,0.04040353593367629,-0.007643878100308421,0.02137591818121254,0.01140118758395925,-0.0015599079770628466,0.0014354939959289048,-0.005555760355591133,0.20430107526881724
1533,2021-06-23,"The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway",AMGN,-0.0050018479899619495,-0.07082678049876434,-0.0013736606959343645,0.006536013110427286,-0.008639372404396384,0.004925218844732626,-0.0011256888217189287,0.00938367378392968,0.17451490056217134
1534,2021-06-23,14 Biotech Stocks To Watch Over The Next 6 Months,AMGN,-0.0050018479899619495,-0.07082678049876434,-0.0013736606959343645,0.006536013110427286,-0.008639372404396384,0.004925218844732626,-0.0011256888217189287,0.00938367378392968,0.17451490056217134
1535,2021-06-29,Amgen Pumps $365M Into New Ohio Facility,AMGN,-0.0015648795056070197,-0.20437912774439226,0.0006593450727254702,0.007180038191920479,0.00938367378392968,-0.0050018479899619495,-0.0013736606959343645,0.005320477171790072,0.7387825306610829
1536,2021-07-02,"The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures",AMGN,0.007290393507270121,-0.07075922738573337,0.01292299646320294,0.005320477171790072,-0.0015648795056070197,0.0006593450727254702,0.007180038191920479,-0.020305496329506068,0.4366639226178226
1537,2021-07-08,How Does Amgen's Debt Look?,AMGN,0.004358230779897054,-0.1626569257253222,-0.0017648525975877405,-0.020305496329506068,0.007290393507270121,0.01292299646320294,0.005320477171790072,0.003766071796606152,-0.19274933560647844
1538,2021-07-08,"The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test",AMGN,0.004358230779897054,-0.1626569257253222,-0.0017648525975877405,-0.020305496329506068,0.007290393507270121,0.01292299646320294,0.005320477171790072,0.003766071796606152,-0.19274933560647844
1539,2021-07-08,Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA,AMGN,0.004358230779897054,-0.1626569257253222,-0.0017648525975877405,-0.020305496329506068,0.007290393507270121,0.01292299646320294,0.005320477171790072,0.003766071796606152,-0.19274933560647844
1540,2021-07-09,"The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO",AMGN,0.003766071796606152,-0.19274933560647844,0.004358230779897054,-0.0017648525975877405,-0.020305496329506068,0.007290393507270121,0.01292299646320294,-0.0033849211060343887,0.3351139822349214
1541,2021-07-09,BeiGene-Amgen's Kyprolis Gets Approval In China For Pre-Treated Multiple Myeloma Patients,AMGN,0.003766071796606152,-0.19274933560647844,0.004358230779897054,-0.0017648525975877405,-0.020305496329506068,0.007290393507270121,0.01292299646320294,-0.0033849211060343887,0.3351139822349214
1542,2021-07-13,"Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions",AMGN,0.0018824084712145694,-0.24713873639155115,-0.0033849211060343887,0.003766071796606152,0.004358230779897054,-0.0017648525975877405,-0.020305496329506068,-0.000530963979076704,0.35038932146829804
1543,2021-07-15,FDA Rebukes Amgen Over Misleading Branding Of Neulasta,AMGN,0.007887315695999542,-0.03592348526450673,-0.000530963979076704,0.0018824084712145694,-0.0033849211060343887,0.003766071796606152,0.004358230779897054,0.005392518192609108,0.49114729197322826
1544,2021-07-19,Analysts See Higher Success Chances For Cytokinetics' Heart Disease Candidate After Positive Phase 2 Data,AMGN,-0.004960441868748111,-0.19465843254599857,0.005392518192609108,0.007887315695999542,-0.000530963979076704,0.0018824084712145694,-0.0033849211060343887,0.0006485221301637534,0.19973121467251675
1545,2021-07-21,Boeing And Chevron Soar As The Dow Jones Finishes Higher,AMGN,-0.008262709995022877,-0.3733856088560885,0.0006485221301637534,-0.004960441868748111,0.005392518192609108,0.007887315695999542,-0.000530963979076704,-0.0004493317195704005,-0.27451495872548504
1546,2021-07-28,Amgen Buys Antibody Player Focused On PSMA In $2.5B Deal,AMGN,-0.0017574233461900013,-0.238783234859675,-0.0016321548664702812,-0.010657198927974565,0.012176178972701512,-0.0004493317195704005,-0.008262709995022877,-0.007328529920470173,-0.09107998302104181
1547,2021-07-28,"The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal",AMGN,-0.0017574233461900013,-0.238783234859675,-0.0016321548664702812,-0.010657198927974565,0.012176178972701512,-0.0004493317195704005,-0.008262709995022877,-0.007328529920470173,-0.09107998302104181
1548,2021-08-03,Another Big Earnings Week Ahead,AMGN,0.01789076604494677,0.2546771926030065,-0.007245272561701044,-0.0037944080781965317,-0.007328529920470173,-0.0017574233461900013,-0.0016321548664702812,-0.06460999478643492,1.996379934494053
1549,2021-08-03,"Earnings Scheduled For August 3, 2021",AMGN,0.01789076604494677,0.2546771926030065,-0.007245272561701044,-0.0037944080781965317,-0.007328529920470173,-0.0017574233461900013,-0.0016321548664702812,-0.06460999478643492,1.996379934494053
1550,2021-08-04,"Amgen Stops Phase 1 For One BiTE Molecule While Resuming Dosing For Another, Plans Second Drug Substance Plant",AMGN,-0.06460999478643492,1.996379934494053,0.01789076604494677,-0.007245272561701044,-0.0037944080781965317,-0.007328529920470173,-0.0017574233461900013,0.024878504223727615,-0.526219652514095
1551,2021-08-04,"Amgen Q2 Profit Falls On Five Prime Acquisition Related Write-off, Disputes IRS Claim On Owing $3.6B In Taxes",AMGN,-0.06460999478643492,1.996379934494053,0.01789076604494677,-0.007245272561701044,-0.0037944080781965317,-0.007328529920470173,-0.0017574233461900013,0.024878504223727615,-0.526219652514095
1552,2021-08-05,Disney And Salesforce Gain As The DIA Finishes Higher Thursday,AMGN,0.024878504223727615,-0.526219652514095,-0.06460999478643492,0.01789076604494677,-0.007245272561701044,-0.0037944080781965317,-0.007328529920470173,-0.016411003185584194,-0.28241401293221213
1553,2021-08-27,Amgen's Repatha Improves Plaque Stability In Heart Patients,AMGN,0.005915012501138683,-0.06454561434346984,-0.0005414708655361311,-0.012434354002852754,-0.005584070290902354,0.009439455288362986,-0.003832629955428102,0.006059852870958338,-0.29279567063775414
1554,2021-09-07,"Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab",AMGN,-0.022220252571614307,0.9721170602728202,0.0018143821122886816,0.011685783306669029,-0.009666162700757375,0.006246330872709427,0.006059852870958338,-0.002123403369013732,-0.3477969407032726
1555,2021-09-07,Disney And Apple Lead The Dow Jones,AMGN,-0.022220252571614307,0.9721170602728202,0.0018143821122886816,0.011685783306669029,-0.009666162700757375,0.006246330872709427,0.006059852870958338,-0.002123403369013732,-0.3477969407032726
1556,2021-09-08,Downgrades On Economy And Pandemic Pharmaceuticals,AMGN,-0.002123403369013732,-0.3477969407032726,-0.022220252571614307,0.0018143821122886816,0.011685783306669029,-0.009666162700757375,0.006246330872709427,-0.023950738294835072,0.5294337507008036
1557,2021-09-09,Amgen Reveals Post-Hoc Data For Its KRAS Inhibitor In Lung Cancer Patients,AMGN,-0.023950738294835072,0.5294337507008036,-0.002123403369013732,-0.022220252571614307,0.0018143821122886816,0.011685783306669029,-0.009666162700757375,-0.008488728774928345,-0.322519550342131
1558,2021-09-14,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",AMGN,-0.0031377769817639845,-0.21700477794313466,0.013894761319290572,-0.008488728774928345,-0.023950738294835072,-0.002123403369013732,-0.022220252571614307,0.009674141099408562,0.2782473865853048
1559,2021-09-16,Amgen's Lumakras Combo Therapy Shows Improved Response Rate In Colorectal Cancer,AMGN,-0.0035298374552575895,0.05478165597120044,0.009674141099408562,-0.0031377769817639845,0.013894761319290572,-0.008488728774928345,-0.023950738294835072,0.009293231294689619,1.0996809615669982
1560,2021-09-17,Apple And Microsoft Lead The Dow Jones Lower,AMGN,0.009293231294689619,1.0996809615669982,-0.0035298374552575895,0.009674141099408562,-0.0031377769817639845,0.013894761319290572,-0.008488728774928345,-0.019463921017326746,-0.41818760048764114
1561,2021-09-21,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",AMGN,0.0011621640131134203,-0.3586091709687216,-0.019463921017326746,0.009293231294689619,-0.0035298374552575895,0.009674141099408562,-0.0031377769817639845,-0.007986588319340404,0.2039202689266606
1562,2021-09-27,Amgen's Repatha Scores FDA Nod For Pediatric Patients Over 10 Years With Inherited Heart Disease,AMGN,-0.002340649863173505,0.018023682280205344,-0.006696220811397646,0.006599954323863955,-0.007986588319340404,0.0011621640131134203,-0.019463921017326746,-0.0039416437160733064,0.5023160061760166
1563,2021-09-27,Acceleron In Advanced $11B Buyout Talks: Bloomberg,AMGN,-0.002340649863173505,0.018023682280205344,-0.006696220811397646,0.006599954323863955,-0.007986588319340404,0.0011621640131134203,-0.019463921017326746,-0.0039416437160733064,0.5023160061760166
1564,2021-10-07,Amgen Highlights Lumakras Combination Data From Solid Tumor Trials,AMGN,-0.004095494064297989,0.137797964619903,-0.00887374923444495,0.001986236374776018,-0.011593169255210922,0.005972470340962488,-0.010470070105722984,-0.0008130487820846577,-0.2947144100609299
1565,2021-10-07,"Amgen, Neumora Collaborate On Precision Therapies for Brain Diseases",AMGN,-0.004095494064297989,0.137797964619903,-0.00887374923444495,0.001986236374776018,-0.011593169255210922,0.005972470340962488,-0.010470070105722984,-0.0008130487820846577,-0.2947144100609299
1566,2021-10-07,"The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results",AMGN,-0.004095494064297989,0.137797964619903,-0.00887374923444495,0.001986236374776018,-0.011593169255210922,0.005972470340962488,-0.010470070105722984,-0.0008130487820846577,-0.2947144100609299
1567,2021-10-08,"The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs",AMGN,-0.0008130487820846577,-0.2947144100609299,-0.004095494064297989,-0.00887374923444495,0.001986236374776018,-0.011593169255210922,0.005972470340962488,-0.0107680596686196,-0.15643884585922208
1568,2021-10-12,"The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology",AMGN,-0.02327042680409086,0.7879124205428312,-0.0107680596686196,-0.0008130487820846577,-0.004095494064297989,-0.00887374923444495,0.001986236374776018,0.008519369684663936,-0.06791760722347628
1569,2021-10-18,Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters,AMGN,-0.022661571472046393,-0.2366878358573522,0.005126321965048364,0.01556893234944412,0.008519369684663936,-0.02327042680409086,-0.0107680596686196,0.017968591168454617,-0.1180444444444444
1570,2021-10-19,3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat,AMGN,0.017968591168454617,-0.1180444444444444,-0.022661571472046393,0.005126321965048364,0.01556893234944412,0.008519369684663936,-0.02327042680409086,0.013927909655060855,-0.0693005442451119
1571,2021-10-20,AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial,AMGN,0.013927909655060855,-0.0693005442451119,0.017968591168454617,-0.022661571472046393,0.005126321965048364,0.01556893234944412,0.008519369684663936,-0.0031955499370360796,-0.16785064541280426
1572,2021-10-21,Economic Reports Reflect Labor Shortages and Moderate Economic Growth,AMGN,-0.0031955499370360796,-0.16785064541280426,0.013927909655060855,0.017968591168454617,-0.022661571472046393,0.005126321965048364,0.01556893234944412,0.0011961964446944862,-0.29764197595127795
1573,2021-11-01,"Mirati Therapeutics COO, CMO Exit, Completing Management Overhaul",AMGN,0.013625146312801428,0.19789376229603062,-0.00096539503245896,0.002856010264118636,-0.010063222797284999,0.005057056541982741,-0.007694509366357072,0.021307001954840254,0.07213473738447163
1574,2021-11-02,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",AMGN,0.021307001954840254,0.07213473738447163,0.013625146312801428,-0.00096539503245896,0.002856010264118636,-0.010063222797284999,0.005057056541982741,0.018062136349847657,0.13405220316583066
1575,2021-11-02,Healthcare Stocks Subject to Government Policy,AMGN,0.021307001954840254,0.07213473738447163,0.013625146312801428,-0.00096539503245896,0.002856010264118636,-0.010063222797284999,0.005057056541982741,0.018062136349847657,0.13405220316583066
1576,2021-11-02,"Earnings Scheduled For November 2, 2021",AMGN,0.021307001954840254,0.07213473738447163,0.013625146312801428,-0.00096539503245896,0.002856010264118636,-0.010063222797284999,0.005057056541982741,0.018062136349847657,0.13405220316583066
1577,2021-11-03,A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Fed Decision,AMGN,0.018062136349847657,0.13405220316583066,0.021307001954840254,0.013625146312801428,-0.00096539503245896,0.002856010264118636,-0.010063222797284999,-0.014670070239243271,-0.26334887170251087
1578,2021-11-03,"5 Stocks To Watch For November 3, 2021",AMGN,0.018062136349847657,0.13405220316583066,0.021307001954840254,0.013625146312801428,-0.00096539503245896,0.002856010264118636,-0.010063222797284999,-0.014670070239243271,-0.26334887170251087
1579,2021-11-03,Amgen Q3 Earnings Saved By Higher Volumes Despite Pricing Pressure On Some Drugs,AMGN,0.018062136349847657,0.13405220316583066,0.021307001954840254,0.013625146312801428,-0.00096539503245896,0.002856010264118636,-0.010063222797284999,-0.014670070239243271,-0.26334887170251087
1580,2021-11-09,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",AMGN,0.001608636729235613,-0.09341071499072207,-0.011227069732552608,-0.0053971299594354205,-0.014670070239243271,0.018062136349847657,0.021307001954840254,0.007085195017014767,0.027914471105691785
1581,2021-11-29,Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis,AMGN,0.011835480207643245,-0.21201413427561833,-0.014119782963008864,-0.0027378714059129727,0.008878862825039358,-0.016255898873828722,0.0100970877715858,-0.02255862197226377,1.142981864359697
1582,2021-11-29,Price Over Earnings Overview: Amgen,AMGN,0.011835480207643245,-0.21201413427561833,-0.014119782963008864,-0.0027378714059129727,0.008878862825039358,-0.016255898873828722,0.0100970877715858,-0.02255862197226377,1.142981864359697
1583,2021-12-02,"The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance",AMGN,0.0018424401315695338,-0.06524511888020412,0.009654130905451197,-0.02255862197226377,0.011835480207643245,-0.014119782963008864,-0.0027378714059129727,0.006313146362805,0.25670002099223277
1584,2021-12-02,Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates,AMGN,0.0018424401315695338,-0.06524511888020412,0.009654130905451197,-0.02255862197226377,0.011835480207643245,-0.014119782963008864,-0.0027378714059129727,0.006313146362805,0.25670002099223277
1585,2021-12-02,Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study,AMGN,0.0018424401315695338,-0.06524511888020412,0.009654130905451197,-0.02255862197226377,0.011835480207643245,-0.014119782963008864,-0.0027378714059129727,0.006313146362805,0.25670002099223277
1586,2021-12-02,Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma,AMGN,0.0018424401315695338,-0.06524511888020412,0.009654130905451197,-0.02255862197226377,0.011835480207643245,-0.014119782963008864,-0.0027378714059129727,0.006313146362805,0.25670002099223277
1587,2021-12-06,A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Up 2%,AMGN,0.03136723226949001,0.11322698293382327,0.006313146362805,0.0018424401315695338,0.009654130905451197,-0.02255862197226377,0.011835480207643245,0.012117568847247462,-0.17233531736107632
1588,2021-12-06,"5 Stocks To Watch For December 6, 2021",AMGN,0.03136723226949001,0.11322698293382327,0.006313146362805,0.0018424401315695338,0.009654130905451197,-0.02255862197226377,0.011835480207643245,0.012117568847247462,-0.17233531736107632
1589,2021-12-07,Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022,AMGN,0.012117568847247462,-0.17233531736107632,0.03136723226949001,0.006313146362805,0.0018424401315695338,0.009654130905451197,-0.02255862197226377,0.010457951589282422,-0.20701012237498106
1590,2021-12-20,AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma,AMGN,-0.01128084042775046,-0.5451120797011209,-0.0003594981750776327,0.015188175148404204,0.025778989262314367,0.011116970450898656,0.0023709031667487057,0.0042273311496501265,0.022346177537471812
1591,2021-12-20,Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut,AMGN,-0.01128084042775046,-0.5451120797011209,-0.0003594981750776327,0.015188175148404204,0.025778989262314367,0.011116970450898656,0.0023709031667487057,0.0042273311496501265,0.022346177537471812
1594,2021-12-21,"Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level",AMGN,0.0042273311496501265,0.022346177537471812,-0.01128084042775046,-0.0003594981750776327,0.015188175148404204,0.025778989262314367,0.011116970450898656,0.002761313038276647,-0.1036987447698745
1595,2021-12-30,These 8 Dow Jones Stocks Are Negative For 2021,AMGN,-0.004964874494955307,0.08492874622139057,0.008105560075759355,0.0026647650026494496,0.0061664839986042,0.010201683965994857,0.002761313038276647,-0.006623320356178408,0.10680642165317766
1596,2022-01-04,Financial Stocks Could be Positioned to Kick Off the Q4 Earnings Season,AMGN,0.005073067768931017,-0.09154878226629726,0.007645369054543938,-0.006623320356178408,-0.004964874494955307,0.008105560075759355,0.0026647650026494496,-0.011850428812258507,0.12613878075209706
1597,2022-01-04,"The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives",AMGN,0.005073067768931017,-0.09154878226629726,0.007645369054543938,-0.006623320356178408,-0.004964874494955307,0.008105560075759355,0.0026647650026494496,-0.011850428812258507,0.12613878075209706
1598,2022-01-10,Europe Approves Amgen's KRAS-Targeted Lung Cancer Therapy,AMGN,0.013550968577067168,0.36231327358087917,0.009415183307143637,0.00013316430118992528,-0.011850428812258507,0.005073067768931017,0.007645369054543938,0.00872510775244062,-0.2738181020708669
1599,2022-01-11,A Look Into Amgen's Price Over Earnings,AMGN,0.00872510775244062,-0.2738181020708669,0.013550968577067168,0.009415183307143637,0.00013316430118992528,-0.011850428812258507,0.005073067768931017,-0.002668050484949114,-0.1864187411018594
1600,2022-01-20,Amgen's Lumakras Approved In Japan For Pretreated Lung Cancer Patients,AMGN,-0.010376157507129835,0.015767514069474187,-0.010819806594361214,-0.0065007962382390705,0.01953650255930217,-0.00392645028092764,-0.002668050484949114,-0.0051550650704781376,0.6883030042508478
1601,2022-01-20,"The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug",AMGN,-0.010376157507129835,0.015767514069474187,-0.010819806594361214,-0.0065007962382390705,0.01953650255930217,-0.00392645028092764,-0.002668050484949114,-0.0051550650704781376,0.6883030042508478
1602,2022-02-03,Price To Earnings Ratio Insights For Amgen,AMGN,-0.0213601723119472,0.25214780215197274,0.0010932650042705383,0.006779889234567182,-0.008728353062085747,0.02294646255475352,0.006560683989998761,-0.008614541578665369,0.05315747402078341
1603,2022-02-07,What's Going On With Amgen Stock During Today's After-Hours Session,AMGN,0.006393291219476849,0.13738140417457312,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.008728353062085747,0.0781997140499835,1.3342231120008896
1604,2022-02-07,"5 Stocks To Watch For February 7, 2022",AMGN,0.006393291219476849,0.13738140417457312,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.008728353062085747,0.0781997140499835,1.3342231120008896
1605,2022-02-07,"Earnings Scheduled For February 7, 2022",AMGN,0.006393291219476849,0.13738140417457312,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.008728353062085747,0.0781997140499835,1.3342231120008896
1606,2022-02-07,A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%,AMGN,0.006393291219476849,0.13738140417457312,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.008728353062085747,0.0781997140499835,1.3342231120008896
1607,2022-02-08,Pfizer And Harley Davidson Lead Out In Tuesday's Earnings With Different Results,AMGN,0.0781997140499835,1.3342231120008896,0.006393291219476849,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.015849912346479478,-0.3954352694525183
1608,2022-02-08,"The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar",AMGN,0.0781997140499835,1.3342231120008896,0.006393291219476849,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.015849912346479478,-0.3954352694525183
1609,2022-02-08,Amgen's Q4 Sales Remain Flat As Its Biggest Product Flounders,AMGN,0.0781997140499835,1.3342231120008896,0.006393291219476849,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.015849912346479478,-0.3954352694525183
1610,2022-02-08,AMD And Pinduoduo Lead The Nasdaq Higher,AMGN,0.0781997140499835,1.3342231120008896,0.006393291219476849,-0.008614541578665369,-0.0213601723119472,0.0010932650042705383,0.006779889234567182,-0.015849912346479478,-0.3954352694525183
1611,2022-02-15,Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer,AMGN,-0.0014715378423426628,-0.3705964644537708,-0.008795133756426488,-0.0027095603120060874,-0.0352881883556001,-0.015849912346479478,0.0781997140499835,-0.005715824032938577,-0.042634875732471156
1612,2022-02-16,"The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa",AMGN,-0.005715824032938577,-0.042634875732471156,-0.0014715378423426628,-0.008795133756426488,-0.0027095603120060874,-0.0352881883556001,-0.015849912346479478,-0.00440135049985424,-0.08948923596454195
1613,2022-02-22,Apple And Nike Lead The Dow Jones Lower Amid Russia-Ukraine Tensions,AMGN,0.002898948237132215,0.014342942985907436,-0.004104964999805727,-0.00440135049985424,-0.005715824032938577,-0.0014715378423426628,-0.008795133756426488,-0.0018517871940179065,0.056031594908142024
1614,2022-02-28,Amgen's Tezspire Reduces Annualized Exacerbation Rate In Severe Asthma Patients,AMGN,-0.002422539520744671,0.3320120322734812,0.03539012190315427,-0.007828040856076912,-0.0018517871940179065,0.002898948237132215,-0.004104964999805727,-0.005607575910621887,-0.03473966357822755
1615,2022-03-02,36 Stocks To Watch After Biden's First State of The Union Address,AMGN,0.015008196317892963,-0.2593855909041216,-0.005607575910621887,-0.002422539520744671,0.03539012190315427,-0.007828040856076912,-0.0018517871940179065,0.01771733633012018,0.07416154936230512
1616,2022-03-03,Markets Close Lower Again In Up And Down Trading Day; Nasdaq Falls 1.5%,AMGN,0.01771733633012018,0.07416154936230512,0.015008196317892963,-0.005607575910621887,-0.002422539520744671,0.03539012190315427,-0.007828040856076912,0.0011605389941575783,0.034630606860158286
1617,2022-03-08,Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study,AMGN,-0.013910184367130762,-0.19883119681137562,0.0062256300107597085,0.0011605389941575783,0.01771733633012018,0.015008196317892963,-0.005607575910621887,0.001557764836032316,-0.11227268143467006
1618,2022-03-09,Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why,AMGN,0.001557764836032316,-0.11227268143467006,-0.013910184367130762,0.0062256300107597085,0.0011605389941575783,0.01771733633012018,0.015008196317892963,-0.019485071267857812,0.4984285660191601
1619,2022-03-09,"AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar",AMGN,0.001557764836032316,-0.11227268143467006,-0.013910184367130762,0.0062256300107597085,0.0011605389941575783,0.01771733633012018,0.015008196317892963,-0.019485071267857812,0.4984285660191601
1620,2022-03-11,Markets Fall Again As Russia-Ukraine War Erodes Investor Sentiment,AMGN,0.008371918328338612,-0.32603861316082083,-0.019485071267857812,0.001557764836032316,-0.013910184367130762,0.0062256300107597085,0.0011605389941575783,0.0015730804754672256,0.08837645294338214
1621,2022-03-15,$100 Invested In This Stock 10 Years Ago Would Be Worth This Much,AMGN,0.010252616423639394,0.09491163399593483,0.0015730804754672256,0.008371918328338612,-0.019485071267857812,0.001557764836032316,-0.013910184367130762,0.0004750022743811311,0.3278900006292871
1622,2022-04-04,$1000 Invested In Amgen 10 Years Ago Would Be Worth This Much,AMGN,0.007198061278815837,0.8678273793725781,0.005375757058440067,-0.0030917944383139773,0.004264343123310033,0.004449556373487429,0.007035504029142103,-0.0012658921286045066,-0.38024326474934633
1623,2022-04-11,Biomea Fusion Shares BMF-219 Preclinical Data At AACR 2022 Meeting,AMGN,-0.004563124883096514,0.08354577900793947,0.0015100741372258142,0.006841984675743484,0.021957731227362665,-0.0012658921286045066,0.007198061278815837,-0.0033085111837745096,-0.24001747781661742
1624,2022-04-11,Amgen's Lumakras Shows Two-Year Overall Survival Of 32.5% In KRAS-Mutated Lung Cancer,AMGN,-0.004563124883096514,0.08354577900793947,0.0015100741372258142,0.006841984675743484,0.021957731227362665,-0.0012658921286045066,0.007198061278815837,-0.0033085111837745096,-0.24001747781661742
1625,2022-04-13,"Deciphera's DCC-3116/KRAS Inhibitor Combo Shows Deeper, Longer Tumor Regressions In Preclinical Studies",AMGN,0.013877809986703626,0.06266861262217516,-0.0033085111837745096,-0.004563124883096514,0.0015100741372258142,0.006841984675743484,0.021957731227362665,0.0020117467827391877,0.1910271350091559
1626,2022-04-19,"Amgen's Stelara-Based Biosimilar Shows Comparable Efficacy, Safety Profile For Psoriasis",AMGN,0.005715864893602873,-0.34861015073987,-0.00822768467384849,0.0020117467827391877,0.013877809986703626,-0.0033085111837745096,-0.004563124883096514,0.007933117821439906,-0.1982930661118424
1627,2022-04-19,"The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu",AMGN,0.005715864893602873,-0.34861015073987,-0.00822768467384849,0.0020117467827391877,0.013877809986703626,-0.0033085111837745096,-0.004563124883096514,0.007933117821439906,-0.1982930661118424
1628,2022-04-20,"If You Invested $100 In Amgen 15 Years Ago, Here's How Much You Would Have Today",AMGN,0.007933117821439906,-0.1982930661118424,0.005715864893602873,-0.00822768467384849,0.0020117467827391877,0.013877809986703626,-0.0033085111837745096,0.00031312803626004637,0.1213918754303267
1629,2022-04-27,"Earnings Scheduled For April 27, 2022",AMGN,-0.004322241418181605,-0.10057471264367812,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,0.00031312803626004637,0.007933117821439906,-0.04284731657334617,1.222801412476879
1630,2022-04-27,Molecular Partners Regains Rights To Early-Stage Cancer Asset From Amgen,AMGN,-0.004322241418181605,-0.10057471264367812,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,0.00031312803626004637,0.007933117821439906,-0.04284731657334617,1.222801412476879
1631,2022-04-27,"The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis",AMGN,-0.004322241418181605,-0.10057471264367812,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,0.00031312803626004637,0.007933117821439906,-0.04284731657334617,1.222801412476879
1632,2022-04-28,Markets Surge Despite Drop In US GDP,AMGN,-0.04284731657334617,1.222801412476879,-0.004322241418181605,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,0.00031312803626004637,-0.02074496589493202,-0.39037748695060137
1633,2022-04-28,"Amgen's Q1 Better Than Expected Sales, Profit Overshadowed By Tax Disclosure",AMGN,-0.04284731657334617,1.222801412476879,-0.004322241418181605,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,0.00031312803626004637,-0.02074496589493202,-0.39037748695060137
1634,2022-04-28,BioMarin Achieves Record Q1 Sales Driven By Recently Approved Achondroplasia Therapy,AMGN,-0.04284731657334617,1.222801412476879,-0.004322241418181605,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,0.00031312803626004637,-0.02074496589493202,-0.39037748695060137
1635,2022-04-28,"The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates",AMGN,-0.04284731657334617,1.222801412476879,-0.004322241418181605,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,0.00031312803626004637,-0.02074496589493202,-0.39037748695060137
1636,2022-04-29,Here's How Much $100 Invested In Amgen 10 Years Ago Would Be Worth Today,AMGN,-0.02074496589493202,-0.39037748695060137,-0.04284731657334617,-0.004322241418181605,-0.009120821761802955,0.007269730954423181,-0.02000304339875536,-0.009734568483891426,0.031146849328667514
1637,2022-05-02,"The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More",AMGN,-0.009734568483891426,0.031146849328667514,-0.02074496589493202,-0.04284731657334617,-0.004322241418181605,-0.009120821761802955,0.007269730954423181,0.005499756624706809,-0.4118128429767979
1638,2022-05-06,Markets Close Turbulent Week On A Down Note,AMGN,0.00917424042806414,0.39468588960710127,-0.007412148534788665,0.01683967898692318,0.005499756624706809,-0.009734568483891426,-0.02074496589493202,0.011585670141966098,-0.06531257341791075
1639,2022-05-09,Markets Sell Off Following Last Week's Federal Reserve Decision,AMGN,0.011585670141966098,-0.06531257341791075,0.00917424042806414,-0.007412148534788665,0.01683967898692318,0.005499756624706809,-0.009734568483891426,0.006144486852162956,-0.032333249548705534
1640,2022-05-11,Executives Sell More Than $220M Of 3 Stocks,AMGN,-0.0002908077476260207,-0.19436573155757064,0.006144486852162956,0.011585670141966098,0.00917424042806414,-0.007412148534788665,0.01683967898692318,0.016954718347710562,0.09426385672831716
1641,2022-05-27,$100 Invested In Amgen 15 Years Ago Would Be Worth This Much,AMGN,0.008733472976069079,0.20546280880169188,0.00015809829664359398,0.004446311008498238,0.011444058260204004,0.00622213415238293,0.011153308765160963,0.0057979525955038635,1.5150248236216357
1642,2022-06-07,Rising Yields And A Stronger Dollar Pose Risk For Stocks,AMGN,0.003952050767080717,0.11604590462775,-0.012115045912347577,0.0006846398412576615,-0.020282485712047604,-0.012931333681275636,0.0057979525955038635,-0.003774224033217588,-0.12617863241517557
1643,2022-06-08,$100 Invested In Amgen 20 Years Ago Would Be Worth This Much Today,AMGN,-0.003774224033217588,-0.12617863241517557,0.003952050767080717,-0.012115045912347577,0.0006846398412576615,-0.020282485712047604,-0.012931333681275636,-0.01519468488255793,0.14499341518331277
1644,2022-06-24,$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today,AMGN,0.00937928361589968,0.40193832053505085,0.01228452551221837,0.0072563410355155344,0.015720885967247744,0.017381102836211637,-0.020672431672521085,-0.0021192086030245028,-0.38876250634980236
1645,2022-06-29,Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial,AMGN,0.007884647060604433,0.07419447759351461,-0.005472831487643881,-0.0021192086030245028,0.00937928361589968,0.01228452551221837,0.0072563410355155344,-0.008678536985891938,0.16219736438859944
1646,2022-07-01,"Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?",AMGN,0.009247865521635923,-0.09502933614608744,-0.008678536985891938,0.007884647060604433,-0.005472831487643881,-0.0021192086030245028,0.00937928361589968,0.0048054968961266376,-0.0953924603897286
1647,2022-07-11,Here's How Much You Would Have Made Owning Amgen Stock In The Last 10 Years,AMGN,-0.0028171284072359137,-0.18524871355060035,0.0042842297909202465,0.008848070192533308,-0.005998463857444736,0.0048054968961266376,0.009247865521635923,-0.0032690500012102497,0.49545706371191134
1648,2022-07-13,Amgen Touts Early Lumakras Combo Data In KRAS Cancer Settings,AMGN,0.00048589445181002056,-0.07457488978624083,-0.0032690500012102497,-0.0028171284072359137,0.0042842297909202465,0.008848070192533308,-0.005998463857444736,-0.006070636095025228,0.15548438751000804
1649,2022-07-18,HC Wainwright Is Bullish On DICE Therapeutics - Read Why,AMGN,-0.019502268499470454,-0.20463375512386384,0.012622710283054506,-0.006070636095025228,0.00048589445181002056,-0.0032690500012102497,-0.0028171284072359137,0.014271750381765536,0.5125033611185803
1650,2022-07-27,$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today,AMGN,0.0023094636514153777,-0.13750692082575333,0.009729831835594727,0.011262435247046287,0.0006916673529959727,-0.003446481003000046,-0.0027899232093798743,-0.007826104330353023,0.015360630932183872
1651,2022-07-27,IDEAYA's Cancer Candidate Shows Early Tumor Modulation,AMGN,0.0023094636514153777,-0.13750692082575333,0.009729831835594727,0.011262435247046287,0.0006916673529959727,-0.003446481003000046,-0.0027899232093798743,-0.007826104330353023,0.015360630932183872
1652,2022-07-28,Meta and Qualcomm Miss— Will Tech Investors Shrug Off These Reports Too?,AMGN,-0.007826104330353023,0.015360630932183872,0.0023094636514153777,0.009729831835594727,0.011262435247046287,0.0006916673529959727,-0.003446481003000046,-0.009129168643154384,0.48559429190751446
1653,2022-07-29,Big Tech Continues To Rally Despite Earnings Misses,AMGN,-0.009129168643154384,0.48559429190751446,-0.007826104330353023,0.0023094636514153777,0.009729831835594727,0.011262435247046287,0.0006916673529959727,-0.0073948713618056106,-0.4040490014287017
1654,2022-08-01,Is The Energy Ready To Rebound?,AMGN,-0.0073948713618056106,-0.4040490014287017,-0.009129168643154384,-0.007826104330353023,0.0023094636514153777,0.009729831835594727,0.011262435247046287,-0.007042826683717696,0.1706707472583524
1655,2022-08-01,"Benzinga Before The Bell: Alibaba's Delisting Concerns, Amgen's Potential $10.7B Tax Bill, Kenya Will Not Shut Facebook Services And Other Top Financial Stories Monday, August 1",AMGN,-0.0073948713618056106,-0.4040490014287017,-0.009129168643154384,-0.007826104330353023,0.0023094636514153777,0.009729831835594727,0.011262435247046287,-0.007042826683717696,0.1706707472583524
1656,2022-08-01,Amgen To Fight IRS Agency Over Tax Bill Of Whooping $10.7B: Report,AMGN,-0.0073948713618056106,-0.4040490014287017,-0.009129168643154384,-0.007826104330353023,0.0023094636514153777,0.009729831835594727,0.011262435247046287,-0.007042826683717696,0.1706707472583524
1657,2022-08-02,10 Highest Yielding Dow Jones Stocks: Which Stocks Pay Out 3.2% To 5.5% To Investors?,AMGN,-0.007042826683717696,0.1706707472583524,-0.0073948713618056106,-0.009129168643154384,-0.007826104330353023,0.0023094636514153777,0.009729831835594727,0.01324262645328611,-0.10182562851291888
1658,2022-08-02,U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now,AMGN,-0.007042826683717696,0.1706707472583524,-0.0073948713618056106,-0.009129168643154384,-0.007826104330353023,0.0023094636514153777,0.009729831835594727,0.01324262645328611,-0.10182562851291888
1659,2022-08-04,ChemoCentryx Stock More Than Doubles On $4B Buyout,AMGN,-0.000647350391623891,0.28582516736198693,0.01324262645328611,-0.007042826683717696,-0.0073948713618056106,-0.009129168643154384,-0.007826104330353023,-0.0029557853368409326,0.02765411604919632
1660,2022-08-04,"Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate",AMGN,-0.000647350391623891,0.28582516736198693,0.01324262645328611,-0.007042826683717696,-0.0073948713618056106,-0.009129168643154384,-0.007826104330353023,-0.0029557853368409326,0.02765411604919632
1661,2022-08-05,"Amgen's Q2 Sales Impacted By Lower Prices, Currency Headwind, Reaffirms FY22 Outlook",AMGN,-0.0029557853368409326,0.02765411604919632,-0.000647350391623891,0.01324262645328611,-0.007042826683717696,-0.0073948713618056106,-0.009129168643154384,0.004223334307371651,0.022210800690186883
1662,2022-08-08,Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern,AMGN,0.004223334307371651,0.022210800690186883,-0.0029557853368409326,-0.000647350391623891,0.01324262645328611,-0.007042826683717696,-0.0073948713618056106,0.004326904978877666,-0.25958913949145235
1663,2022-08-09,Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock,AMGN,0.004326904978877666,-0.25958913949145235,0.004223334307371651,-0.0029557853368409326,-0.000647350391623891,0.01324262645328611,-0.007042826683717696,0.01501854906619493,0.27502910360884747
1664,2022-08-12,Senate Finance Committee Expands Amgen's Tax Probe: Report,AMGN,0.00016100192504220345,0.28813874725520106,-0.014835921033122812,0.01501854906619493,0.004326904978877666,0.004223334307371651,-0.0029557853368409326,0.010829786673462793,-0.23171823986593854
1665,2022-08-12,$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today,AMGN,0.00016100192504220345,0.28813874725520106,-0.014835921033122812,0.01501854906619493,0.004326904978877666,0.004223334307371651,-0.0029557853368409326,0.010829786673462793,-0.23171823986593854
1666,2022-08-16,Amgen Moves to Dismiss Regeneron's Antitrust Case Regarding Cholesterol Drug,AMGN,0.008244367712112455,-0.17035839193712154,0.010829786673462793,0.00016100192504220345,-0.014835921033122812,0.01501854906619493,0.004326904978877666,-0.002507874783583386,-0.14682018040886635
1667,2022-08-23,Amgen Touts Positive Data From Soliris-Based Biosimilar For Rare Blood Disorder,AMGN,-0.009842011793087968,-0.1359841470941754,-0.01578575195248244,0.00464559276682408,-0.003511885248436597,-0.002507874783583386,0.008244367712112455,8.184929965282528e-05,-0.12426213482723614
1668,2022-08-23,Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary,AMGN,-0.009842011793087968,-0.1359841470941754,-0.01578575195248244,0.00464559276682408,-0.003511885248436597,-0.002507874783583386,0.008244367712112455,8.184929965282528e-05,-0.12426213482723614
1669,2022-08-29,"Amgen's Repatha Shows Long Term Lowering Of Bad Cholesterol, Tolerance",AMGN,-0.005277324232120573,-0.2884084326800027,-0.020473716508094708,0.004867194055906854,8.184929965282528e-05,-0.009842011793087968,-0.01578575195248244,-0.0010862125530715083,0.7382867960246096
1670,2022-08-31,"Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know",AMGN,0.004934755406098779,0.171766947998911,-0.0010862125530715083,-0.005277324232120573,-0.020473716508094708,0.004867194055906854,8.184929965282528e-05,0.02163959693358697,-0.42187318478589186
1671,2022-09-01,Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years,AMGN,0.02163959693358697,-0.42187318478589186,0.004934755406098779,-0.0010862125530715083,-0.005277324232120573,-0.020473716508094708,0.004867194055906854,-0.012749454775399793,-0.06554939313560004
1672,2022-09-12,"Livent, Amgen And Some Other Big Stocks Moving Lower On Monday",AMGN,-0.040655690844941694,1.7155306298533217,0.009126099646005414,0.002696229647369597,0.010610182942198287,-0.0006189008007149166,-0.012749454775399793,-0.045282359453958976,-0.2934896578019255
1673,2022-09-12,Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis,AMGN,-0.040655690844941694,1.7155306298533217,0.009126099646005414,0.002696229647369597,0.010610182942198287,-0.0006189008007149166,-0.012749454775399793,-0.045282359453958976,-0.2934896578019255
1674,2022-09-12,"Top Financial Stories Monday, September 12: Netflix Collaborates With Assassin's Creed Maker, Gun Sales Could Soon Be Tracked Via Payment Processors, Xi Jinping To Meet Vladimir Putin In First Foreign Trip And More...",AMGN,-0.040655690844941694,1.7155306298533217,0.009126099646005414,0.002696229647369597,0.010610182942198287,-0.0006189008007149166,-0.012749454775399793,-0.045282359453958976,-0.2934896578019255
1675,2022-09-12,Amgen's Lumakras Cuts Risk Of Progression By 34% In KRAS-Mutated Lung Cancer Patients,AMGN,-0.040655690844941694,1.7155306298533217,0.009126099646005414,0.002696229647369597,0.010610182942198287,-0.0006189008007149166,-0.012749454775399793,-0.045282359453958976,-0.2934896578019255
1676,2022-09-13,Biden Administration Pushes 'Cancer Moonshot' Initiative: Report,AMGN,-0.045282359453958976,-0.2934896578019255,-0.040655690844941694,0.009126099646005414,0.002696229647369597,0.010610182942198287,-0.0006189008007149166,0.0055540464131433875,-0.3893685914732865
1677,2022-09-14,"US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing",AMGN,0.0055540464131433875,-0.3893685914732865,-0.045282359453958976,-0.040655690844941694,0.009126099646005414,0.002696229647369597,0.010610182942198287,-0.0020164412183740765,-0.18761967889232578
1678,2022-09-16,Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report,AMGN,0.01528594365146052,1.086986084039708,-0.0020164412183740765,0.0055540464131433875,-0.045282359453958976,-0.040655690844941694,0.009126099646005414,-0.0016440177521998,-0.569644447340414
1679,2022-09-21,$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today,AMGN,-0.01427255123469895,0.25224812417664233,-0.013217189640832294,-0.0016440177521998,0.01528594365146052,-0.0020164412183740765,0.0055540464131433875,0.014657360226451477,-0.04807208525819884
1680,2022-10-03,The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short,AMGN,0.0223602252127022,-0.00853188645120706,-0.013178034189426091,-0.011126497757126264,0.02208059553166075,-0.003878773221400622,-0.0004406639172461757,0.011195953534956615,-0.07562358726256102
1681,2022-10-06,$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today,AMGN,-0.012317172868969828,-0.2604348670161134,0.003433250071786631,0.011195953534956615,0.0223602252127022,-0.013178034189426091,-0.011126497757126264,-0.008270630115410404,0.3518834492715579
1682,2022-10-11,A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading,AMGN,0.05724748665043844,2.8378013618796394,0.01362271101958279,-0.008270630115410404,-0.012317172868969828,0.003433250071786631,0.011195953534956615,0.00407433336065588,-0.578037084398977
1683,2022-10-11,"DICE Therapeutics, Amgen And Some Other Big Stocks Moving Higher On Tuesday",AMGN,0.05724748665043844,2.8378013618796394,0.01362271101958279,-0.008270630115410404,-0.012317172868969828,0.003433250071786631,0.011195953534956615,0.00407433336065588,-0.578037084398977
1684,2022-10-11,"US Stocks Headed For Another Tough Trading Day As S&P 500, Nasdaq Futures Plunge; Apple, Chip and Energy Stocks In Focus",AMGN,0.05724748665043844,2.8378013618796394,0.01362271101958279,-0.008270630115410404,-0.012317172868969828,0.003433250071786631,0.011195953534956615,0.00407433336065588,-0.578037084398977
1685,2022-10-11,Apple To $155? Plus Morgan Stanley Cuts Price Target On Zoom Video,AMGN,0.05724748665043844,2.8378013618796394,0.01362271101958279,-0.008270630115410404,-0.012317172868969828,0.003433250071786631,0.011195953534956615,0.00407433336065588,-0.578037084398977
1686,2022-10-14,Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts,AMGN,-0.0012715575378862143,-0.12907050989692603,0.02118158165226869,0.00407433336065588,0.05724748665043844,0.01362271101958279,-0.008270630115410404,0.006326107073362897,-0.10030023739701155
1687,2022-10-21,Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years,AMGN,0.018145077943491517,0.7158406219630709,-0.0029815960881539594,-0.015587781925235356,-0.0032025185310194937,0.006326107073362897,-0.0012715575378862143,0.03723117630466488,-0.1835070231082918
1688,2022-11-03,"US Stocks In For Another Tough Day After Fed Rate Hike As Nasdaq, S&P 500 Futures Fall — Roku, Qualcomm Plunge On Earnings Disappointment",AMGN,-0.01163527919161933,0.053918780571038605,-0.011210757477854716,0.006325076095149873,-0.012636456625119474,0.024622914996504264,0.0021375725810397483,0.011885111059449116,0.2239611440906637
1689,2022-11-04,"Amgen Reports Q3 Higher Profit, Despite Slight Fall In Topline Growth",AMGN,0.011885111059449116,0.2239611440906637,-0.01163527919161933,-0.011210757477854716,0.006325076095149873,-0.012636456625119474,0.024622914996504264,0.029660937857541647,-0.13971193415637861
1690,2022-11-04,"Musk Reportedly Suspends Twitter Work On Crypto Wallet, Boeing's Jeppesen Hit By Potential Ransomware Attack, Lyft Cuts Workforce: Top Stories Friday, Nov. 04",AMGN,0.011885111059449116,0.2239611440906637,-0.01163527919161933,-0.011210757477854716,0.006325076095149873,-0.012636456625119474,0.024622914996504264,0.029660937857541647,-0.13971193415637861
1691,2022-11-07,Amgen's Olpasiran Reduced Cholesterol Levels In 95% Of Patients In Mid-Stage Study,AMGN,0.029660937857541647,-0.13971193415637861,0.011885111059449116,-0.01163527919161933,-0.011210757477854716,0.006325076095149873,-0.012636456625119474,0.055483435493164146,1.3614651313766357
1692,2022-11-18,Credit Suisse Sets Bearish Tone For Amgen; Says Current Setup Not Ideal For Growth,AMGN,-3.471943163002589e-05,0.09194290976058928,0.012439665020846702,0.007491183226570275,-0.005958541200476564,0.00098242852677477,-0.020583532066525523,0.003028196800857641,0.17852173546401318
1693,2022-11-22,$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today,AMGN,-0.0038520776539537893,0.30084791241816045,0.003028196800857641,-3.471943163002589e-05,0.012439665020846702,0.007491183226570275,-0.005958541200476564,-0.012715484164284918,-0.20913091309130916
1694,2022-11-30,Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout,AMGN,0.01563889101479976,1.705099985950452,-0.0022291005078902693,-0.003947239216541498,0.0011996386418564597,-0.012715484164284918,-0.0038520776539537893,-0.001606197415228272,-0.49541220871853464
1695,2022-11-30,"iPhone Pro Shipments May Miss Consensus, Tesla Rival Charts Ambitious Expansion Plan In Mexico, Amazon Cloud Unit To Add More Employees: Top Stories Wednesday, Nov. 30",AMGN,0.01563889101479976,1.705099985950452,-0.0022291005078902693,-0.003947239216541498,0.0011996386418564597,-0.012715484164284918,-0.0038520776539537893,-0.001606197415228272,-0.49541220871853464
1696,2022-11-30,Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies,AMGN,0.01563889101479976,1.705099985950452,-0.0022291005078902693,-0.003947239216541498,0.0011996386418564597,-0.012715484164284918,-0.0038520776539537893,-0.001606197415228272,-0.49541220871853464
1697,2022-12-02,"If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash",AMGN,-0.0015038047325651727,-0.22219172442187607,-0.001606197415228272,0.01563889101479976,-0.0022291005078902693,-0.003947239216541498,0.0011996386418564597,-0.0021015099730337106,0.44450816056462283
1698,2022-12-02,"Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors",AMGN,-0.0015038047325651727,-0.22219172442187607,-0.001606197415228272,0.01563889101479976,-0.0022291005078902693,-0.003947239216541498,0.0011996386418564597,-0.0021015099730337106,0.44450816056462283
1699,2022-12-06,"Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy",AMGN,-0.005685993750593643,-0.2033468714691422,-0.0021015099730337106,-0.0015038047325651727,-0.001606197415228272,0.01563889101479976,-0.0022291005078902693,0.00871904199430995,-0.0445415516712665
1700,2022-12-08,Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration,AMGN,-0.0006649479865661334,-0.28997833587418764,0.00871904199430995,-0.005685993750593643,-0.0021015099730337106,-0.0015038047325651727,-0.001606197415228272,-0.02423230793993414,0.24629901683806077
1701,2022-12-12,Here's Where Amgen's Loan To Acquire Horizon Therapeutics For $28B Ranks Among M&A Deals In 2022,AMGN,-0.006710872541593305,0.5538831210046697,-0.02423230793993414,-0.0006649479865661334,0.00871904199430995,-0.005685993750593643,-0.0021015099730337106,-0.016330591249803628,0.1295150843204762
1702,2022-12-12,"Tesla, Apple, Rivian, Horizon, Paypal: Why These 5 Stocks Are Drawing Investors' Attention Today",AMGN,-0.006710872541593305,0.5538831210046697,-0.02423230793993414,-0.0006649479865661334,0.00871904199430995,-0.005685993750593643,-0.0021015099730337106,-0.016330591249803628,0.1295150843204762
1703,2022-12-12,"Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share",AMGN,-0.006710872541593305,0.5538831210046697,-0.02423230793993414,-0.0006649479865661334,0.00871904199430995,-0.005685993750593643,-0.0021015099730337106,-0.016330591249803628,0.1295150843204762
1704,2022-12-12,"Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12",AMGN,-0.006710872541593305,0.5538831210046697,-0.02423230793993414,-0.0006649479865661334,0.00871904199430995,-0.005685993750593643,-0.0021015099730337106,-0.016330591249803628,0.1295150843204762
1705,2022-12-13,Cramers Says These 3 Big Deals Aided Monday's Market Rally: 'When Companies Start Buying Each Other At A Big Premium...',AMGN,-0.016330591249803628,0.1295150843204762,-0.006710872541593305,-0.02423230793993414,-0.0006649479865661334,0.00871904199430995,-0.005685993750593643,-0.0041504267349720125,-0.019709141632009874
1706,2022-12-13,"Nasdaq, S&P 500 Futures Skyrocket As Consumer Price Inflation Cools Off Notably In November: Oracle, Tesla, Pinterest Among Early Movers",AMGN,-0.016330591249803628,0.1295150843204762,-0.006710872541593305,-0.02423230793993414,-0.0006649479865661334,0.00871904199430995,-0.005685993750593643,-0.0041504267349720125,-0.019709141632009874
1707,2022-12-13,Pinterest To Rally Around 23%? Here Are 10 Other Price Target Changes For Tuesday,AMGN,-0.016330591249803628,0.1295150843204762,-0.006710872541593305,-0.02423230793993414,-0.0006649479865661334,0.00871904199430995,-0.005685993750593643,-0.0041504267349720125,-0.019709141632009874
1708,2022-12-22,Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday,AMGN,-0.0037557788662339053,-0.037870685464268306,0.005703593387097028,-0.0035755216851601768,-0.006394622452132737,0.004771858079473779,-0.018404460046664295,-0.005051614677108129,-0.2595118993481885
1709,2022-12-27,"If You Invested $100 In This Stock 20 Years Ago, You Would Have $500 Today",AMGN,-0.002008158149774175,0.09498464687819852,-0.005051614677108129,-0.0037557788662339053,0.005703593387097028,-0.0035755216851601768,-0.006394622452132737,-0.007479442316398077,-0.1590328410294759
1710,2022-12-29,10 Highest-Yielding Dow Jones Stocks Heading Into 2023,AMGN,0.006655967123163853,0.07180437198962575,-0.007479442316398077,-0.002008158149774175,-0.005051614677108129,-0.0037557788662339053,0.005703593387097028,-0.001976053382337528,0.12140486725663724
1711,2023-01-10,Illumina Shares Tank After Annual Guidance Fall Short Of Expectations,AMGN,0.013919780640733181,-0.17461933632619053,-0.018459380569741946,0.03125244072266975,0.009342208561496257,0.01047206910906695,-0.003769449024171423,-0.0035416850268793487,0.14634966917124603
1712,2023-01-10,$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today,AMGN,0.013919780640733181,-0.17461933632619053,-0.018459380569741946,0.03125244072266975,0.009342208561496257,0.01047206910906695,-0.003769449024171423,-0.0035416850268793487,0.14634966917124603
1713,2023-01-19,Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide,AMGN,-0.00892626957457543,-0.057526712050854356,-0.01866971082756841,-0.008501154458882887,0.002989805683085267,-0.007291748100663131,-0.0035416850268793487,0.00461782973634195,0.23133221717292507
1714,2023-01-30,Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years,AMGN,-0.008121427675422788,-0.031802455092658444,-0.004825883539941955,-0.0064707401505709194,-0.012167919710365571,-0.004866392165546296,-0.008623294883868038,0.003219516904819253,0.6733405130213432
1715,2023-01-31,"Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times",AMGN,0.003219516904819253,0.6733405130213432,-0.008121427675422788,-0.004825883539941955,-0.0064707401505709194,-0.012167919710365571,-0.004866392165546296,-0.02373211124905905,0.563554983471316
1716,2023-02-01,Why Amgen Shares Are Falling,AMGN,-0.02373211124905905,0.563554983471316,0.003219516904819253,-0.008121427675422788,-0.004825883539941955,-0.0064707401505709194,-0.012167919710365571,0.00048695744304305677,0.02701741912548883
1717,2023-02-01,Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline,AMGN,-0.02373211124905905,0.563554983471316,0.003219516904819253,-0.008121427675422788,-0.004825883539941955,-0.0064707401505709194,-0.012167919710365571,0.00048695744304305677,0.02701741912548883
1718,2023-02-03,Top 5 Health Care Stocks That May Rally,AMGN,-0.005516581150813105,-0.4401632325882203,0.00048695744304305677,-0.02373211124905905,0.003219516904819253,-0.008121427675422788,-0.004825883539941955,-0.005383937870549915,-0.2850959973966808
1719,2023-02-13,$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today,AMGN,0.004783555811187501,-0.13594075617743373,0.010416682033295155,-0.0008326637459884489,-0.015573782799038871,0.0006151028195116037,-0.005383937870549915,-0.0020701992701834815,-0.13178862138765668
1720,2023-02-13,Top 5 Health Care Stocks That Could Blast Off This Month,AMGN,0.004783555811187501,-0.13594075617743373,0.010416682033295155,-0.0008326637459884489,-0.015573782799038871,0.0006151028195116037,-0.005383937870549915,-0.0020701992701834815,-0.13178862138765668
1721,2023-02-16,"Devon Energy, Broadcom, Amgen And This Company Report Earnings Next Week: CNBC's 'Final Trades'",AMGN,-0.024367917378429915,0.845903661750687,-0.0039828712605900485,-0.0020701992701834815,0.004783555811187501,0.010416682033295155,-0.0008326637459884489,0.02694047274232525,-0.09529740567470679
1722,2023-03-01,A Look Into Amgen's Debt,AMGN,0.01955451397602559,-0.06667431280345604,-0.011900163456810553,0.0033809521259582365,-0.016665228248679886,0.006182213043860907,-0.00873069922387304,,
